id.exposure	id.outcome	outcome	exposure	method	Q	Q_df	Q_pval
063OaL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	56.4835681921348	28	0.00112265420371613
063OaL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	54.8784573156933	27	0.00118630127416122
063OaL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	56.4909252798548	28	0.00112032444330438
063OaL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0561508431385474	28	1
063OaL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	44.8194751188158	28	0.0230091128538707
063OaL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	43.9279266329038	27	0.0210350217204549
063OaL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	44.836539140286	28	0.0229180699950933
063OaL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0621209246380914	28	1
063OaL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	41.87784069212	27	0.0338393509105864
063OaL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	40.3357827774363	26	0.0361504478190716
063OaL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	41.9339220406155	27	0.0334123071519267
063OaL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.379482339100468	27	1
07G1yd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	72.1460192149771	54	0.050058981278763
07G1yd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	71.7859745983218	53	0.0438130570183041
07G1yd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	72.1766741530087	54	0.0498081655255665
07G1yd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0972929064452983	54	1
07G1yd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	66.5483244562602	54	0.117432643838223
07G1yd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	65.8148308174878	53	0.11121257752138
07G1yd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	66.5566190327121	54	0.117295887133663
07G1yd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.109742978553928	54	1
07G1yd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	64.9733563416771	51	0.0903019185582314
07G1yd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	64.8804755651547	50	0.0767985606171117
07G1yd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	65.1103741017723	51	0.0884373539699043
07G1yd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.953447519753482	51	1
0NkkFm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int.imputed.txt_snps.txt	Maximum likelihood	83.9393267450036	62	0.0332688894130181
0NkkFm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int.imputed.txt_snps.txt	MR Egger	83.0236154774766	61	0.0319206862332691
0NkkFm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int.imputed.txt_snps.txt	Inverse variance weighted	83.9419835838008	62	0.0332544195562789
0NkkFm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_int.imputed.txt_snps.txt	Unweighted regression	0.104896550336067	62	1
0NkkFm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int.imputed.txt_snps.txt	Maximum likelihood	79.7199583562337	62	0.0643253271820102
0NkkFm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int.imputed.txt_snps.txt	MR Egger	79.7188692656712	61	0.0541346445319369
0NkkFm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int.imputed.txt_snps.txt	Inverse variance weighted	79.7273258978592	62	0.0642549263696394
0NkkFm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_int.imputed.txt_snps.txt	Unweighted regression	0.130479117993307	62	1
0NkkFm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int.imputed.txt_snps.txt	Maximum likelihood	63.4740671540176	58	0.289594873944719
0NkkFm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int.imputed.txt_snps.txt	MR Egger	63.4247344554712	57	0.260297404326658
0NkkFm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int.imputed.txt_snps.txt	Inverse variance weighted	63.4741155843029	58	0.2895934265589
0NkkFm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_int.imputed.txt_snps.txt	Unweighted regression	0.576535312662381	58	1
0NNzig	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	97.8735378169107	67	0.00826543000733328
0NNzig	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	96.1426677222319	66	0.009099840918905
0NNzig	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	97.8817451367455	67	0.00825297721851382
0NNzig	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0969763054337327	67	1
0NNzig	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	84.8463063706511	67	0.0695377078570224
0NNzig	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	82.7654737155282	66	0.0795342516894516
0NNzig	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	84.8719514440428	67	0.0692850730022576
0NNzig	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.116277241741096	67	1
0NNzig	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	88.6623399413473	64	0.0223751138537936
0NNzig	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	88.4900200663082	63	0.0188131338888787
0NNzig	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	88.6646114533788	64	0.0223664961491219
0NNzig	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.737590809315052	64	1
0TZISn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetate_int.imputed.txt_snps.txt	Maximum likelihood	30.3784936152257	8	0.000181162295516598
0TZISn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetate_int.imputed.txt_snps.txt	MR Egger	28.3258427482587	7	0.000191913001956669
0TZISn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetate_int.imputed.txt_snps.txt	Inverse variance weighted	31.6441478648452	8	0.000107847071567299
0TZISn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetate_int.imputed.txt_snps.txt	Unweighted regression	0.0109511643151132	8	0.999999999962709
0TZISn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetate_int.imputed.txt_snps.txt	Maximum likelihood	27.4097081766582	8	0.000600539683166396
0TZISn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetate_int.imputed.txt_snps.txt	MR Egger	22.5945651675421	7	0.00200488315196104
0TZISn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetate_int.imputed.txt_snps.txt	Inverse variance weighted	28.5242134327169	8	0.000384181819488159
0TZISn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetate_int.imputed.txt_snps.txt	Unweighted regression	0.0137770155753799	8	0.999999999906697
0TZISn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetate_int.imputed.txt_snps.txt	Maximum likelihood	12.8382809837076	8	0.117536313185373
0TZISn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetate_int.imputed.txt_snps.txt	MR Egger	12.7627839664283	7	0.0781034168103466
0TZISn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetate_int.imputed.txt_snps.txt	Inverse variance weighted	12.8864639838084	8	0.115816190663372
0TZISn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetate_int.imputed.txt_snps.txt	Unweighted regression	0.111218556274508	8	0.999999618868266
1gaErX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	71.0325952693597	54	0.0599256191611629
1gaErX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	70.6847652861297	53	0.052604062886862
1gaErX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	71.0379507462891	54	0.0598745003073518
1gaErX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0828307445226048	54	1
1gaErX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	66.2947262311674	54	0.12167398446635
1gaErX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	66.2173564392739	53	0.10494163585323
1gaErX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	66.2947386611118	54	0.121673773711967
1gaErX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.111575538476871	54	1
1gaErX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	51.6981801169048	54	0.56367144378446
1gaErX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	49.4376326671701	53	0.613670978677448
1gaErX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	51.7175605784697	54	0.562916026896505
1gaErX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.578432943240069	54	1
2j3DdV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	121.988616635009	77	0.00083521941242242
2j3DdV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	121.973980521551	76	0.000647054087426471
2j3DdV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	122.031031475259	77	0.000828035312147208
2j3DdV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0976478360001998	77	1
2j3DdV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	123.683556341089	77	0.000589553190951282
2j3DdV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	123.578521584371	76	0.000462593540726236
2j3DdV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	123.70379102694	77	0.000587084125325529
2j3DdV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.164241259040146	77	1
2j3DdV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	89.1706934660026	75	0.12611933514052
2j3DdV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	84.184561383982	74	0.196051665127722
2j3DdV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	89.1815789773765	75	0.125955359625657
2j3DdV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.68415761504159	75	1
2O58DB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	125.784001815441	77	0.000379544032813312
2O58DB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int.imputed.txt_snps.txt	MR Egger	124.736881519613	76	0.000361802511432856
2O58DB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	125.789787473015	77	0.000379078931013002
2O58DB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.181894052267983	77	1
2O58DB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	113.914502158515	77	0.00400681857809311
2O58DB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int.imputed.txt_snps.txt	MR Egger	112.410301583053	76	0.0042274173017077
2O58DB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	113.916838031356	77	0.0040050927366784
2O58DB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.220057916595336	77	1
2O58DB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	110.895485947134	72	0.00221524389479972
2O58DB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int.imputed.txt_snps.txt	MR Egger	110.909820377767	71	0.0017251783260903
2O58DB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	110.91699480333	72	0.00220587301430036
2O58DB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	1.50913369255768	72	1
31dlA4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	104.303575803609	74	0.0116762562257196
31dlA4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int.imputed.txt_snps.txt	MR Egger	103.116213274937	73	0.0116762332545177
31dlA4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	104.361550001433	74	0.0115608635156238
31dlA4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0887318772414273	74	1
31dlA4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	102.97582853344	74	0.0146204922644154
31dlA4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int.imputed.txt_snps.txt	MR Egger	98.9999886877889	73	0.0231444241392462
31dlA4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	103.038883624156	74	0.0144668290099734
31dlA4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.124341808826595	74	1
31dlA4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	111.507035469796	72	0.00196282309290423
31dlA4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int.imputed.txt_snps.txt	MR Egger	107.981633560715	71	0.00307644294571487
31dlA4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	111.68258114258	72	0.00189550522128897
31dlA4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_pct_int.imputed.txt_snps.txt	Unweighted regression	1.224057630268	72	1
3EmDe6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	123.299061771635	87	0.00637500147948641
3EmDe6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	121.412776924471	86	0.00717402398953527
3EmDe6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	123.299698658716	87	0.00637431310400764
3EmDe6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.123622035815966	87	1
3EmDe6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	126.547617685476	87	0.00362919901083275
3EmDe6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	123.98762744703	86	0.00461002291422643
3EmDe6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	126.557706898335	87	0.00362271459693905
3EmDe6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.159748744816179	87	1
3EmDe6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	95.2215470177445	84	0.189192870297292
3EmDe6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	94.0853188180938	83	0.190504866536641
3EmDe6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	95.2512996634494	84	0.188622132759281
3EmDe6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.653265766303029	84	1
3mvu3r	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	116.428899146378	65	9.37981230644237e-05
3mvu3r	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int.imputed.txt_snps.txt	MR Egger	116.395616664097	64	6.86719897471854e-05
3mvu3r	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	116.429150761516	65	9.3792499007438e-05
3mvu3r	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0957432352890188	65	1
3mvu3r	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	115.081236937447	65	0.000129071767781887
3mvu3r	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int.imputed.txt_snps.txt	MR Egger	112.530701537666	64	0.000172397036018928
3mvu3r	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	115.081236937447	65	0.000129071767781887
3mvu3r	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.132047999205884	65	1
3mvu3r	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	93.0616109418662	63	0.00821813972674844
3mvu3r	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int.imputed.txt_snps.txt	MR Egger	93.0212761126549	62	0.00656558736420142
3mvu3r	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	93.1501139960511	63	0.00808229415517609
3mvu3r	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.95668419364441	63	1
3ZQeYV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int.imputed.txt_snps.txt	Maximum likelihood	32.24351738779	33	0.504589219539121
3ZQeYV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int.imputed.txt_snps.txt	MR Egger	32.1741687099624	32	0.458128703138257
3ZQeYV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	32.2502400031124	33	0.504254551333818
3ZQeYV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0754400103373424	33	1
3ZQeYV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int.imputed.txt_snps.txt	Maximum likelihood	31.1065113888671	33	0.561633309679866
3ZQeYV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int.imputed.txt_snps.txt	MR Egger	30.9706444190619	32	0.518502921268823
3ZQeYV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	31.1267779757267	33	0.5606121054866
3ZQeYV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.156888910594252	33	1
3ZQeYV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int.imputed.txt_snps.txt	Maximum likelihood	37.0246475978678	32	0.248142848276396
3ZQeYV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int.imputed.txt_snps.txt	MR Egger	36.8545044985564	31	0.21627868014761
3ZQeYV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	37.0425281102006	32	0.247502235175853
3ZQeYV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.83658368202537	32	1
47gbHp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	99.2170131036658	79	0.0617039404985348
47gbHp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	98.8257599003243	78	0.0558216003218409
47gbHp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	99.2261329124958	79	0.0616280330476604
47gbHp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0760851548175363	79	1
47gbHp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	109.410178209222	79	0.0133577333196776
47gbHp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	109.305360899689	78	0.0111682538172948
47gbHp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	109.42281078669	79	0.0133299781344059
47gbHp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.128817199615619	79	1
47gbHp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	94.0472329679981	75	0.067645499895326
47gbHp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	92.1387118974963	74	0.0752343084544481
47gbHp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	94.0636918156514	75	0.0674944089415102
47gbHp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.781161257170324	75	1
4AkaQH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	149.758263693649	90	7.85446888312171e-05
4AkaQH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	149.784547848118	89	5.91700984870298e-05
4AkaQH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	149.804155208723	90	7.77749718507218e-05
4AkaQH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.173026154796218	90	1
4AkaQH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	140.439698459789	90	0.000534949781214816
4AkaQH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	140.280625579266	89	0.000431157788926062
4AkaQH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	140.440475602524	90	0.000534867938094535
4AkaQH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.181075073180793	90	1
4AkaQH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	116.856369646482	88	0.0215072745824246
4AkaQH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	115.501008836585	87	0.0221693932331858
4AkaQH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	116.987004799188	88	0.0210905353482152
4AkaQH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	1.64449734124394	88	1
4LVK7F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	123.730569011905	73	0.000194697956693934
4LVK7F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int.imputed.txt_snps.txt	MR Egger	122.340676749177	72	0.000198925782643977
4LVK7F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	123.751622910993	73	0.000193787896756196
4LVK7F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.113633895169302	73	1
4LVK7F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	120.035480635948	73	0.000436625417353478
4LVK7F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int.imputed.txt_snps.txt	MR Egger	119.222577643653	72	0.000395049336240833
4LVK7F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	120.041936822932	73	0.000436020999084387
4LVK7F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.163582070413384	73	1
4LVK7F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	83.6428566634639	69	0.110535616938204
4LVK7F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int.imputed.txt_snps.txt	MR Egger	82.5507343688348	68	0.11035236286772
4LVK7F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	83.6719973400123	69	0.110124412566711
4LVK7F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.671732646778993	69	1
5CTKrK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	117.612348162844	96	0.0663812391087645
5CTKrK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int.imputed.txt_snps.txt	MR Egger	117.594779339332	95	0.0579474030126418
5CTKrK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	117.627381253879	96	0.0662591424950724
5CTKrK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.104641264449995	96	1
5CTKrK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	127.236715680159	96	0.0180973983663535
5CTKrK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int.imputed.txt_snps.txt	MR Egger	124.689566894527	95	0.0221905192493371
5CTKrK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	127.237011935412	96	0.0180966090815874
5CTKrK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.203858927846883	96	1
5CTKrK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	104.274415551025	95	0.241926880716634
5CTKrK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int.imputed.txt_snps.txt	MR Egger	98.3861641714468	94	0.358112008230108
5CTKrK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	104.326735904348	95	0.240815067663816
5CTKrK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.715704937799153	95	1
5dXgNC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int.imputed.txt_snps.txt	Maximum likelihood	63.8598175289886	39	0.00725259992215081
5dXgNC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int.imputed.txt_snps.txt	MR Egger	63.8171711214145	38	0.0054461345810853
5dXgNC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int.imputed.txt_snps.txt	Inverse variance weighted	63.8634006695767	39	0.0072466994993784
5dXgNC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_3_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0768440465153189	39	1
5dXgNC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int.imputed.txt_snps.txt	Maximum likelihood	58.0976698337089	39	0.0251141329731114
5dXgNC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int.imputed.txt_snps.txt	MR Egger	58.0874672648485	38	0.0195065039659326
5dXgNC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int.imputed.txt_snps.txt	Inverse variance weighted	58.1000761855766	39	0.025101844274484
5dXgNC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_3_pct_int.imputed.txt_snps.txt	Unweighted regression	0.13792372777738	39	1
5dXgNC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int.imputed.txt_snps.txt	Maximum likelihood	32.0779399175192	38	0.73910659067136
5dXgNC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int.imputed.txt_snps.txt	MR Egger	30.8205127918162	37	0.753021455853462
5dXgNC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int.imputed.txt_snps.txt	Inverse variance weighted	32.0838150209908	38	0.738861536084121
5dXgNC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_3_pct_int.imputed.txt_snps.txt	Unweighted regression	0.492368863982476	38	1
5imWff	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	119.042104074706	87	0.0128313228739307
5imWff	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int.imputed.txt_snps.txt	MR Egger	117.125196779997	86	0.0144471392075172
5imWff	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	119.043538206771	87	0.0128283973703981
5imWff	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0790159017332787	87	1
5imWff	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	126.0177010561	87	0.00398528259640276
5imWff	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int.imputed.txt_snps.txt	MR Egger	125.55690259347	86	0.00349366129430939
5imWff	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	126.024272586485	87	0.00398067553093998
5imWff	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.140281203527541	87	1
5imWff	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	115.704227352971	85	0.0150386486704467
5imWff	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int.imputed.txt_snps.txt	MR Egger	101.175991865912	84	0.0976735403982072
5imWff	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	115.710147304335	85	0.015024596618043
5imWff	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.836895683690315	85	1
5PqiW0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int.imputed.txt_snps.txt	Maximum likelihood	129.068943732461	69	1.59551522716596e-05
5PqiW0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int.imputed.txt_snps.txt	MR Egger	127.440008473237	68	1.70878423327089e-05
5PqiW0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int.imputed.txt_snps.txt	Inverse variance weighted	129.082083687565	69	1.59032593193209e-05
5PqiW0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0779699920855759	69	1
5PqiW0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int.imputed.txt_snps.txt	Maximum likelihood	128.250787282371	69	1.95307818427184e-05
5PqiW0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int.imputed.txt_snps.txt	MR Egger	125.145373560698	68	3.00774481570374e-05
5PqiW0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int.imputed.txt_snps.txt	Inverse variance weighted	128.251704657231	69	1.95263677382464e-05
5PqiW0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_PL_int.imputed.txt_snps.txt	Unweighted regression	0.111347810872	69	1
5PqiW0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int.imputed.txt_snps.txt	Maximum likelihood	92.7529083222869	69	0.0298495008519321
5PqiW0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int.imputed.txt_snps.txt	MR Egger	92.2532521020088	68	0.0268343993059266
5PqiW0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int.imputed.txt_snps.txt	Inverse variance weighted	92.753131927628	69	0.0298484402647468
5PqiW0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_PL_int.imputed.txt_snps.txt	Unweighted regression	0.767831908929834	69	1
5zLeiS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int.imputed.txt_snps.txt	Maximum likelihood	112.89516117028	64	0.000158282467691407
5zLeiS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int.imputed.txt_snps.txt	MR Egger	111.88072080625	63	0.000147305777227124
5zLeiS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int.imputed.txt_snps.txt	Inverse variance weighted	112.960412254893	64	0.000155875458033446
5zLeiS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0738308318104802	64	1
5zLeiS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int.imputed.txt_snps.txt	Maximum likelihood	104.665329645967	64	0.00101105086602937
5zLeiS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int.imputed.txt_snps.txt	MR Egger	104.593027600835	63	0.000777935482219373
5zLeiS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int.imputed.txt_snps.txt	Inverse variance weighted	104.714306394219	64	0.00100043531233246
5zLeiS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_CE_int.imputed.txt_snps.txt	Unweighted regression	0.10729216171823	64	1
5zLeiS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int.imputed.txt_snps.txt	Maximum likelihood	84.6320457678392	62	0.0296770137364154
5zLeiS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int.imputed.txt_snps.txt	MR Egger	84.0585616981873	61	0.0268404259830603
5zLeiS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int.imputed.txt_snps.txt	Inverse variance weighted	84.6823335165439	62	0.029430004445743
5zLeiS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_CE_int.imputed.txt_snps.txt	Unweighted regression	0.698267479683142	62	1
6CEpv0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	122.709830706593	71	0.000136509180262554
6CEpv0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	119.872853989438	70	0.000193394984569385
6CEpv0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	122.75300333574	71	0.000135172023572842
6CEpv0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.104101394318501	71	1
6CEpv0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	101.563517386466	71	0.0101027633181979
6CEpv0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	99.1914601745789	70	0.0124220128833696
6CEpv0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	101.632521629492	71	0.0099804492294321
6CEpv0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.13111637542505	71	1
6CEpv0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	97.5197569647106	69	0.01350828277671
6CEpv0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	95.5927356546507	68	0.0153524277129197
6CEpv0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	97.5211771685582	69	0.0135049531516882
6CEpv0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	1.10163677877847	69	1
6XXdiF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	92.3581692706373	80	0.16283372527923
6XXdiF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	92.0924650233634	79	0.14884319897706
6XXdiF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	92.3874533436835	80	0.162316633328514
6XXdiF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.128384747453465	80	1
6XXdiF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	94.749486131629	80	0.124414323514027
6XXdiF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	93.077408919595	79	0.133090658800752
6XXdiF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	94.7731470808403	80	0.124071791471024
6XXdiF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.188956787836883	80	1
6XXdiF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	109.798824120482	79	0.012527236216623
6XXdiF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	109.195218956825	78	0.0113771480820271
6XXdiF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	109.892301942234	79	0.0123345582781934
6XXdiF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	1.18844928294416	79	1
75Af9Z	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int.imputed.txt_snps.txt	Maximum likelihood	89.1150649479954	64	0.0207146469669024
75Af9Z	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int.imputed.txt_snps.txt	MR Egger	88.8752868701384	63	0.0175894531650989
75Af9Z	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int.imputed.txt_snps.txt	Inverse variance weighted	89.1198689574738	64	0.0206976309459915
75Af9Z	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_int.imputed.txt_snps.txt	Unweighted regression	0.0418537043446466	64	1
75Af9Z	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int.imputed.txt_snps.txt	Maximum likelihood	79.3463997573434	64	0.0935976108752086
75Af9Z	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int.imputed.txt_snps.txt	MR Egger	78.11467182757	63	0.0950790057225716
75Af9Z	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int.imputed.txt_snps.txt	Inverse variance weighted	79.3729570349173	64	0.093257935799682
75Af9Z	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_int.imputed.txt_snps.txt	Unweighted regression	0.0722965093224877	64	1
75Af9Z	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int.imputed.txt_snps.txt	Maximum likelihood	64.3457280289392	62	0.394433795323817
75Af9Z	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int.imputed.txt_snps.txt	MR Egger	61.3567693698029	61	0.463105734846053
75Af9Z	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int.imputed.txt_snps.txt	Inverse variance weighted	64.4239994909564	62	0.391800310992072
75Af9Z	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_int.imputed.txt_snps.txt	Unweighted regression	0.482003000900419	62	1
7eTTWW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	101.339385007525	73	0.0157832579931716
7eTTWW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	100.141929571984	72	0.0158324485805304
7eTTWW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	101.341790519416	73	0.0157769160984697
7eTTWW	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.153371806961181	73	1
7eTTWW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	99.3973395262432	73	0.0217122651253615
7eTTWW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	97.9461168151468	72	0.0227300415183538
7eTTWW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	99.3973395262432	73	0.0217122651253615
7eTTWW	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.188988819646339	73	1
7eTTWW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	106.302694623025	70	0.00335628473460086
7eTTWW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	106.331131005971	69	0.00262134195322165
7eTTWW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	106.339983256074	70	0.00333212610966407
7eTTWW	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	1.48255605304294	70	1
7G6Zco	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	100.473951933304	64	0.00243878480429808
7G6Zco	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	99.5001657517655	63	0.00230388217245907
7G6Zco	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	100.476245956436	64	0.00243764051097272
7G6Zco	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.118049501412829	64	1
7G6Zco	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	79.7308090162397	64	0.0887763561593989
7G6Zco	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	78.8479407335861	63	0.0858814641547012
7G6Zco	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	79.7322886978693	64	0.0887581910915621
7G6Zco	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.121932590159808	64	1
7G6Zco	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	95.8643211524892	63	0.00479354554407159
7G6Zco	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	95.5963923171883	62	0.00395685252279605
7G6Zco	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	95.8821765789228	63	0.00477676151153833
7G6Zco	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.1909727519282	63	1
7IEdvu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	105.177061853185	71	0.00524385719285128
7IEdvu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	102.857233513829	70	0.00643879679393649
7IEdvu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	105.267662168362	71	0.00515597453536829
7IEdvu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.100849869182539	71	1
7IEdvu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	112.555069717727	71	0.00123487273148833
7IEdvu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	111.27565702605	70	0.00124117094545796
7IEdvu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	112.652193446992	71	0.00121048852685006
7IEdvu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.17590564430896	71	1
7IEdvu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	88.6442091405366	67	0.0395665061381992
7IEdvu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	80.7698077856695	66	0.104275432538694
7IEdvu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	88.6493984012923	67	0.0395347038617623
7IEdvu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.773317319876128	67	1
7lFCvo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int.imputed.txt_snps.txt	Maximum likelihood	81.4195711924643	64	0.0699143961834643
7lFCvo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int.imputed.txt_snps.txt	MR Egger	80.0059317838862	63	0.0728330493077463
7lFCvo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int.imputed.txt_snps.txt	Inverse variance weighted	81.455246498302	64	0.0695546302730339
7lFCvo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_by_MUFA_int.imputed.txt_snps.txt	Unweighted regression	0.085329224692293	64	1
7lFCvo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int.imputed.txt_snps.txt	Maximum likelihood	82.7291091043726	64	0.0576775252468389
7lFCvo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int.imputed.txt_snps.txt	MR Egger	80.7098497221567	63	0.0657299001766131
7lFCvo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int.imputed.txt_snps.txt	Inverse variance weighted	82.7320103240471	64	0.0576525487778488
7lFCvo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_by_MUFA_int.imputed.txt_snps.txt	Unweighted regression	0.123859374049183	64	1
7lFCvo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int.imputed.txt_snps.txt	Maximum likelihood	96.1367077460432	63	0.00454334515895148
7lFCvo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int.imputed.txt_snps.txt	MR Egger	95.5815191072338	62	0.00396866030699266
7lFCvo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int.imputed.txt_snps.txt	Inverse variance weighted	96.2469119189867	63	0.00444559987430252
7lFCvo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_by_MUFA_int.imputed.txt_snps.txt	Unweighted regression	1.08207204497522	63	1
7PF0gb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int.imputed.txt_snps.txt	Maximum likelihood	12.7084030095279	17	0.75547721430969
7PF0gb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int.imputed.txt_snps.txt	MR Egger	12.281087962627	16	0.724414139749444
7PF0gb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int.imputed.txt_snps.txt	Inverse variance weighted	12.7165058921638	17	0.754947628148482
7PF0gb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_BCAA_int.imputed.txt_snps.txt	Unweighted regression	0.0169156938470597	17	1
7PF0gb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int.imputed.txt_snps.txt	Maximum likelihood	10.338026661561	17	0.888840080772223
7PF0gb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int.imputed.txt_snps.txt	MR Egger	9.87441170414609	16	0.873103978386727
7PF0gb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int.imputed.txt_snps.txt	Inverse variance weighted	10.362796414557	17	0.887711347711695
7PF0gb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_BCAA_int.imputed.txt_snps.txt	Unweighted regression	0.0152185128089957	17	1
7PF0gb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int.imputed.txt_snps.txt	Maximum likelihood	16.5238297284647	17	0.487050377402634
7PF0gb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int.imputed.txt_snps.txt	MR Egger	13.519428091242	16	0.634467092600062
7PF0gb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int.imputed.txt_snps.txt	Inverse variance weighted	16.531700430585	17	0.486503724312913
7PF0gb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_BCAA_int.imputed.txt_snps.txt	Unweighted regression	0.131052673519666	17	0.999999999999999
8202nS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	137.393070464277	68	1.31774191312409e-06
8202nS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int.imputed.txt_snps.txt	MR Egger	137.401663847435	67	9.02856640372441e-07
8202nS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	137.401831384598	68	1.31467527032563e-06
8202nS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0670431974778391	68	1
8202nS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	129.78454106409	68	9.49250817951702e-06
8202nS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int.imputed.txt_snps.txt	MR Egger	129.584613732492	67	7.05038303620283e-06
8202nS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	129.797608078999	68	9.46119143489701e-06
8202nS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.110232484855854	68	1
8202nS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	85.8799433467325	67	0.059939590694368
8202nS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int.imputed.txt_snps.txt	MR Egger	85.8608897263601	66	0.0507889819134853
8202nS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	86.1406352687857	67	0.057701677711806
8202nS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.597809868150418	67	1
8tQTfK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	117.571203537421	88	0.0193129180421194
8tQTfK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	117.585012702183	87	0.0161325891109529
8tQTfK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	117.585411095877	88	0.0192713922662557
8tQTfK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0734234636485359	88	1
8tQTfK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	96.0400482091529	88	0.261600914514057
8tQTfK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	95.6735691894188	87	0.246028723549406
8tQTfK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	96.0425890037605	88	0.261542152776055
8tQTfK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.089009801292363	88	1
8tQTfK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	106.285059652639	85	0.0589812510082615
8tQTfK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	105.669863328284	84	0.0551411987998808
8tQTfK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	106.367757007644	85	0.0583414012067521
8tQTfK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.68074545914176	85	1
941UGb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	149.676266369801	108	0.00493931684348005
941UGb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int.imputed.txt_snps.txt	MR Egger	149.38690292773	107	0.0042844724628841
941UGb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	149.67868093194	108	0.00493742216522488
941UGb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.160200179797285	108	1
941UGb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	140.216455985382	108	0.0201852050354622
941UGb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int.imputed.txt_snps.txt	MR Egger	140.138736629365	107	0.0173928787944379
941UGb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	140.216955728515	108	0.0201838089266429
941UGb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.206091451460632	108	1
941UGb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	130.083173944883	104	0.0425733935586064
941UGb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int.imputed.txt_snps.txt	MR Egger	130.043993348137	103	0.0370276500217006
941UGb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	130.095424700786	104	0.0425070580653492
941UGb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	1.05345944416728	104	1
94MERP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int.imputed.txt_snps.txt	Maximum likelihood	22.1622757923347	18	0.224860247518267
94MERP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int.imputed.txt_snps.txt	MR Egger	20.3816624256486	17	0.255174720629454
94MERP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int.imputed.txt_snps.txt	Inverse variance weighted	22.162288352372	18	0.224859702215295
94MERP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	His_int.imputed.txt_snps.txt	Unweighted regression	0.0373865410148414	18	1
94MERP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int.imputed.txt_snps.txt	Maximum likelihood	24.6295040628538	18	0.135466468089503
94MERP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int.imputed.txt_snps.txt	MR Egger	23.2895979447556	17	0.140057978077882
94MERP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int.imputed.txt_snps.txt	Inverse variance weighted	24.630931039593	18	0.135424493292203
94MERP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	His_int.imputed.txt_snps.txt	Unweighted regression	0.0567684398834987	18	1
94MERP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int.imputed.txt_snps.txt	Maximum likelihood	16.2860346259409	18	0.572592479117568
94MERP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int.imputed.txt_snps.txt	MR Egger	16.1545851505549	17	0.512903827275028
94MERP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int.imputed.txt_snps.txt	Inverse variance weighted	16.2996706489356	18	0.571642035895441
94MERP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	His_int.imputed.txt_snps.txt	Unweighted regression	0.326412878584039	18	0.999999999999804
98lJD5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int.imputed.txt_snps.txt	Maximum likelihood	124.508577005293	64	9.00753689344407e-06
98lJD5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int.imputed.txt_snps.txt	MR Egger	124.471269009565	63	6.35089506340207e-06
98lJD5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int.imputed.txt_snps.txt	Inverse variance weighted	124.615703113187	64	8.76174405169608e-06
98lJD5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0593358610502823	64	1
98lJD5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int.imputed.txt_snps.txt	Maximum likelihood	115.162516230711	64	9.24328761878197e-05
98lJD5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int.imputed.txt_snps.txt	MR Egger	114.084968885282	63	8.69630150859397e-05
98lJD5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int.imputed.txt_snps.txt	Inverse variance weighted	115.239658347661	64	9.07390413031939e-05
98lJD5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FC_int.imputed.txt_snps.txt	Unweighted regression	0.094777780638266	64	1
98lJD5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int.imputed.txt_snps.txt	Maximum likelihood	69.3602360811646	61	0.216346358513298
98lJD5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int.imputed.txt_snps.txt	MR Egger	67.0437022012177	60	0.248326694237122
98lJD5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int.imputed.txt_snps.txt	Inverse variance weighted	69.3603990614683	61	0.216342388377674
98lJD5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FC_int.imputed.txt_snps.txt	Unweighted regression	0.584280344332446	61	1
9EbosA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	75.3191269381274	46	0.00411263110851162
9EbosA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	73.1794916375478	45	0.004985137620984
9EbosA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	75.3436439524346	46	0.00409021913944787
9EbosA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0619560582277994	46	1
9EbosA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	78.6426274961294	46	0.00192610698938681
9EbosA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	78.4440530303637	45	0.00148253204275295
9EbosA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	78.6891043036657	46	0.00190530978205416
9EbosA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.130434668104965	46	1
9EbosA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	52.03000531743	45	0.219142832079009
9EbosA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	52.0224080058132	44	0.189903165281848
9EbosA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	52.0558002231611	45	0.218414933425692
9EbosA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.392154990314384	45	1
9GPGuu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	136.174406715155	89	0.00096304871969352
9GPGuu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int.imputed.txt_snps.txt	MR Egger	132.379367577285	88	0.00156525319146142
9GPGuu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	136.196987502397	89	0.000958893087564639
9GPGuu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.105715066890863	89	1
9GPGuu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	142.10295329821	89	0.000298560433328564
9GPGuu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int.imputed.txt_snps.txt	MR Egger	140.894466877461	88	0.000295583478836333
9GPGuu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	142.121250281135	89	0.000297450987611388
9GPGuu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.168906149880051	89	1
9GPGuu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	101.834340385292	87	0.132158226937838
9GPGuu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int.imputed.txt_snps.txt	MR Egger	83.8341675042161	86	0.546008081345585
9GPGuu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	101.845913012916	87	0.131989288209351
9GPGuu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.838781904610224	87	1
9j9oAk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	152.13051560452	102	0.000956155247506008
9j9oAk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int.imputed.txt_snps.txt	MR Egger	152.144196279076	101	0.000762471852754098
9j9oAk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	152.16806277822	102	0.000949643893276694
9j9oAk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.110480171389707	102	1
9j9oAk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	143.877422255121	102	0.00401096110239792
9j9oAk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int.imputed.txt_snps.txt	MR Egger	142.223529496001	101	0.00433362315647042
9j9oAk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	143.920562315788	102	0.00398245779329159
9j9oAk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.136830175981667	102	1
9j9oAk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	114.468779049489	97	0.108761478597707
9j9oAk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int.imputed.txt_snps.txt	MR Egger	110.985834188859	96	0.140650540468367
9j9oAk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	114.499391244029	97	0.108394811108984
9j9oAk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.797263398506496	97	1
9lt8cy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	117.657133014413	68	0.000177035574864194
9lt8cy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int.imputed.txt_snps.txt	MR Egger	115.942996233296	67	0.000194409099121997
9lt8cy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	117.671995351256	68	0.00017643418782767
9lt8cy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.111135205923199	68	1
9lt8cy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	101.06869652788	68	0.00571603061888683
9lt8cy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int.imputed.txt_snps.txt	MR Egger	100.292056136325	67	0.00525643104532463
9lt8cy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	101.074817049208	68	0.00570944777360401
9lt8cy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.14169301051283	68	1
9lt8cy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	80.3209277676809	68	0.145692445511452
9lt8cy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int.imputed.txt_snps.txt	MR Egger	78.3025863852782	67	0.162755627560993
9lt8cy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	80.390723385368	68	0.144471629619151
9lt8cy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.798630316877231	68	1
9QzrTL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int.imputed.txt_snps.txt	Maximum likelihood	121.094273651876	83	0.0040638211011326
9QzrTL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int.imputed.txt_snps.txt	MR Egger	119.131435232487	82	0.00465294718984001
9QzrTL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int.imputed.txt_snps.txt	Inverse variance weighted	121.121100355663	83	0.0040443511882363
9QzrTL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoA1_int.imputed.txt_snps.txt	Unweighted regression	0.079434207235642	83	1
9QzrTL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int.imputed.txt_snps.txt	Maximum likelihood	133.48993020087	83	0.000370917273286827
9QzrTL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int.imputed.txt_snps.txt	MR Egger	132.821700811213	82	0.000327806347684883
9QzrTL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int.imputed.txt_snps.txt	Inverse variance weighted	133.533529805078	83	0.000367591758672977
9QzrTL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoA1_int.imputed.txt_snps.txt	Unweighted regression	0.128958173941404	83	1
9QzrTL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int.imputed.txt_snps.txt	Maximum likelihood	100.422293415082	82	0.0816254620492809
9QzrTL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int.imputed.txt_snps.txt	MR Egger	82.8773103912482	81	0.421256537459268
9QzrTL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int.imputed.txt_snps.txt	Inverse variance weighted	100.450530268566	82	0.0813349933541
9QzrTL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoA1_int.imputed.txt_snps.txt	Unweighted regression	0.877286502344768	82	1
9s2XzI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	83.6461791720666	54	0.00596405673950411
9s2XzI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int.imputed.txt_snps.txt	MR Egger	82.0596953184284	53	0.0063997814865797
9s2XzI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	83.7371722982368	54	0.00585392642718689
9s2XzI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0721533294370867	54	1
9s2XzI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	90.5962867853013	54	0.00133604477916351
9s2XzI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int.imputed.txt_snps.txt	MR Egger	90.6926694778517	53	0.000972882546980118
9s2XzI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	90.6927716340416	54	0.0013072900390851
9s2XzI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.117324631359801	54	1
9s2XzI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	65.0914501364027	53	0.123217107045188
9s2XzI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int.imputed.txt_snps.txt	MR Egger	65.2628380310752	52	0.102379510603744
9s2XzI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	65.263665722246	53	0.120271936548512
9s2XzI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.821247271163012	53	1
A1Vv4t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	136.87796410043	81	0.000104429509482978
A1Vv4t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int.imputed.txt_snps.txt	MR Egger	136.397957349109	80	8.72259672620258e-05
A1Vv4t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	136.934408385816	81	0.000103139596451993
A1Vv4t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.177288717424	81	1
A1Vv4t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	138.030055814575	81	8.09327382062666e-05
A1Vv4t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int.imputed.txt_snps.txt	MR Egger	136.528110734648	80	8.47331034745825e-05
A1Vv4t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	138.067925755069	81	8.02540374190267e-05
A1Vv4t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.240782824341276	81	1
A1Vv4t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	99.7136238210607	78	0.0493249286132351
A1Vv4t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int.imputed.txt_snps.txt	MR Egger	99.6990305377909	77	0.0420238021953073
A1Vv4t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	99.7746157933397	78	0.0489030960118278
A1Vv4t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.45141964639685	78	1
a7Ck5t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	114.045032997361	52	1.5382916677008e-06
a7Ck5t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int.imputed.txt_snps.txt	MR Egger	114.046644246525	51	1.00848773982734e-06
a7Ck5t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	114.046647063882	52	1.5375792370863e-06
a7Ck5t	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0789829534461333	52	1
a7Ck5t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	114.992927597821	52	1.17096789844198e-06
a7Ck5t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int.imputed.txt_snps.txt	MR Egger	113.877036104384	51	1.05951781436713e-06
a7Ck5t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	115.014117625979	52	1.16382642958772e-06
a7Ck5t	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.135364534087735	52	1
a7Ck5t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	51.6009557662416	51	0.450151713157909
a7Ck5t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int.imputed.txt_snps.txt	MR Egger	51.1797822237048	50	0.427138938776841
a7Ck5t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	51.8081880672756	51	0.442123189665919
a7Ck5t	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.484871252109337	51	1
aGzdbg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int.imputed.txt_snps.txt	Maximum likelihood	151.115788013151	84	9.9361733288518e-06
aGzdbg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int.imputed.txt_snps.txt	MR Egger	151.147697762098	83	7.19010569761895e-06
aGzdbg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int.imputed.txt_snps.txt	Inverse variance weighted	151.156391614482	84	9.84150867107154e-06
aGzdbg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_TG_int.imputed.txt_snps.txt	Unweighted regression	0.189930998683237	84	1
aGzdbg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int.imputed.txt_snps.txt	Maximum likelihood	144.740712923316	83	3.21012239925016e-05
aGzdbg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int.imputed.txt_snps.txt	MR Egger	144.458427498879	82	2.53487590401273e-05
aGzdbg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int.imputed.txt_snps.txt	Inverse variance weighted	144.747412984877	83	3.20522260461517e-05
aGzdbg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_TG_int.imputed.txt_snps.txt	Unweighted regression	0.231959847117125	83	1
aGzdbg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int.imputed.txt_snps.txt	Maximum likelihood	112.065327662551	82	0.0153656535905496
aGzdbg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int.imputed.txt_snps.txt	MR Egger	112.017256566575	81	0.012810486984426
aGzdbg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int.imputed.txt_snps.txt	Inverse variance weighted	112.173656777974	82	0.0151016070489985
aGzdbg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_TG_int.imputed.txt_snps.txt	Unweighted regression	1.44209650528852	82	1
aijp1F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int.imputed.txt_snps.txt	Maximum likelihood	11.7259970220221	13	0.550229983141256
aijp1F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int.imputed.txt_snps.txt	MR Egger	11.0097578218156	12	0.528082623832905
aijp1F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int.imputed.txt_snps.txt	Inverse variance weighted	11.7264403757821	13	0.550193264307911
aijp1F	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phe_int.imputed.txt_snps.txt	Unweighted regression	0.0189776211422739	13	1
aijp1F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int.imputed.txt_snps.txt	Maximum likelihood	10.4234576222456	13	0.658994078602049
aijp1F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int.imputed.txt_snps.txt	MR Egger	8.91647824697762	12	0.710047276269955
aijp1F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int.imputed.txt_snps.txt	Inverse variance weighted	10.4267267733071	13	0.658722322053084
aijp1F	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phe_int.imputed.txt_snps.txt	Unweighted regression	0.0269304512999197	13	1
aijp1F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int.imputed.txt_snps.txt	Maximum likelihood	17.9614448325729	12	0.116866213216443
aijp1F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int.imputed.txt_snps.txt	MR Egger	17.9865324046588	11	0.0818936360714943
aijp1F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int.imputed.txt_snps.txt	Inverse variance weighted	18.1366456013924	12	0.111604045672831
aijp1F	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phe_int.imputed.txt_snps.txt	Unweighted regression	0.189149158230473	12	0.999999999083488
amGYTI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	140.230446094191	87	0.000261505428287927
amGYTI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int.imputed.txt_snps.txt	MR Egger	139.083227685514	86	0.000255292952683749
amGYTI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	140.2416147944	87	0.000260903265033756
amGYTI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.104583736374122	87	1
amGYTI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	145.921593031421	87	7.83251143640536e-05
amGYTI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int.imputed.txt_snps.txt	MR Egger	141.402829987452	86	0.000156943740873342
amGYTI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	145.923533568801	87	7.8292116234291e-05
amGYTI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.171615892903441	87	1
amGYTI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	124.846793693767	85	0.00319524273976463
amGYTI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int.imputed.txt_snps.txt	MR Egger	117.961740767931	84	0.00860202189572178
amGYTI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	124.963542178529	85	0.00312856267968413
amGYTI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.96004427159925	85	1
AmwH7E	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int.imputed.txt_snps.txt	Maximum likelihood	41.4939058301353	35	0.208567041131681
AmwH7E	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int.imputed.txt_snps.txt	MR Egger	41.036328893434	34	0.189350644497629
AmwH7E	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int.imputed.txt_snps.txt	Inverse variance weighted	41.569663129591	35	0.206257552433522
AmwH7E	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ala_int.imputed.txt_snps.txt	Unweighted regression	0.032027530879615	35	1
AmwH7E	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int.imputed.txt_snps.txt	Maximum likelihood	39.152121250201	35	0.288785206530025
AmwH7E	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int.imputed.txt_snps.txt	MR Egger	38.205840589446	34	0.284149228666063
AmwH7E	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int.imputed.txt_snps.txt	Inverse variance weighted	39.2316423944866	35	0.285785125863376
AmwH7E	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ala_int.imputed.txt_snps.txt	Unweighted regression	0.0619296546717789	35	1
AmwH7E	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int.imputed.txt_snps.txt	Maximum likelihood	50.2541072173698	35	0.0457501963445819
AmwH7E	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int.imputed.txt_snps.txt	MR Egger	49.6889047468299	34	0.0402198987320421
AmwH7E	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int.imputed.txt_snps.txt	Inverse variance weighted	50.2896798506757	35	0.0454296402884219
AmwH7E	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ala_int.imputed.txt_snps.txt	Unweighted regression	0.589951266029047	35	1
aNmea0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	92.0245549781879	67	0.0229987593102988
aNmea0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int.imputed.txt_snps.txt	MR Egger	91.9842641427146	66	0.0189950630771943
aNmea0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	92.024702863417	67	0.0229981948617215
aNmea0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.0935608058882106	67	1
aNmea0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	93.4136797549009	67	0.018208028651865
aNmea0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int.imputed.txt_snps.txt	MR Egger	93.3644119109133	66	0.0149661589652298
aNmea0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	93.4155058021333	67	0.0182023665079756
aNmea0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.137521438247591	67	1
aNmea0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	97.419445082405	63	0.00351974922306039
aNmea0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int.imputed.txt_snps.txt	MR Egger	93.946073768498	62	0.00548601673512391
aNmea0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	97.4194663584016	63	0.00351973418530462
aNmea0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.822371331412746	63	1
apVx77	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	134.666520239339	75	2.88007504120333e-05
apVx77	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int.imputed.txt_snps.txt	MR Egger	134.141432426298	74	2.37804086332293e-05
apVx77	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	134.71518159738	75	2.84707712070626e-05
apVx77	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.126251830832156	75	1
apVx77	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	117.593486362706	75	0.00122573236629882
apVx77	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int.imputed.txt_snps.txt	MR Egger	115.043960952916	74	0.00159159274770037
apVx77	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	117.616028704534	75	0.00122018399456393
apVx77	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.166212358792736	75	1
apVx77	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	103.522522595911	74	0.0133356533768264
apVx77	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int.imputed.txt_snps.txt	MR Egger	103.523907238984	73	0.0108822412740184
apVx77	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	103.556319109627	74	0.0132596672885611
apVx77	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	1.1138313180137	74	1
ASYEI9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	120.350116929633	56	1.32616382846675e-06
ASYEI9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	120.259549019959	55	9.03127551313197e-07
ASYEI9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	120.351562867994	56	1.32562357113408e-06
ASYEI9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0680034047814329	56	1
ASYEI9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	111.116933395994	56	1.6555136452858e-05
ASYEI9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	110.895750432997	55	1.21094451429311e-05
ASYEI9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	111.122134013603	56	1.6532371162085e-05
ASYEI9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.100631273041086	56	1
ASYEI9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	72.6291778276793	53	0.037965264927119
ASYEI9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	71.6232690117246	52	0.0368760747931553
ASYEI9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	72.7299550724308	53	0.0373138266032098
ASYEI9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.774411883903456	53	1
AVUnQZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	135.462431732656	85	0.000414758720312112
AVUnQZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	135.310422117529	84	0.000330474091070884
AVUnQZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	135.462542274763	85	0.000414749383966593
AVUnQZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.128513397147614	85	1
AVUnQZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	139.944797569104	85	0.000163179152564365
AVUnQZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	139.538247411199	84	0.000135455367879524
AVUnQZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	139.949955330771	85	0.000163000390099216
AVUnQZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.190686338978616	85	1
AVUnQZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	115.378080342663	83	0.0108586676140874
AVUnQZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	114.504361489494	82	0.0103224363442951
AVUnQZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	115.406941708871	83	0.0108071580623318
AVUnQZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	1.52465366682383	83	1
Awgua3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int.imputed.txt_snps.txt	Maximum likelihood	139.863258995671	102	0.00765359341491493
Awgua3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int.imputed.txt_snps.txt	MR Egger	139.52274077718	101	0.006712294157192
Awgua3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	139.887875093339	102	0.00762414144851679
Awgua3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_size_int.imputed.txt_snps.txt	Unweighted regression	0.109585602549639	102	1
Awgua3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int.imputed.txt_snps.txt	Maximum likelihood	136.528413685725	102	0.0127431506633814
Awgua3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int.imputed.txt_snps.txt	MR Egger	135.973168235175	101	0.0116404550007922
Awgua3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	136.548423809692	102	0.0127051800360786
Awgua3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_size_int.imputed.txt_snps.txt	Unweighted regression	0.146548043470125	102	1
Awgua3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int.imputed.txt_snps.txt	Maximum likelihood	135.561915131725	99	0.00866527175517031
Awgua3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int.imputed.txt_snps.txt	MR Egger	131.133876510399	98	0.014293107993822
Awgua3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	135.562088536659	99	0.00866503627478056
Awgua3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_size_int.imputed.txt_snps.txt	Unweighted regression	0.812188939462313	99	1
axdKQC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int.imputed.txt_snps.txt	Maximum likelihood	136.132343154468	78	5.14214333125375e-05
axdKQC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int.imputed.txt_snps.txt	MR Egger	135.866916323492	77	4.03888856025593e-05
axdKQC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int.imputed.txt_snps.txt	Inverse variance weighted	136.132361601054	78	5.14212160462898e-05
axdKQC	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_int.imputed.txt_snps.txt	Unweighted regression	0.0668727631393862	78	1
axdKQC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int.imputed.txt_snps.txt	Maximum likelihood	116.640407424441	78	0.00302687401171697
axdKQC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int.imputed.txt_snps.txt	MR Egger	114.895870661384	77	0.003339416420142
axdKQC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int.imputed.txt_snps.txt	Inverse variance weighted	116.642754771532	78	0.00302554380658191
axdKQC	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_int.imputed.txt_snps.txt	Unweighted regression	0.103118971068564	78	1
axdKQC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int.imputed.txt_snps.txt	Maximum likelihood	81.360389828959	77	0.345147490731283
axdKQC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int.imputed.txt_snps.txt	MR Egger	78.4594025665096	76	0.400777368320812
axdKQC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int.imputed.txt_snps.txt	Inverse variance weighted	81.434718744545	77	0.343024373583515
axdKQC	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_int.imputed.txt_snps.txt	Unweighted regression	0.515020845572789	77	1
b1P8Wa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	130.593966203216	78	0.000177530107295031
b1P8Wa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int.imputed.txt_snps.txt	MR Egger	127.993713704724	77	0.000236398940728423
b1P8Wa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	130.619319741125	78	0.000176550263789273
b1P8Wa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.109695667276117	78	1
b1P8Wa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	112.982790533583	78	0.00590514442336865
b1P8Wa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int.imputed.txt_snps.txt	MR Egger	110.821362654068	77	0.00700256164587495
b1P8Wa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	113.00727353747	78	0.00587944812911173
b1P8Wa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.143553444539701	78	1
b1P8Wa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	107.192750166136	77	0.0130542016118223
b1P8Wa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int.imputed.txt_snps.txt	MR Egger	104.272421366361	76	0.0174004974682012
b1P8Wa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	107.199982547606	77	0.0130384696235445
b1P8Wa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	1.14045121302713	77	1
bAmFZB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	156.260855837979	87	7.55445063344e-06
bAmFZB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int.imputed.txt_snps.txt	MR Egger	155.498783792292	86	6.6103010743233e-06
bAmFZB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	156.269391234216	87	7.53931968834517e-06
bAmFZB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.165449140071505	87	1
bAmFZB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	146.066269195621	87	7.5901253200393e-05
bAmFZB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int.imputed.txt_snps.txt	MR Egger	144.487172870448	86	8.08912543161939e-05
bAmFZB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	146.077550983398	87	7.57153032490249e-05
bAmFZB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.22948900193002	87	1
bAmFZB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	124.981928749784	84	0.00249845360156661
bAmFZB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int.imputed.txt_snps.txt	MR Egger	122.486082182216	83	0.00316037136106355
bAmFZB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	124.991812324061	84	0.00249390255368634
bAmFZB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.33940078767004	84	1
bI9hWn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	108.822646237318	63	0.000300628331832478
bI9hWn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	108.595004826656	62	0.000234004591433833
bI9hWn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	108.829896748883	63	0.00030012784944676
bI9hWn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.113639969432596	63	1
bI9hWn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	110.775313235875	63	0.000191101031681175
bI9hWn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	110.238300278608	62	0.000158933944119754
bI9hWn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	110.7954620043	63	0.000190201143366293
bI9hWn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.136798039007554	63	1
bI9hWn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	80.7167029359358	61	0.0463453228749367
bI9hWn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	80.3373992764097	60	0.040945902769918
bI9hWn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	80.7255578317443	61	0.0462807230535149
bI9hWn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.522783207833501	61	1
bJj9ql	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	68.8277442286511	55	0.0995461894867478
bJj9ql	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int.imputed.txt_snps.txt	MR Egger	65.5364779460014	54	0.135062697930219
bJj9ql	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	68.8452583723874	55	0.0992948184504314
bJj9ql	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.054395817716729	55	1
bJj9ql	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	63.8009546430404	55	0.194631098741344
bJj9ql	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int.imputed.txt_snps.txt	MR Egger	63.569354745645	54	0.174960755128672
bJj9ql	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	63.8224745874834	55	0.194119947902789
bJj9ql	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0809876607895561	55	1
bJj9ql	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	50.4786068134681	54	0.611007034337383
bJj9ql	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int.imputed.txt_snps.txt	MR Egger	49.8155333060622	53	0.598932492015056
bJj9ql	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	50.5750791868404	54	0.607284968271954
bJj9ql	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.403403182276714	54	1
bjmvl1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	125.578666144584	74	0.000172073901444661
bjmvl1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	125.351048513628	73	0.000135387874654983
bjmvl1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	125.593220333246	74	0.000171517255249044
bjmvl1	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.089467645131162	74	1
bjmvl1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	107.834441440985	73	0.00502532412865828
bjmvl1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	107.703449483215	72	0.00410195461192214
bjmvl1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	107.834956053115	73	0.00502484557605968
bjmvl1	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.11905117725875	73	1
bjmvl1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	90.5884786722157	72	0.0684706988898898
bjmvl1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	90.6257498243329	71	0.0581403092990472
bjmvl1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	90.6356666782442	72	0.0680262005251834
bjmvl1	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	1.02728351906753	72	1
bmjwgs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	112.255230351105	71	0.00131310544850539
bmjwgs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int.imputed.txt_snps.txt	MR Egger	112.190341177717	70	0.00102675743837287
bmjwgs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	112.335195455703	71	0.00129179663616231
bmjwgs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0946980703087148	71	1
bmjwgs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	108.237398477941	71	0.00292740874028824
bmjwgs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int.imputed.txt_snps.txt	MR Egger	106.824808897314	70	0.00303239571401987
bmjwgs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	108.309581461188	71	0.0028865815737878
bmjwgs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.166166315007593	71	1
bmjwgs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	69.8423749588368	69	0.449015084020047
bmjwgs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int.imputed.txt_snps.txt	MR Egger	68.9876588439189	68	0.443768324363156
bmjwgs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	69.940873760811	69	0.445730086596594
bmjwgs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.626897144925063	69	1
bONap7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	103.044553666388	70	0.00621986546628767
bONap7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int.imputed.txt_snps.txt	MR Egger	102.834683217975	69	0.00515494771393471
bONap7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	103.045448110121	70	0.00621883670061192
bONap7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.103818560976919	70	1
bONap7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	102.013516149156	70	0.00751537177835334
bONap7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int.imputed.txt_snps.txt	MR Egger	101.991865689657	69	0.00603779933082089
bONap7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	102.014418890746	70	0.00751413661294483
bONap7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.154287387840798	70	1
bONap7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	85.614798603089	69	0.0853059460057182
bONap7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int.imputed.txt_snps.txt	MR Egger	80.8534719147023	68	0.136569016496399
bONap7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	85.7179934141561	69	0.0841250110386104
bONap7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.983344687849872	69	1
BTMZ5K	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	151.68757781341	87	2.17403406996373e-05
BTMZ5K	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	151.357918228333	86	1.73703604357207e-05
BTMZ5K	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	151.728929568202	87	2.15369161996265e-05
BTMZ5K	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.146609398483665	87	1
BTMZ5K	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	137.431594723338	87	0.000462381420956266
BTMZ5K	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	137.349476445809	86	0.000364735297078177
BTMZ5K	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	137.455374895983	87	0.000460178171086325
BTMZ5K	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.221664441089634	87	1
BTMZ5K	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	122.947992064193	82	0.00231792467938143
BTMZ5K	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	122.859300546755	81	0.001870473900194
BTMZ5K	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	123.074966406041	82	0.00226346544336572
BTMZ5K	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.991834634017983	82	1
CFdCar	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	131.14610011683	83	0.000598450680198879
CFdCar	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	131.007837206859	82	0.000476984003289888
CFdCar	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	131.172172047514	83	0.000595312249981557
CFdCar	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.120273976176078	83	1
CFdCar	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	137.45947727209	83	0.000160827840449419
CFdCar	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	137.389038758968	82	0.000123788042562846
CFdCar	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	137.468072556348	83	0.000160531665832867
CFdCar	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.188691390407895	83	1
CFdCar	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	113.61460047885	81	0.00983003097506117
CFdCar	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	112.375620898994	80	0.00992139756732841
CFdCar	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	113.708427643334	81	0.00967628433873251
CFdCar	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	1.35033441178472	81	1
cJf1k6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int.imputed.txt_snps.txt	Maximum likelihood	92.5131777666374	67	0.0211993634200521
cJf1k6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int.imputed.txt_snps.txt	MR Egger	92.2673030502165	66	0.0180975281553359
cJf1k6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int.imputed.txt_snps.txt	Inverse variance weighted	92.5714388513253	67	0.0209933740291009
cJf1k6	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_int.imputed.txt_snps.txt	Unweighted regression	0.0940867821475582	67	1
cJf1k6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int.imputed.txt_snps.txt	Maximum likelihood	96.6609827622818	67	0.0103055377291267
cJf1k6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int.imputed.txt_snps.txt	MR Egger	94.8991224820333	66	0.0114024099549824
cJf1k6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int.imputed.txt_snps.txt	Inverse variance weighted	96.682152086341	67	0.0102663035866761
cJf1k6	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_int.imputed.txt_snps.txt	Unweighted regression	0.141190955139891	67	1
cJf1k6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int.imputed.txt_snps.txt	Maximum likelihood	82.0769423882271	62	0.044857796295617
cJf1k6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int.imputed.txt_snps.txt	MR Egger	81.9143538798389	61	0.0382790416462489
cJf1k6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int.imputed.txt_snps.txt	Inverse variance weighted	82.1073078647415	62	0.0446441197441529
cJf1k6	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_int.imputed.txt_snps.txt	Unweighted regression	0.676945840246813	62	1
d4ecam	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	77.9723640017422	56	0.0277520094034541
d4ecam	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	77.3666935516128	55	0.0250613238658267
d4ecam	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	77.9729461885856	56	0.0277491901409706
d4ecam	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0793263409067301	56	1
d4ecam	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	102.851924925101	56	0.000137251509956064
d4ecam	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	101.468201585046	55	0.000138611739171329
d4ecam	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	102.864667986269	56	0.000136820469724309
d4ecam	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.182945722347682	56	1
d4ecam	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	46.8981604616623	51	0.637224406697888
d4ecam	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	46.9013123459579	50	0.598486970620599
d4ecam	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	46.9022281919338	51	0.637064776944296
d4ecam	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.449906209964333	51	1
DfVjtw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	124.636236504984	92	0.0133203762285511
DfVjtw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int.imputed.txt_snps.txt	MR Egger	123.816565114587	91	0.0126237084159576
DfVjtw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	124.675256412264	92	0.0132401165756238
DfVjtw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0790855998130778	92	1
DfVjtw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	123.903136014176	92	0.014911642875531
DfVjtw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int.imputed.txt_snps.txt	MR Egger	123.889144539004	91	0.0124811596955203
DfVjtw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	123.987217151195	92	0.0147208820519472
DfVjtw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.110372750325087	92	1
DfVjtw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	127.737619212112	89	0.00448507010207738
DfVjtw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int.imputed.txt_snps.txt	MR Egger	119.287212993507	88	0.0148353561813973
DfVjtw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	127.755051933698	89	0.00447157163093742
DfVjtw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.675158722034763	89	1
dG3Gd7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	110.834449660544	73	0.00285083463856741
dG3Gd7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int.imputed.txt_snps.txt	MR Egger	110.017157347238	72	0.00263130509556617
dG3Gd7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	110.926871242768	73	0.00280045457815946
dG3Gd7	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.112245286541675	73	1
dG3Gd7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	98.2962080678797	73	0.0258866098664587
dG3Gd7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int.imputed.txt_snps.txt	MR Egger	96.8055319776175	72	0.0272704166839124
dG3Gd7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	98.3510017317297	73	0.0256632976434392
dG3Gd7	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.146642658802753	73	1
dG3Gd7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	84.4029266824505	71	0.132205643826211
dG3Gd7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int.imputed.txt_snps.txt	MR Egger	83.8853495657132	70	0.123158993563166
dG3Gd7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	84.4057677570921	71	0.132160177990385
dG3Gd7	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	1.18727027138322	71	1
DlWyEr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	90.1054197003106	60	0.00718887986739503
DlWyEr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	89.8471112803539	59	0.00594489478204281
DlWyEr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	90.1116672210929	60	0.00718017703616316
DlWyEr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0500011661843444	60	1
DlWyEr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	75.444484747397	60	0.0862758764290935
DlWyEr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	75.1351816756638	59	0.0766046931010335
DlWyEr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	75.4445008141948	60	0.0862756782189234
DlWyEr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0597882896892019	60	1
DlWyEr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	58.692996731343	59	0.486782923887629
DlWyEr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	53.0706405973467	58	0.658704937716699
DlWyEr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	58.7654796579838	59	0.484117050230207
DlWyEr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.517451327593814	59	1
E2GzXs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	51.5720017230438	20	0.000131415421971778
E2GzXs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	51.026209116195	19	9.24224753364918e-05
E2GzXs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	51.5728615333291	20	0.000131377639802493
E2GzXs	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0372750912257191	20	1
E2GzXs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	40.7276461590171	20	0.00403694542797349
E2GzXs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	38.9936423873571	19	0.00442548367136074
E2GzXs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	40.7400833210513	20	0.00402218793052891
E2GzXs	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0345568188922904	20	1
E2GzXs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	30.2078974126661	20	0.0665542853848499
E2GzXs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	30.0721610989243	19	0.050887236424554
E2GzXs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	30.2272891296277	20	0.0662535217534693
E2GzXs	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.236860154871722	20	1
eArtoJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	123.141461484407	71	0.000123693083965579
eArtoJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int.imputed.txt_snps.txt	MR Egger	122.433095869668	70	0.000107729471928252
eArtoJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	123.157412578843	71	0.000123242333055081
eArtoJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.103337213694	71	1
eArtoJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	112.322307375305	71	0.00129520883676559
eArtoJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int.imputed.txt_snps.txt	MR Egger	110.991408527318	70	0.00131597563560859
eArtoJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	112.348097297648	71	0.00128838927751477
eArtoJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.138810826730946	71	1
eArtoJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	103.950983582592	69	0.00416865400972845
eArtoJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int.imputed.txt_snps.txt	MR Egger	102.75976475399	68	0.00414113631224044
eArtoJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	103.987599127724	69	0.00413948119313343
eArtoJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.961862369676972	69	1
eBQgVb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	115.39297875261	77	0.00304222637147296
eBQgVb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	115.384865442113	76	0.00241408756453649
eBQgVb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	115.434829449296	77	0.0030183637725953
eBQgVb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.113890578631937	77	1
eBQgVb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	107.383355659371	77	0.0126452568287481
eBQgVb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	106.251963059832	76	0.0125398124593345
eBQgVb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	107.414200526015	77	0.0125801756809298
eBQgVb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.155955026509036	77	1
eBQgVb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	108.022835493678	75	0.00751789563650028
eBQgVb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	106.834509752443	74	0.00750299164892708
eBQgVb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	108.026765871919	75	0.00751266011391685
eBQgVb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	1.02720400623466	75	1
eKk3fb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	125.736932271268	73	0.000124068274605502
eKk3fb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	120.38950368651	72	0.000306346270662684
eKk3fb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	125.746756504516	73	0.000123792301236707
eKk3fb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.116255171079048	73	1
eKk3fb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	104.131122668732	73	0.00979017087303822
eKk3fb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	100.799492249832	72	0.0141681877588848
eKk3fb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	104.143443686831	73	0.00976908101060282
eKk3fb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.138257450340837	73	1
eKk3fb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	107.489199787274	72	0.00427111388653444
eKk3fb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	96.1883817336135	71	0.0250012916305242
eKk3fb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	107.493866688464	72	0.00426736134703043
eKk3fb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	1.14927344186962	72	1
EKWrOg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	110.188658976139	67	0.000700445151642084
EKWrOg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int.imputed.txt_snps.txt	MR Egger	103.841369104429	66	0.0020417439175217
EKWrOg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	110.191548478353	67	0.000700007940028596
EKWrOg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0832357455080468	67	1
EKWrOg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	98.9332894054983	67	0.00679232718308049
EKWrOg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int.imputed.txt_snps.txt	MR Egger	91.3391301012993	66	0.0211906927683661
EKWrOg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	98.9491568861588	67	0.00677222851257592
EKWrOg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.119733313572983	67	1
EKWrOg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	81.6652197133558	67	0.107236623735213
EKWrOg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int.imputed.txt_snps.txt	MR Egger	78.0020364971829	66	0.148120586546929
EKWrOg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	81.7808053087719	67	0.105630119994715
EKWrOg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.673590076466455	67	1
epqYDf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int.imputed.txt_snps.txt	Maximum likelihood	41.1723395599188	28	0.0517826805111222
epqYDf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int.imputed.txt_snps.txt	MR Egger	40.4102161278264	27	0.0468803088275292
epqYDf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int.imputed.txt_snps.txt	Inverse variance weighted	41.1724209810745	28	0.0517817862879769
epqYDf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Pyruvate_int.imputed.txt_snps.txt	Unweighted regression	0.0287153380104866	28	1
epqYDf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int.imputed.txt_snps.txt	Maximum likelihood	34.2861875558661	28	0.1916089531542
epqYDf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int.imputed.txt_snps.txt	MR Egger	34.1078107288812	27	0.162935676193865
epqYDf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int.imputed.txt_snps.txt	Inverse variance weighted	34.2914069760952	28	0.191442924303264
epqYDf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Pyruvate_int.imputed.txt_snps.txt	Unweighted regression	0.0377648682021269	28	1
epqYDf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int.imputed.txt_snps.txt	Maximum likelihood	32.7676047233552	28	0.2444073995982
epqYDf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int.imputed.txt_snps.txt	MR Egger	31.3368014262905	27	0.257535804554335
epqYDf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int.imputed.txt_snps.txt	Inverse variance weighted	32.8123035693503	28	0.242724809017222
epqYDf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Pyruvate_int.imputed.txt_snps.txt	Unweighted regression	0.286096964232753	28	1
ErlaRo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int.imputed.txt_snps.txt	Maximum likelihood	125.649669690647	89	0.00640208386782691
ErlaRo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int.imputed.txt_snps.txt	MR Egger	122.854692039712	88	0.0083709573871873
ErlaRo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	125.649777364506	89	0.00640196807749237
ErlaRo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_size_int.imputed.txt_snps.txt	Unweighted regression	0.121917024060994	89	1
ErlaRo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int.imputed.txt_snps.txt	Maximum likelihood	114.783372224652	89	0.0342931817377938
ErlaRo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int.imputed.txt_snps.txt	MR Egger	112.137992815869	88	0.0422869265881939
ErlaRo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	114.7839983822	89	0.0342901684809852
ErlaRo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_size_int.imputed.txt_snps.txt	Unweighted regression	0.172247299484689	89	1
ErlaRo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int.imputed.txt_snps.txt	Maximum likelihood	107.421145340721	85	0.0506848263236811
ErlaRo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int.imputed.txt_snps.txt	MR Egger	107.037701523047	84	0.0457848370785237
ErlaRo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	107.425494083217	85	0.050655058919908
ErlaRo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_size_int.imputed.txt_snps.txt	Unweighted regression	1.18572363516815	85	1
eUbK7s	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	135.98187845416	77	3.93253387564909e-05
eUbK7s	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int.imputed.txt_snps.txt	MR Egger	135.088998266423	76	3.56082764327751e-05
eUbK7s	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	136.00718389986	77	3.90948888520192e-05
eUbK7s	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.12177506451472	77	1
eUbK7s	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	132.869951233967	76	5.95801854288802e-05
eUbK7s	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int.imputed.txt_snps.txt	MR Egger	132.103483390636	75	5.25149460897489e-05
eUbK7s	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	132.875559228954	76	5.95034300994659e-05
eUbK7s	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.161162839264261	76	1
eUbK7s	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	99.9857607274104	75	0.0285530468692122
eUbK7s	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int.imputed.txt_snps.txt	MR Egger	99.5756080295396	74	0.0254082710519147
eUbK7s	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	100.050578685255	75	0.028268526653536
eUbK7s	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.15944750705839	75	1
eVdC9N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	60.718638795428	60	0.449791484467478
eVdC9N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int.imputed.txt_snps.txt	MR Egger	60.6410059567063	59	0.416455740194534
eVdC9N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	60.727820376731	60	0.449462717630681
eVdC9N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	PUFA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0438347868395894	60	1
eVdC9N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	65.1487990691992	59	0.27146093428523
eVdC9N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int.imputed.txt_snps.txt	MR Egger	64.3566145188118	58	0.263915295439717
eVdC9N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	65.1637624153212	59	0.271033938647949
eVdC9N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	PUFA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0730810270473622	59	1
eVdC9N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	76.5098659967787	58	0.0521697250473381
eVdC9N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int.imputed.txt_snps.txt	MR Egger	76.0439705936703	57	0.0467290833341865
eVdC9N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	76.5113309964849	58	0.052157647847511
eVdC9N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	PUFA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.668446894849904	58	1
EXT0Z5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	117.359436769831	84	0.00951079985092534
EXT0Z5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	117.301625080366	83	0.00787250429448703
EXT0Z5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	117.361990132282	84	0.00950676988861015
EXT0Z5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0993067171464833	84	1
EXT0Z5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	116.282589285915	84	0.0113552518517103
EXT0Z5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	116.013050268314	83	0.009775261275261
EXT0Z5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	116.282614871743	84	0.0113552044309052
EXT0Z5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.134742311017863	84	1
EXT0Z5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	104.829486275797	82	0.0454385256460741
EXT0Z5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	100.305905320679	81	0.0718502289810316
EXT0Z5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	104.850091907144	82	0.0453080631402692
EXT0Z5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.763750699182501	82	1
EyVDoF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	141.520034534988	105	0.0101521026286514
EyVDoF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int.imputed.txt_snps.txt	MR Egger	140.991259655627	104	0.0092221922354804
EyVDoF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	141.531802755954	105	0.0101341087963704
EyVDoF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0995166118330102	105	1
EyVDoF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	151.43439005316	105	0.00205129607771506
EyVDoF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int.imputed.txt_snps.txt	MR Egger	148.481751549623	104	0.00276587194530421
EyVDoF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	151.470543884823	105	0.0020386130151808
EyVDoF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.196469911962971	105	1
EyVDoF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	121.204572403508	102	0.0943533199799637
EyVDoF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int.imputed.txt_snps.txt	MR Egger	117.204429484178	101	0.129104197089534
EyVDoF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	121.307007799002	102	0.0932827619054403
EyVDoF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.836911056327389	102	1
Fb9G4m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int.imputed.txt_snps.txt	Maximum likelihood	137.510045302337	72	5.35304723289645e-06
Fb9G4m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int.imputed.txt_snps.txt	MR Egger	136.909871019281	71	4.40700933118485e-06
Fb9G4m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int.imputed.txt_snps.txt	Inverse variance weighted	137.544879026257	72	5.30620800329215e-06
Fb9G4m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Cholines_int.imputed.txt_snps.txt	Unweighted regression	0.0921294739597721	72	1
Fb9G4m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int.imputed.txt_snps.txt	Maximum likelihood	146.790593330469	72	4.79768006291301e-07
Fb9G4m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int.imputed.txt_snps.txt	MR Egger	146.799512639027	71	3.27689586075587e-07
Fb9G4m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int.imputed.txt_snps.txt	Inverse variance weighted	146.836789862079	72	4.73880370177588e-07
Fb9G4m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Cholines_int.imputed.txt_snps.txt	Unweighted regression	0.149056948095601	72	1
Fb9G4m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int.imputed.txt_snps.txt	Maximum likelihood	95.1674535431059	69	0.0201519111984745
Fb9G4m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int.imputed.txt_snps.txt	MR Egger	95.0331851078937	68	0.0168988048690651
Fb9G4m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int.imputed.txt_snps.txt	Inverse variance weighted	95.1689170138984	69	0.020147002269863
Fb9G4m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Cholines_int.imputed.txt_snps.txt	Unweighted regression	0.710541741670371	69	1
fC8R9n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	122.392289513918	79	0.00126928447579789
fC8R9n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	122.425218843617	78	0.000984608812631036
fC8R9n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	122.427137013239	79	0.00126059874128541
fC8R9n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.134683740809906	79	1
fC8R9n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	97.6922887951362	79	0.0755274082157303
fC8R9n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	97.6897169105346	78	0.0651638671077811
fC8R9n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	97.7287312005334	79	0.0751697788582126
fC8R9n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.15757689519011	79	1
fC8R9n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	102.464196354891	74	0.0159225120852854
fC8R9n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	101.778702184392	73	0.0146622243087923
fC8R9n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	102.471794993847	74	0.0159024384985064
fC8R9n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.655902346665488	74	1
FGTpxe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Maximum likelihood	44.1176854192605	48	0.632648987176543
FGTpxe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	MR Egger	42.159574290284	47	0.672946159338528
FGTpxe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Inverse variance weighted	44.1212256844493	48	0.632505141522529
FGTpxe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Unweighted regression	0.0764067812598772	48	1
FGTpxe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Maximum likelihood	43.9917372179894	48	0.63775920772224
FGTpxe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	MR Egger	42.5995395903954	47	0.655232103718747
FGTpxe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Inverse variance weighted	43.9917610878026	48	0.637758240589606
FGTpxe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Unweighted regression	0.143341604041428	48	1
FGTpxe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Maximum likelihood	51.6983041139241	47	0.29542532088766
FGTpxe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	MR Egger	50.9291473830638	46	0.285836372639804
FGTpxe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Inverse variance weighted	51.7015198512701	47	0.295317963333293
FGTpxe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_by_Omega_3_int.imputed.txt_snps.txt	Unweighted regression	0.842903000016176	47	1
fOEU0x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	107.672382600334	70	0.0025679468036528
fOEU0x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	103.384929199364	69	0.00464457989264799
fOEU0x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	107.672563659857	70	0.00256785510016356
fOEU0x	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.11392546335382	70	1
fOEU0x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	90.9223292843476	70	0.0471942645031904
fOEU0x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	88.4006672057315	69	0.0577936239275996
fOEU0x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	90.9223292912446	70	0.0471942644549162
fOEU0x	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.129695226346083	70	1
fOEU0x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	99.3906518938125	68	0.00780867806215101
fOEU0x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	97.0249386999455	67	0.00964962376109242
fOEU0x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	99.4025926521106	68	0.00779158232569554
fOEU0x	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	1.04870190273594	68	1
FPwE3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	118.193081781209	54	1.07694897164039e-06
FPwE3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int.imputed.txt_snps.txt	MR Egger	117.387022639486	53	8.93746354688635e-07
FPwE3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	118.207696908376	54	1.07245555030211e-06
FPwE3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0891935787504497	54	1
FPwE3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	121.197220062525	54	4.52513925968212e-07
FPwE3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int.imputed.txt_snps.txt	MR Egger	118.638727260564	53	6.21837953547096e-07
FPwE3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	121.210396445402	54	4.50781247815488e-07
FPwE3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.152666670849503	54	1
FPwE3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	53.2869949305188	52	0.424469602286395
FPwE3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int.imputed.txt_snps.txt	MR Egger	50.152358496338	51	0.507274736008755
FPwE3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	53.3984210834951	52	0.42026993936935
FPwE3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.487438230640402	52	1
FRK2JB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int.imputed.txt_snps.txt	Maximum likelihood	128.949723306895	72	4.34615060269307e-05
FRK2JB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int.imputed.txt_snps.txt	MR Egger	127.745402367672	71	4.22140981985702e-05
FRK2JB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int.imputed.txt_snps.txt	Inverse variance weighted	129.007434217172	72	4.28716833267159e-05
FRK2JB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	GlycA_int.imputed.txt_snps.txt	Unweighted regression	0.207254952649139	72	1
FRK2JB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int.imputed.txt_snps.txt	Maximum likelihood	112.125315287461	72	0.00173521734487558
FRK2JB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int.imputed.txt_snps.txt	MR Egger	111.205208556128	71	0.00162545328315841
FRK2JB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int.imputed.txt_snps.txt	Inverse variance weighted	112.196365602319	72	0.00171071072789203
FRK2JB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	GlycA_int.imputed.txt_snps.txt	Unweighted regression	0.23403367455457	72	1
FRK2JB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int.imputed.txt_snps.txt	Maximum likelihood	83.3183869032201	66	0.0735949650891434
FRK2JB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int.imputed.txt_snps.txt	MR Egger	83.3057890371955	65	0.0626606501051174
FRK2JB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int.imputed.txt_snps.txt	Inverse variance weighted	83.3214302186968	66	0.0735633089299756
FRK2JB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	GlycA_int.imputed.txt_snps.txt	Unweighted regression	0.967746875940751	66	1
fu0i4d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	96.0909482398672	49	6.75617287315901e-05
fu0i4d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int.imputed.txt_snps.txt	MR Egger	96.0810979444479	48	4.67642555123253e-05
fu0i4d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	96.0942565142193	49	6.75027087816367e-05
fu0i4d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0607666287548841	49	1
fu0i4d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	100.794733758979	49	1.90234384161672e-05
fu0i4d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int.imputed.txt_snps.txt	MR Egger	98.5584366522311	48	2.38505155507243e-05
fu0i4d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	100.797158693923	49	1.901077714309e-05
fu0i4d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.115538847886303	49	1
fu0i4d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	49.9243783087659	46	0.32019512742922
fu0i4d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int.imputed.txt_snps.txt	MR Egger	49.7356261805348	45	0.290329413910312
fu0i4d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	49.9869799610573	46	0.317990891279961
fu0i4d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.325577034000741	46	1
g1eez5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	177.997901048231	95	5.37099705543121e-07
g1eez5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	176.248725367777	94	5.91954954283264e-07
g1eez5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	178.031328778309	95	5.32729264325985e-07
g1eez5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.139394803879782	95	1
g1eez5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	166.890749895791	95	7.42324646991333e-06
g1eez5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	166.275458525873	94	6.32415441004515e-06
g1eez5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	166.898873977791	95	7.40949877419603e-06
g1eez5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.187105370539892	95	1
g1eez5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	123.379690700043	90	0.0112491623951278
g1eez5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	120.700635515379	89	0.0142703198500255
g1eez5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	123.405201794344	90	0.011203648065456
g1eez5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	1.12890761454814	90	1
g4MXg9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	98.151232021994	75	0.0377100895399814
g4MXg9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int.imputed.txt_snps.txt	MR Egger	97.3002165791681	74	0.036076078112129
g4MXg9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	98.1757512154923	75	0.0375726992052883
g4MXg9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0928033093929018	75	1
g4MXg9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	105.615749825809	75	0.0114279624294949
g4MXg9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int.imputed.txt_snps.txt	MR Egger	104.902655828428	74	0.0105325761442405
g4MXg9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	105.621482408883	75	0.0114167862630556
g4MXg9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.14858723731837	75	1
g4MXg9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	91.2706708514155	71	0.0529925559454284
g4MXg9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int.imputed.txt_snps.txt	MR Egger	91.2982543021584	70	0.0446246863882604
g4MXg9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	91.3953287405414	71	0.0520431371285634
g4MXg9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	1.12742123264148	71	1
G74Dzk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int.imputed.txt_snps.txt	Maximum likelihood	150.292100972195	73	2.73567736355223e-07
G74Dzk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int.imputed.txt_snps.txt	MR Egger	150.144293901403	72	1.94141862482194e-07
G74Dzk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int.imputed.txt_snps.txt	Inverse variance weighted	150.302067188638	73	2.72834562139953e-07
G74Dzk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_P_int.imputed.txt_snps.txt	Unweighted regression	0.108840142797933	73	1
G74Dzk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int.imputed.txt_snps.txt	Maximum likelihood	155.97852123076	73	5.78066191702351e-08
G74Dzk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int.imputed.txt_snps.txt	MR Egger	155.827622295871	72	4.03802970549452e-08
G74Dzk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int.imputed.txt_snps.txt	Inverse variance weighted	155.980179403114	73	5.7780039132901e-08
G74Dzk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_P_int.imputed.txt_snps.txt	Unweighted regression	0.147618139974853	73	1
G74Dzk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int.imputed.txt_snps.txt	Maximum likelihood	105.508936458202	71	0.0049285245355963
G74Dzk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int.imputed.txt_snps.txt	MR Egger	102.881677871594	70	0.0064098310293212
G74Dzk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int.imputed.txt_snps.txt	Inverse variance weighted	105.594073172975	71	0.00485050332187961
G74Dzk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_P_int.imputed.txt_snps.txt	Unweighted regression	0.650848847862699	71	1
GBu6Zg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int.imputed.txt_snps.txt	Maximum likelihood	104.161852536033	63	0.000855023027996091
GBu6Zg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int.imputed.txt_snps.txt	MR Egger	103.789879168686	62	0.000699547143583588
GBu6Zg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int.imputed.txt_snps.txt	Inverse variance weighted	104.207059320849	63	0.000846613094078832
GBu6Zg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_C_int.imputed.txt_snps.txt	Unweighted regression	0.060690031201676	63	1
GBu6Zg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int.imputed.txt_snps.txt	Maximum likelihood	100.467481273212	63	0.00188434470147723
GBu6Zg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int.imputed.txt_snps.txt	MR Egger	99.8464093814116	62	0.00164683935559112
GBu6Zg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int.imputed.txt_snps.txt	Inverse variance weighted	100.501073799443	63	0.0018711524907574
GBu6Zg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_C_int.imputed.txt_snps.txt	Unweighted regression	0.0903682727828003	63	1
GBu6Zg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int.imputed.txt_snps.txt	Maximum likelihood	85.6290102782969	61	0.0204890554953099
GBu6Zg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int.imputed.txt_snps.txt	MR Egger	85.4593831938555	60	0.0171070683319824
GBu6Zg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int.imputed.txt_snps.txt	Inverse variance weighted	85.6406070798677	61	0.0204476120559445
GBu6Zg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_C_int.imputed.txt_snps.txt	Unweighted regression	0.572674479538055	61	1
gewBRM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int.imputed.txt_snps.txt	Maximum likelihood	90.7806867034385	69	0.0405808034585554
gewBRM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int.imputed.txt_snps.txt	MR Egger	90.7901864847414	68	0.0338937859007542
gewBRM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int.imputed.txt_snps.txt	Inverse variance weighted	90.8118584072335	69	0.0403882656696259
gewBRM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Creatinine_int.imputed.txt_snps.txt	Unweighted regression	0.0501829604294119	69	1
gewBRM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int.imputed.txt_snps.txt	Maximum likelihood	88.3543687077382	69	0.058181524167678
gewBRM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int.imputed.txt_snps.txt	MR Egger	88.2495552139953	68	0.0500045332450567
gewBRM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int.imputed.txt_snps.txt	Inverse variance weighted	88.3721418283922	69	0.0580323596740155
gewBRM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Creatinine_int.imputed.txt_snps.txt	Unweighted regression	0.082025950976147	69	1
gewBRM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int.imputed.txt_snps.txt	Maximum likelihood	70.4430293206609	69	0.429092790725324
gewBRM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int.imputed.txt_snps.txt	MR Egger	69.657201932618	68	0.421500273643055
gewBRM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int.imputed.txt_snps.txt	Inverse variance weighted	70.5199023268702	69	0.426563119615504
gewBRM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Creatinine_int.imputed.txt_snps.txt	Unweighted regression	0.4602677685291	69	1
GEwhVq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	97.1206206855541	55	0.000398693329566964
GEwhVq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	97.0806856816027	54	0.000292909989547863
GEwhVq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	97.12127079663	55	0.000398631724164124
GEwhVq	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.091979387094991	55	1
GEwhVq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	86.3178427677092	55	0.004444899812841
GEwhVq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	86.3254156045984	54	0.00340803434520038
GEwhVq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	86.329407126569	55	0.00443423371393038
GEwhVq	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.129787088475749	55	1
GEwhVq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	52.5045711201402	54	0.532236473392347
GEwhVq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	50.5201269006862	53	0.571291821455656
GEwhVq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	52.5871028814726	54	0.529022785549771
GEwhVq	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.398303560192465	54	1
GFs133	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	124.233264404825	78	0.000682299013781106
GFs133	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	124.097759978183	77	0.000540923261091741
GFs133	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	124.260325722504	78	0.000678526352898406
GFs133	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.103585930422528	78	1
GFs133	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	119.796743017037	78	0.00165615068713712
GFs133	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	119.167261126992	77	0.0014701677829143
GFs133	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	119.844772357256	78	0.00164072341989053
GFs133	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.190949385588552	78	1
GFs133	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	88.8464596014074	76	0.148741435544397
GFs133	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	82.3172775335625	75	0.263334699682451
GFs133	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	89.0435185043645	76	0.145429689408764
GFs133	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.97778540910005	76	1
gnWCCG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	87.6394055986605	68	0.0547228708778631
gnWCCG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	87.3630960861529	67	0.0481211835391107
gnWCCG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	87.6476951851913	68	0.0546563388219789
gnWCCG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.111295745147844	68	1
gnWCCG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	94.918322996883	68	0.0172329797067881
gnWCCG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	93.5660205778741	67	0.0177410274943581
gnWCCG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	94.9566369758497	68	0.0171208593468452
gnWCCG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.189750396516672	68	1
gnWCCG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	68.6912532360271	67	0.419800957157648
gnWCCG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	63.767599122574	66	0.55500158927427
gnWCCG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	68.6969647652808	67	0.419611456305903
gnWCCG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.748533045466997	67	1
GvnDoZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int.imputed.txt_snps.txt	Maximum likelihood	8.1325821015377	10	0.615888215296838
GvnDoZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int.imputed.txt_snps.txt	MR Egger	8.07099597540945	9	0.527007691622434
GvnDoZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int.imputed.txt_snps.txt	Inverse variance weighted	8.1326957334135	10	0.615877121382326
GvnDoZ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Ile_int.imputed.txt_snps.txt	Unweighted regression	0.021098508778582	10	0.999999999998921
GvnDoZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int.imputed.txt_snps.txt	Maximum likelihood	9.29252933191274	10	0.504584797955144
GvnDoZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int.imputed.txt_snps.txt	MR Egger	8.42142769582723	9	0.4922963798786
GvnDoZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int.imputed.txt_snps.txt	Inverse variance weighted	9.29734920519472	10	0.504135752616932
GvnDoZ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Ile_int.imputed.txt_snps.txt	Unweighted regression	0.0233973808868714	10	0.999999999998192
GvnDoZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int.imputed.txt_snps.txt	Maximum likelihood	8.16302560575774	10	0.612916401827454
GvnDoZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int.imputed.txt_snps.txt	MR Egger	8.18993750158845	9	0.515124373940097
GvnDoZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int.imputed.txt_snps.txt	Inverse variance weighted	8.21690833671279	10	0.607658831107936
GvnDoZ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Ile_int.imputed.txt_snps.txt	Unweighted regression	0.197889169162121	10	0.999999927219996
gWkQhb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int.imputed.txt_snps.txt	Maximum likelihood	118.986086745691	64	3.64109735341766e-05
gWkQhb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int.imputed.txt_snps.txt	MR Egger	118.806843068452	63	2.71706890316932e-05
gWkQhb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	118.996968236594	64	3.63130195224391e-05
gWkQhb	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0938375435014483	64	1
gWkQhb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int.imputed.txt_snps.txt	Maximum likelihood	121.339227361373	64	2.02239304988186e-05
gWkQhb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int.imputed.txt_snps.txt	MR Egger	119.830787308392	63	2.09876168031822e-05
gWkQhb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	121.366823714927	64	2.00836604163246e-05
gWkQhb	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.136449606775641	64	1
gWkQhb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int.imputed.txt_snps.txt	Maximum likelihood	81.2836509519823	62	0.0507579086866942
gWkQhb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int.imputed.txt_snps.txt	MR Egger	81.0660976348061	61	0.0438540746850001
gWkQhb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	81.3568056248302	62	0.0501875503091491
gWkQhb	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.840420088966639	62	1
h4P6xM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	131.141285475189	94	0.00686871361714314
h4P6xM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int.imputed.txt_snps.txt	MR Egger	130.245218603802	93	0.00655506115620833
h4P6xM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	131.173567399247	94	0.00683257431310993
h4P6xM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.137182630203656	94	1
h4P6xM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	111.119227058424	94	0.109750251620824
h4P6xM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int.imputed.txt_snps.txt	MR Egger	110.924455403519	93	0.0991521052926667
h4P6xM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	111.148897814454	94	0.109387286504085
h4P6xM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.164637246209772	94	1
h4P6xM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	107.051477420951	88	0.0817720218804238
h4P6xM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int.imputed.txt_snps.txt	MR Egger	105.820919615281	87	0.0830352620431384
h4P6xM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	107.098510078207	88	0.0813026897489662
h4P6xM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.748567784161846	88	1
h66TLA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	92.4687984510328	66	0.0174818586395478
h66TLA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int.imputed.txt_snps.txt	MR Egger	92.1333289210697	65	0.0150743256940215
h66TLA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	92.5048718405919	66	0.0173736350014411
h66TLA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0808021778730675	66	1
h66TLA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	84.3539157868436	66	0.0634512403317253
h66TLA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int.imputed.txt_snps.txt	MR Egger	84.0819626702198	65	0.0558739613028669
h66TLA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	84.3853603159882	66	0.0631623669667275
h66TLA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.111581941327885	66	1
h66TLA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	78.8974082147291	63	0.0852877708742713
h66TLA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int.imputed.txt_snps.txt	MR Egger	76.7897164001841	62	0.0978353228252286
h66TLA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	78.8974748433106	63	0.0852869734614504
h66TLA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.635773676536438	63	1
hC2Za3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	69.7139057476817	45	0.0105227699281596
hC2Za3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	69.502471879359	44	0.0084429999775109
hC2Za3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	69.7446541984242	45	0.0104552446110696
hC2Za3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0971345585757549	45	1
hC2Za3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	66.8573115703245	45	0.0188402809246934
hC2Za3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	66.8254223751334	44	0.0148089449504535
hC2Za3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	66.8787070624329	45	0.0187604719988039
hC2Za3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.111250449324673	45	1
hC2Za3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	57.0461837036095	44	0.089704114722252
hC2Za3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	56.9809475741278	43	0.0749662081374968
hC2Za3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	57.1083412652474	44	0.0888045204164008
hC2Za3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.711704074230015	44	1
HCwI59	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	120.293741821505	83	0.00468626829920788
HCwI59	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	118.896004428145	82	0.00485173639218119
HCwI59	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	120.319869509115	83	0.00466463585965135
HCwI59	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.09237052978337	83	1
HCwI59	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	128.912335671181	83	0.000933986671073491
HCwI59	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	128.269838430541	82	0.000829259468878682
HCwI59	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	128.913322750874	83	0.000933805193520783
HCwI59	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.15495497367979	83	1
HCwI59	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	133.478488237522	83	0.000371794730163365
HCwI59	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	124.281955270307	82	0.00180224628565889
HCwI59	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	133.534625078038	83	0.000367508584486048
HCwI59	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	1.00686968826084	83	1
hKOvuj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int.imputed.txt_snps.txt	Maximum likelihood	15.2705562253354	17	0.576000734672759
hKOvuj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int.imputed.txt_snps.txt	MR Egger	13.6968293971853	16	0.621287980367172
hKOvuj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int.imputed.txt_snps.txt	Inverse variance weighted	15.27350331777	17	0.575788707608682
hKOvuj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Leu_int.imputed.txt_snps.txt	Unweighted regression	0.0202594711982719	17	1
hKOvuj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int.imputed.txt_snps.txt	Maximum likelihood	16.0400045689808	17	0.521000730742529
hKOvuj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int.imputed.txt_snps.txt	MR Egger	14.0494750717053	16	0.595027927528263
hKOvuj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int.imputed.txt_snps.txt	Inverse variance weighted	16.0461142799161	17	0.520568197535038
hKOvuj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Leu_int.imputed.txt_snps.txt	Unweighted regression	0.0238129358547009	17	1
hKOvuj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int.imputed.txt_snps.txt	Maximum likelihood	9.25851304064432	17	0.93180078701447
hKOvuj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int.imputed.txt_snps.txt	MR Egger	9.19779302264051	16	0.905044929208935
hKOvuj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int.imputed.txt_snps.txt	Inverse variance weighted	9.25856306747557	17	0.931799081497356
hKOvuj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Leu_int.imputed.txt_snps.txt	Unweighted regression	0.0948090330016349	17	1
HKtqEM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	130.319962163291	77	0.00014205228329701
HKtqEM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int.imputed.txt_snps.txt	MR Egger	115.780055513156	76	0.00223723875475527
HKtqEM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	130.334591079858	77	0.000141593113462058
HKtqEM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.110960963457899	77	1
HKtqEM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	112.380870466362	77	0.0053008802591874
HKtqEM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int.imputed.txt_snps.txt	MR Egger	104.655769250939	76	0.0163450063954545
HKtqEM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	112.39336806532	77	0.00528893242822603
HKtqEM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.143512147806909	77	1
HKtqEM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	107.486170206295	76	0.0101669353550959
HKtqEM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int.imputed.txt_snps.txt	MR Egger	97.6029629494734	75	0.0408971111261952
HKtqEM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	107.520351053827	76	0.0101074416949966
HKtqEM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	1.12985904951121	76	1
hm6d8u	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	129.766111991793	91	0.00477084830890331
hm6d8u	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	129.309085288365	90	0.00420328227453948
hm6d8u	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	129.780101982463	91	0.0047594772587767
hm6d8u	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.150336531361961	91	1
hm6d8u	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	122.936627579166	91	0.0144720836743258
hm6d8u	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	122.44504470844	90	0.0130360404817547
hm6d8u	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	122.94507087247	91	0.0144532531281249
hm6d8u	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.21613395918662	91	1
hm6d8u	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	112.533406873427	88	0.0400508185990595
hm6d8u	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	110.555426824073	87	0.0449848607982089
hm6d8u	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	112.546151802863	88	0.0399804580929889
hm6d8u	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	1.27267206177378	88	1
hUQVGl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	122.673295663716	72	0.000184659933592338
hUQVGl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int.imputed.txt_snps.txt	MR Egger	122.473115715039	71	0.000144069468336666
hUQVGl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	122.692549077001	72	0.000183864907523447
hUQVGl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.11037586427041	72	1
hUQVGl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	106.676079752747	72	0.00497359052576918
hUQVGl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int.imputed.txt_snps.txt	MR Egger	106.200945115	71	0.00432657413397215
hUQVGl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	106.72008832284	72	0.00493299175697146
hUQVGl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.133460545489889	72	1
hUQVGl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	71.7628214539742	70	0.419169752533256
hUQVGl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int.imputed.txt_snps.txt	MR Egger	65.837256714085	69	0.585681143769749
hUQVGl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	71.860441214401	70	0.41600567142886
hUQVGl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.541072981140894	70	1
hVFgr3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int.imputed.txt_snps.txt	Maximum likelihood	10.4271220335513	12	0.578543373619857
hVFgr3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int.imputed.txt_snps.txt	MR Egger	10.1900585231629	11	0.513376731088558
hVFgr3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int.imputed.txt_snps.txt	Inverse variance weighted	10.5132079523515	12	0.571031210023369
hVFgr3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetone_int.imputed.txt_snps.txt	Unweighted regression	0.0110260774110225	12	1
hVFgr3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int.imputed.txt_snps.txt	Maximum likelihood	3.57287040569475	12	0.989970796472478
hVFgr3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int.imputed.txt_snps.txt	MR Egger	2.1755875698309	11	0.997777824354031
hVFgr3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int.imputed.txt_snps.txt	Inverse variance weighted	3.61596419796398	12	0.989412722395261
hVFgr3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetone_int.imputed.txt_snps.txt	Unweighted regression	0.00912724648127487	12	1
hVFgr3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int.imputed.txt_snps.txt	Maximum likelihood	10.2629927140136	11	0.506897547199001
hVFgr3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int.imputed.txt_snps.txt	MR Egger	10.2568625143558	10	0.418254350899383
hVFgr3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int.imputed.txt_snps.txt	Inverse variance weighted	10.263047788746	11	0.506892665371181
hVFgr3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetone_int.imputed.txt_snps.txt	Unweighted regression	0.0950593923325947	11	0.999999999823546
hw63fe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	88.9191274395646	83	0.30839733568484
hw63fe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	86.5337828549813	82	0.344740382863508
hw63fe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	88.919129657994	83	0.308397277828638
hw63fe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0825554394039208	83	1
hw63fe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	81.4427872663976	83	0.527812909244832
hw63fe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	81.0140610316014	82	0.510036048401535
hw63fe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	81.4433013740768	83	0.527796837948636
hw63fe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.15934953718174	83	1
hw63fe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	102.117220732163	81	0.0564939786149173
hw63fe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	100.80188365315	80	0.0579723675381233
hw63fe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	102.15047905686	81	0.0562398536480119
hw63fe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	1.19786091403173	81	1
I87azm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	90.7279660053752	50	0.000375836549085676
I87azm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int.imputed.txt_snps.txt	MR Egger	90.2087154394211	49	0.000306595648350765
I87azm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	90.7479589464042	50	0.000373992128958903
I87azm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0499180998237325	50	1
I87azm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	97.2444181172063	50	7.17266657615909e-05
I87azm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int.imputed.txt_snps.txt	MR Egger	96.3941961946452	49	6.23539791590266e-05
I87azm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	97.2622857716903	50	7.13916809005823e-05
I87azm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0747873925966681	50	1
I87azm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	48.4169306880848	49	0.496672478302332
I87azm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int.imputed.txt_snps.txt	MR Egger	48.1246907248866	48	0.467796996959808
I87azm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	48.4502194602798	49	0.49532211502937
I87azm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.290556387577607	49	1
i9HCrw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	127.703143221999	76	0.000190341046833699
i9HCrw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int.imputed.txt_snps.txt	MR Egger	123.233952728199	75	0.000379938135632289
i9HCrw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	127.720078285508	76	0.000189634386723836
i9HCrw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0958043524214344	76	1
i9HCrw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	115.586158487386	76	0.002322437867053
i9HCrw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int.imputed.txt_snps.txt	MR Egger	108.872735840286	75	0.00646034663491097
i9HCrw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	115.58629088777	76	0.00232237866896607
i9HCrw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.137478227304167	76	1
i9HCrw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	91.0103025396106	75	0.100645934069179
i9HCrw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int.imputed.txt_snps.txt	MR Egger	90.3376396922032	74	0.0952570440514596
i9HCrw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	91.0571340583608	75	0.100054498683712
i9HCrw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.787558707072338	75	1
imAlIl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int.imputed.txt_snps.txt	Maximum likelihood	94.3193971046066	53	0.000414065900396751
imAlIl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int.imputed.txt_snps.txt	MR Egger	93.9604349647118	52	0.00032737281438137
imAlIl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	94.3575022988291	53	0.000410291267212838
imAlIl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0666498442646396	53	1
imAlIl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int.imputed.txt_snps.txt	Maximum likelihood	93.710559432468	53	0.000479067697174493
imAlIl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int.imputed.txt_snps.txt	MR Egger	91.9537590101014	52	0.000531739036165213
imAlIl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	93.7142029023016	53	0.000478651198542548
imAlIl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0996797529862903	53	1
imAlIl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int.imputed.txt_snps.txt	Maximum likelihood	60.0799085778721	51	0.179893108655481
imAlIl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int.imputed.txt_snps.txt	MR Egger	59.8555930690251	50	0.160339856284586
imAlIl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	60.0863709352179	51	0.179742734609431
imAlIl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.669409062844011	51	1
ImTR6n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	51.8691502081314	32	0.0146043472017355
ImTR6n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	49.3488415786141	31	0.0194515050059442
ImTR6n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	51.909152032707	32	0.0144701745899529
ImTR6n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0957410724723373	32	1
ImTR6n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	49.9258226579353	32	0.0226625964955585
ImTR6n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	49.073447631792	31	0.0207048180759691
ImTR6n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	49.9629979719819	32	0.0224766926396083
ImTR6n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.118674863384745	32	1
ImTR6n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	32.69307474276	29	0.290290552263531
ImTR6n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	32.6882750487954	28	0.247412756706085
ImTR6n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	32.7478907110525	29	0.288023780532214
ImTR6n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.5513059506181	29	1
IPtxSt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	68.0313208133871	50	0.0457146247667944
IPtxSt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	67.7852238041635	49	0.0389008412577313
IPtxSt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	68.0323499885539	50	0.0457065672561292
IPtxSt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0826169726483477	50	1
IPtxSt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	60.5285032239943	49	0.125031221468986
IPtxSt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	60.4307801246756	48	0.107488870272915
IPtxSt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	60.5367796338458	49	0.124881760097464
IPtxSt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0879468453653974	49	1
IPtxSt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	60.11598603132	47	0.0948390637290749
IPtxSt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	59.2784689283213	46	0.0904571086401161
IPtxSt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	60.1560577532967	47	0.0942481522915966
IPtxSt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.857723285837552	47	1
IUs49N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	107.10928134457	50	4.86977167686528e-06
IUs49N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int.imputed.txt_snps.txt	MR Egger	107.144494740886	49	3.19393735960443e-06
IUs49N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	107.147809544193	50	4.81700228724441e-06
IUs49N	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0698388298377663	50	1
IUs49N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	96.0915517076496	50	9.68676446452624e-05
IUs49N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int.imputed.txt_snps.txt	MR Egger	95.4192072030145	49	8.06381389029975e-05
IUs49N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	96.1380090079113	50	9.57075173352873e-05
IUs49N	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0978259261469073	50	1
IUs49N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	51.2788861435586	49	0.384424969295035
IUs49N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int.imputed.txt_snps.txt	MR Egger	50.5550851273935	48	0.372930633565779
IUs49N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	51.2956673224562	49	0.383797510571857
IUs49N	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.421624389952139	49	1
IY8oxz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	124.630083060921	84	0.00266560057542074
IY8oxz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	122.823763543666	83	0.0029712820416328
IY8oxz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	124.674098066631	84	0.00264413524210818
IY8oxz	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0918131220186835	84	1
IY8oxz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	117.397253042036	84	0.00945127285323919
IY8oxz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	116.879640084573	83	0.0084548026989403
IY8oxz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	117.3996670425	84	0.0094474844576304
IY8oxz	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.119770850827012	84	1
IY8oxz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	95.5601964275295	80	0.113081983057382
IY8oxz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	95.546062932049	79	0.0991427884206122
IY8oxz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	95.6937828998722	80	0.111293516310058
IY8oxz	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	1.15997882638672	80	1
J63trI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	106.405282356483	54	2.76083905750597e-05
J63trI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int.imputed.txt_snps.txt	MR Egger	106.30102404924	53	1.96127273454655e-05
J63trI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	106.421446727455	54	2.74909921607024e-05
J63trI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.050030451136462	54	1
J63trI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	107.271700879671	54	2.19538160943196e-05
J63trI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int.imputed.txt_snps.txt	MR Egger	107.107483550566	53	1.57922451196539e-05
J63trI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	107.28654456793	54	2.18674897781914e-05
J63trI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0851256043823317	54	1
J63trI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	62.6372384747193	53	0.171425098299334
J63trI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int.imputed.txt_snps.txt	MR Egger	61.0845197391692	52	0.181890103218749
J63trI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	62.6792598464865	53	0.170498246140124
J63trI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.668570366547644	53	1
jAGRNu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	106.591593547683	68	0.00193926446417481
jAGRNu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int.imputed.txt_snps.txt	MR Egger	106.217692835177	67	0.00162066182347858
jAGRNu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	106.63666539499	68	0.0019215990333083
jAGRNu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.109350263270373	68	1
jAGRNu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	117.878367585857	68	0.000168283387994678
jAGRNu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int.imputed.txt_snps.txt	MR Egger	117.729257432647	67	0.000128647775896003
jAGRNu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	117.929873205528	68	0.000166306175821616
jAGRNu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.209233161111838	68	1
jAGRNu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	99.9401598448339	66	0.00444427121056732
jAGRNu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int.imputed.txt_snps.txt	MR Egger	99.9091403767506	65	0.00351069448614586
jAGRNu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	99.9449468931742	66	0.00444014386713284
jAGRNu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.21542100682156	66	1
JC4Mzk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	99.4833090141653	48	1.84858096866282e-05
JC4Mzk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int.imputed.txt_snps.txt	MR Egger	98.3145497015345	47	1.72360285906783e-05
JC4Mzk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	99.4890108152152	48	1.84566895105396e-05
JC4Mzk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Clinical_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0656970839635916	48	1
JC4Mzk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	99.8090210271353	48	1.68919215347956e-05
JC4Mzk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int.imputed.txt_snps.txt	MR Egger	99.4009206189059	47	1.2716507933681e-05
JC4Mzk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	99.8376536679223	48	1.67583777133679e-05
JC4Mzk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Clinical_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.112374172025367	48	1
JC4Mzk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	46.5225002083197	45	0.409488121699139
JC4Mzk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int.imputed.txt_snps.txt	MR Egger	46.1617468336357	44	0.382992232286319
JC4Mzk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	46.5700824189657	45	0.407585677013663
JC4Mzk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Clinical_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.31763674019082	45	1
jcD5v5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	139.994413363595	83	9.28098105823127e-05
jcD5v5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	139.820797709086	82	7.24944751703654e-05
jcD5v5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	140.03974487238	83	9.18915782015494e-05
jcD5v5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.136827830044644	83	1
jcD5v5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	114.246228926337	83	0.0130622479390171
jcD5v5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	113.669254927379	82	0.0118496203922321
jcD5v5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	114.262231394718	83	0.0130284752131708
jcD5v5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.163646215279286	83	1
jcD5v5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	126.663157982822	80	0.000693316079258841
jcD5v5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	126.750411346367	79	0.000526584704687413
jcD5v5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	126.759678440959	80	0.000679869254432792
jcD5v5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.27139284051138	80	1
jIDtTD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	115.245796653047	65	0.00012416322837994
jIDtTD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int.imputed.txt_snps.txt	MR Egger	114.791606832039	64	0.000101011313217697
jIDtTD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	115.245833177796	65	0.000124162159093832
jIDtTD	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0961681306702225	65	1
jIDtTD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	104.874724392824	65	0.00126763394043561
jIDtTD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int.imputed.txt_snps.txt	MR Egger	104.587770071006	64	0.00102807991530978
jIDtTD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	104.875346066903	65	0.0012674672023683
jIDtTD	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.135882131040881	65	1
jIDtTD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	86.1014651814199	63	0.0282381798208878
jIDtTD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int.imputed.txt_snps.txt	MR Egger	85.9265409728241	62	0.0238667520625216
jIDtTD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	86.1829644717724	63	0.0278582827263032
jIDtTD	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.9303754462486	63	1
jkmvWu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	140.684031239094	78	1.77862628459343e-05
jkmvWu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int.imputed.txt_snps.txt	MR Egger	140.484644833776	77	1.35678761187235e-05
jkmvWu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	140.826439630058	78	1.71948290259367e-05
jkmvWu	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.164425162267929	78	1
jkmvWu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	129.16352717225	77	0.000183235179254869
jkmvWu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int.imputed.txt_snps.txt	MR Egger	128.359726728494	76	0.000164708913888903
jkmvWu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	129.255117395717	77	0.000179595425571309
jkmvWu	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.197462387053953	77	1
jkmvWu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	103.720094867653	74	0.0128969404634803
jkmvWu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int.imputed.txt_snps.txt	MR Egger	102.931451461202	73	0.0120530252673174
jkmvWu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	103.796675590386	74	0.012730421047494
jkmvWu	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	1.51395273428171	74	1
jn36gO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	128.642861968932	73	6.36682658734007e-05
jn36gO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int.imputed.txt_snps.txt	MR Egger	126.741350299002	72	7.29577053857992e-05
jn36gO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	128.659080411759	73	6.34286591099157e-05
jn36gO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.123021744110269	73	1
jn36gO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	118.674252288088	73	0.000583516718465773
jn36gO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int.imputed.txt_snps.txt	MR Egger	115.712161524029	72	0.000833502983167347
jn36gO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	118.694882488585	73	0.000580975731247755
jn36gO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.164678429940838	73	1
jn36gO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	113.632118783419	71	0.000988601878959887
jn36gO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int.imputed.txt_snps.txt	MR Egger	110.533616154827	70	0.00144544471756477
jn36gO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	113.660484812434	71	0.000982790705611926
jn36gO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	1.20837349330767	71	1
JTVyRj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	109.072160688855	64	0.000382040617363713
JTVyRj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int.imputed.txt_snps.txt	MR Egger	109.066151813232	63	0.000284248952435505
JTVyRj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	109.077205069937	64	0.00038160510292015
JTVyRj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0790130741864146	64	1
JTVyRj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	106.263388561215	64	0.000714277464108009
JTVyRj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int.imputed.txt_snps.txt	MR Egger	104.024031976118	63	0.000881153487937506
JTVyRj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	106.265995749336	64	0.000713868989868562
JTVyRj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.116983987499595	64	1
JTVyRj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	92.0000456769425	63	0.0100184765253605
JTVyRj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int.imputed.txt_snps.txt	MR Egger	91.8737296407061	62	0.00817610528841493
JTVyRj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	92.0329820546474	63	0.00995760478836717
JTVyRj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.957931548236069	63	1
jxgLN5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int.imputed.txt_snps.txt	Maximum likelihood	77.127755067212	65	0.144218287386245
jxgLN5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int.imputed.txt_snps.txt	MR Egger	76.6088374812859	64	0.134200375766485
jxgLN5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int.imputed.txt_snps.txt	Inverse variance weighted	77.1845816324188	65	0.143211117284465
jxgLN5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_pct_int.imputed.txt_snps.txt	Unweighted regression	0.067410691056177	65	1
jxgLN5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int.imputed.txt_snps.txt	Maximum likelihood	78.0086752966977	64	0.112020161562954
jxgLN5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int.imputed.txt_snps.txt	MR Egger	78.0198664852439	63	0.0963235526766108
jxgLN5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int.imputed.txt_snps.txt	Inverse variance weighted	78.0230977705288	64	0.11180744655818
jxgLN5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_pct_int.imputed.txt_snps.txt	Unweighted regression	0.106608940430433	64	1
jxgLN5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int.imputed.txt_snps.txt	Maximum likelihood	63.3488535287713	65	0.534832074578629
jxgLN5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int.imputed.txt_snps.txt	MR Egger	60.306764088727	64	0.607835388751555
jxgLN5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int.imputed.txt_snps.txt	Inverse variance weighted	63.4262476324911	65	0.532090341686261
jxgLN5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_pct_int.imputed.txt_snps.txt	Unweighted regression	0.766585697493571	65	1
k2uhnP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	140.765364739479	91	0.000639807320405925
k2uhnP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int.imputed.txt_snps.txt	MR Egger	140.056989752912	90	0.000576729441793308
k2uhnP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	140.766336164903	91	0.000639686605864147
k2uhnP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0999430768639321	91	1
k2uhnP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	152.368426732413	91	5.90170893682426e-05
k2uhnP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int.imputed.txt_snps.txt	MR Egger	152.366994618359	90	4.46080390647411e-05
k2uhnP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	152.368557979729	91	5.90154157217652e-05
k2uhnP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.181626568035783	91	1
k2uhnP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	126.009306139797	88	0.00491732927216193
k2uhnP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int.imputed.txt_snps.txt	MR Egger	115.354402666847	87	0.0226609490476348
k2uhnP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	126.01557099693	88	0.00491202081598962
k2uhnP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.938244714564209	88	1
K95QXS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	139.654585974963	88	0.000380258575581422
K95QXS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	136.670299004906	87	0.000538449894385099
K95QXS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	139.774975879127	88	0.000371120079480231
K95QXS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.10855170076203	88	1
K95QXS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	125.594324139756	88	0.00528095302600858
K95QXS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	123.263047832319	87	0.00641403789526509
K95QXS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	125.693991490394	88	0.00519143157946132
K95QXS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.147259603246885	88	1
K95QXS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	101.731661783836	86	0.118315944463383
K95QXS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	101.447665504797	85	0.107746654157446
K95QXS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	101.847922489445	86	0.1167539811206
K95QXS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.975261958714573	86	1
KBwwvg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int.imputed.txt_snps.txt	Maximum likelihood	56.3049806158392	47	0.165872957454561
KBwwvg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int.imputed.txt_snps.txt	MR Egger	56.258463813486	46	0.142905714139621
KBwwvg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int.imputed.txt_snps.txt	Inverse variance weighted	56.3206153951355	47	0.165517237972417
KBwwvg	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gln_int.imputed.txt_snps.txt	Unweighted regression	0.0678444193214173	47	1
KBwwvg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int.imputed.txt_snps.txt	Maximum likelihood	50.5517479924043	47	0.335089358200248
KBwwvg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int.imputed.txt_snps.txt	MR Egger	49.7313540421496	46	0.327043043891195
KBwwvg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int.imputed.txt_snps.txt	Inverse variance weighted	50.5807258522802	47	0.334053890919377
KBwwvg	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gln_int.imputed.txt_snps.txt	Unweighted regression	0.0833788477462724	47	1
KBwwvg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int.imputed.txt_snps.txt	Maximum likelihood	43.279228397799	45	0.545055414998394
KBwwvg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int.imputed.txt_snps.txt	MR Egger	42.6498571882982	44	0.529534290065264
KBwwvg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int.imputed.txt_snps.txt	Inverse variance weighted	43.3031451155303	45	0.544031023467781
KBwwvg	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gln_int.imputed.txt_snps.txt	Unweighted regression	0.450788230143286	45	1
Kncb4w	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	69.4075214676559	40	0.00268191962755998
Kncb4w	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	69.3786214978606	39	0.00195857540451573
Kncb4w	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	69.4137717962543	40	0.00267789270149133
Kncb4w	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0507167323941237	40	1
Kncb4w	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	71.1750149478303	40	0.00174436995411511
Kncb4w	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	70.9445436596916	39	0.00132532369278493
Kncb4w	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	71.1878496963173	40	0.00173886429809664
Kncb4w	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.101558898294417	40	1
Kncb4w	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	41.9751479783414	38	0.302609567745864
Kncb4w	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	40.1553419975366	37	0.332170678068703
Kncb4w	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	42.0378396868642	38	0.300268573348842
Kncb4w	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.286869158034224	38	1
kv3OWr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	132.756412561715	83	0.000431346532265494
kv3OWr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	132.727489243898	82	0.000334310605650251
kv3OWr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	132.759268444892	83	0.000431094055657308
kv3OWr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.126936796559851	83	1
kv3OWr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	132.58083080323	83	0.000447141877432751
kv3OWr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	132.559785239606	82	0.000346194108043321
kv3OWr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	132.584361878014	83	0.000446818873219178
kv3OWr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.160539040004703	83	1
kv3OWr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	107.672069408079	81	0.0254264217800839
kv3OWr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	106.518874805986	80	0.0254222429796786
kv3OWr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	107.688176931186	81	0.0253643393953629
kv3OWr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.994731391635303	81	1
KWybOA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	142.378819347345	95	0.00119592425901701
KWybOA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int.imputed.txt_snps.txt	MR Egger	142.264489173339	94	0.000973101127357305
KWybOA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	142.40375136371	95	0.00119043551282147
KWybOA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0895649423320811	95	1
KWybOA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	146.914534645551	95	0.000507385674514802
KWybOA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int.imputed.txt_snps.txt	MR Egger	146.631106281249	94	0.000421071043909945
KWybOA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	146.97414253097	95	0.000501565077095439
KWybOA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.119749876024997	95	1
KWybOA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	127.861789629433	92	0.00798229821563794
KWybOA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int.imputed.txt_snps.txt	MR Egger	125.443304679464	91	0.00975660480255325
KWybOA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	127.882900272899	92	0.00795493725202046
KWybOA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.650545704359499	92	1
KyrUt5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	90.4599132311214	73	0.0810888552876489
KyrUt5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int.imputed.txt_snps.txt	MR Egger	87.5246094953059	72	0.102831975013391
KyrUt5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	90.4920031887823	73	0.0807435350340601
KyrUt5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.0935818200413681	73	1
KyrUt5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	107.70801006349	73	0.0051441791272145
KyrUt5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int.imputed.txt_snps.txt	MR Egger	102.086003650048	72	0.0113599065871094
KyrUt5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	107.74706231436	73	0.00510719311338445
KyrUt5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.17507187599064	73	1
KyrUt5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	65.4114005827202	71	0.664774761991774
KyrUt5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int.imputed.txt_snps.txt	MR Egger	59.743698182234	70	0.804024089317426
KyrUt5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	65.467696267708	71	0.662956171315405
KyrUt5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.611433131979418	71	1
kZb20m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	106.161160273958	69	0.00271097358737932
kZb20m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	105.363577989976	68	0.00248340454236742
kZb20m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	106.165577124975	69	0.00270860865396644
kZb20m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0874593179609151	69	1
kZb20m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	84.6865616380446	69	0.0965382102305393
kZb20m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	84.0482451084904	68	0.0906348747043043
kZb20m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	84.6938282983699	69	0.0964459235011873
kZb20m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.101009212626381	69	1
kZb20m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	79.5994840751835	68	0.158760796125459
kZb20m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	79.1057093666734	67	0.147894395547624
kZb20m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	79.6262383325022	68	0.15826142790748
kZb20m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.605082986317024	68	1
l74y3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	103.632348967046	86	0.0947181737944873
l74y3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	103.544356559318	85	0.0837021317365004
l74y3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	103.632559979713	86	0.0947157768284799
l74y3T	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.135879581078035	86	1
l74y3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	102.77970577561	86	0.104800710024427
l74y3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	102.775306071909	85	0.0919681722935883
l74y3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	102.780343081416	86	0.104792873071958
l74y3T	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.262261164267141	86	1
l74y3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	90.4649050560814	81	0.221120825164009
l74y3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	90.3099758149691	80	0.201951446484048
l74y3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	90.4675262130446	81	0.221064038694947
l74y3T	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	1.48093996646616	81	1
lEN5jh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	130.047986106633	107	0.0643041346751049
lEN5jh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int.imputed.txt_snps.txt	MR Egger	129.519387685463	106	0.0600583934020238
lEN5jh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	130.048238297597	107	0.064302230369344
lEN5jh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.137553787432687	107	1
lEN5jh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	118.880763254977	107	0.203527556412338
lEN5jh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int.imputed.txt_snps.txt	MR Egger	117.658720945328	106	0.206530045451823
lEN5jh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	118.882463632051	107	0.203496909599986
lEN5jh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.182034039514791	107	1
lEN5jh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	120.706863461728	102	0.0996929216425838
lEN5jh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int.imputed.txt_snps.txt	MR Egger	120.699084838774	101	0.0883215948981355
lEN5jh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	120.725103137173	102	0.0994931616185607
lEN5jh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	1.2350798744396	102	1
lG2lFG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	106.930149253921	78	0.0165329241624862
lG2lFG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	106.924225564792	77	0.0136505365992594
lG2lFG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	106.930432217805	78	0.0165321668911649
lG2lFG	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.115010167432897	78	1
lG2lFG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	94.373958921485	78	0.0999945169894338
lG2lFG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	93.3502973652689	77	0.0990065228171706
lG2lFG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	94.3739831917189	78	0.0999942165748889
lG2lFG	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.134591936519711	78	1
lG2lFG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	106.229634669743	73	0.00673989205169336
lG2lFG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	104.693022102422	72	0.00715692041377162
lG2lFG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	106.236788580906	73	0.00673118111236278
lG2lFG	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.95213038710094	73	1
lJAcwO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	110.610033323307	52	4.07878391918703e-06
lJAcwO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int.imputed.txt_snps.txt	MR Egger	110.601990651725	51	2.72073431377945e-06
lJAcwO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	110.614843061311	52	4.07328079577819e-06
lJAcwO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0771380660275245	52	1
lJAcwO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	110.86041682275	52	3.80173315277291e-06
lJAcwO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int.imputed.txt_snps.txt	MR Egger	108.269213899732	51	5.26246281232573e-06
lJAcwO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	110.862254596109	52	3.79976917809426e-06
lJAcwO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.113954045020092	52	1
lJAcwO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	48.2461007320355	49	0.503612249125485
lJAcwO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int.imputed.txt_snps.txt	MR Egger	47.3806431790737	48	0.498127132446193
lJAcwO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	48.2920778879197	49	0.501742889020852
lJAcwO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.313037941145959	49	1
lQMy6J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	55.8440773809414	30	0.0028451267570881
lQMy6J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	55.3419220724401	29	0.00225963036199645
lQMy6J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	55.8653667958132	30	0.00282918832304576
lQMy6J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0784345733687114	30	1
lQMy6J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	51.2431770491645	30	0.00917892021288083
lQMy6J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	51.2367568773977	29	0.0066230843334999
lQMy6J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	51.2432910418244	30	0.00917866399871144
lQMy6J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0983410008239651	30	1
lQMy6J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	51.6882300202191	26	0.00196575448515308
lQMy6J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	51.4654032552186	25	0.00140013322613095
lQMy6J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	51.6896196528451	26	0.00196498564569408
lQMy6J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.56080951110362	26	1
Lrw1NT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	91.8367277145233	70	0.0411525875410201
Lrw1NT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	89.8761385412306	69	0.0465210632870714
Lrw1NT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	91.8471600605363	70	0.0410876734285727
Lrw1NT	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.108089732497942	70	1
Lrw1NT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	96.2410717688613	70	0.0204904828526522
Lrw1NT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	95.6402747386915	69	0.0186201810281453
Lrw1NT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	96.2546476922539	70	0.0204445742000009
Lrw1NT	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.146597185076922	70	1
Lrw1NT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	66.1901066123402	66	0.470272639983226
Lrw1NT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	66.0378280674141	65	0.44078485610381
Lrw1NT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	66.211771821465	66	0.469524637992458
Lrw1NT	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.859790856650945	66	1
lXmJAl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	121.929405811015	60	4.10707192773918e-06
lXmJAl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int.imputed.txt_snps.txt	MR Egger	121.357544781659	59	3.27661565823173e-06
lXmJAl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	121.9569558307	60	4.07675906671221e-06
lXmJAl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	non_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0714867680247719	60	1
lXmJAl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	118.349665231249	60	1.06272017567141e-05
lXmJAl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int.imputed.txt_snps.txt	MR Egger	117.92021250599	59	8.24933939669705e-06
lXmJAl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	118.390423524018	60	1.05142057380727e-05
lXmJAl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	non_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.120197946981993	60	1
lXmJAl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	66.5949428562951	57	0.180273635404013
lXmJAl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int.imputed.txt_snps.txt	MR Egger	66.5295571723506	56	0.158470484377057
lXmJAl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	66.6256798820118	57	0.179593134331852
lXmJAl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	non_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.690503523203817	57	1
M1T7aO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	107.156251344914	63	0.000439465790549853
M1T7aO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int.imputed.txt_snps.txt	MR Egger	106.918250860301	62	0.000345051884463295
M1T7aO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	107.156738018654	63	0.000439417481302343
M1T7aO	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0718042372511833	63	1
M1T7aO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	101.694322367962	63	0.00145509393628097
M1T7aO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int.imputed.txt_snps.txt	MR Egger	101.192578333899	62	0.00123500617514091
M1T7aO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	101.700909289159	63	0.00145306031692332
M1T7aO	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0941806812890554	63	1
M1T7aO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	66.2010713520137	62	0.334088183425102
M1T7aO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int.imputed.txt_snps.txt	MR Egger	62.6647830872916	61	0.416973903652571
M1T7aO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	66.3544463588154	62	0.329311079741349
M1T7aO	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.446181672104893	62	1
M2B8xL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	116.652537964461	74	0.00115180827037117
M2B8xL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int.imputed.txt_snps.txt	MR Egger	116.497133877382	73	0.000919815525506487
M2B8xL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	116.653764662956	74	0.0011515215516796
M2B8xL	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.0982806102724497	74	1
M2B8xL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	120.360762527817	74	0.000534139784173665
M2B8xL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int.imputed.txt_snps.txt	MR Egger	120.272392683098	73	0.000414960370184944
M2B8xL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	120.410462505082	74	0.000528555154095681
M2B8xL	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.162857742148751	74	1
M2B8xL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	79.5758552411854	72	0.252843832306506
M2B8xL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int.imputed.txt_snps.txt	MR Egger	79.4680279436016	71	0.229761144477494
M2B8xL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	79.5805082984567	72	0.252727945574993
M2B8xL	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.78010941920796	72	1
m2CUMo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int.imputed.txt_snps.txt	Maximum likelihood	17.0976323761161	12	0.145961469816284
m2CUMo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int.imputed.txt_snps.txt	MR Egger	11.080469285238	11	0.436546655769778
m2CUMo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int.imputed.txt_snps.txt	Inverse variance weighted	17.1013253651524	12	0.145825379720203
m2CUMo	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Lactate_int.imputed.txt_snps.txt	Unweighted regression	0.0101833101311194	12	1
m2CUMo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int.imputed.txt_snps.txt	Maximum likelihood	20.5491119560912	12	0.0573858593686939
m2CUMo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int.imputed.txt_snps.txt	MR Egger	14.1374027655482	11	0.225483469225884
m2CUMo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int.imputed.txt_snps.txt	Inverse variance weighted	20.5746713926956	12	0.0569665370439085
m2CUMo	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Lactate_int.imputed.txt_snps.txt	Unweighted regression	0.0141664124935278	12	1
m2CUMo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int.imputed.txt_snps.txt	Maximum likelihood	7.40132038282946	12	0.829993963297501
m2CUMo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int.imputed.txt_snps.txt	MR Egger	7.11869007965868	11	0.789391866966124
m2CUMo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int.imputed.txt_snps.txt	Inverse variance weighted	7.40477558732719	12	0.829747010528178
m2CUMo	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Lactate_int.imputed.txt_snps.txt	Unweighted regression	0.0213121262194116	12	0.999999999999998
m6Q5U3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	121.997541172933	63	1.20715164484976e-05
m6Q5U3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	121.137802801006	62	1.05622380692928e-05
m6Q5U3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	122.018727226376	63	1.2005880142455e-05
m6Q5U3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0845466101280385	63	1
m6Q5U3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	117.219542066753	63	4.03782957496632e-05
m6Q5U3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	116.16997601077	62	3.74538275177776e-05
m6Q5U3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	117.297488532866	63	3.96050657631886e-05
m6Q5U3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.109136407623576	63	1
m6Q5U3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	66.1403842296424	62	0.33598791683766
m6Q5U3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	65.975958371758	61	0.308956808823188
m6Q5U3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	66.1934683332708	62	0.334325891513858
m6Q5U3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.432186521540136	62	1
m7l279	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	83.4135977864668	55	0.00801981314337799
m7l279	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int.imputed.txt_snps.txt	MR Egger	82.0138072463033	54	0.00829455804876258
m7l279	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	83.4335132101892	55	0.00798815175148796
m7l279	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0993509466893025	55	1
m7l279	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	89.3485724746915	55	0.00233584849796993
m7l279	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int.imputed.txt_snps.txt	MR Egger	88.9036606883503	54	0.00194866025013816
m7l279	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	89.351813896626	55	0.00233420789685287
m7l279	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.131832848893543	55	1
m7l279	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	55.6147540640986	52	0.340308051806426
m7l279	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int.imputed.txt_snps.txt	MR Egger	55.0741287109697	51	0.323197768164695
m7l279	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	55.6515551773149	52	0.3390456680577
m7l279	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.311866862434521	52	1
mGR4st	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	107.954951842257	74	0.0061346085363699
mGR4st	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	102.647315168753	73	0.0126539473627967
mGR4st	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	107.95498301695	74	0.00613457388115683
mGR4st	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0855039830503365	74	1
mGR4st	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	106.909739447008	74	0.00740301935072567
mGR4st	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	103.286323888059	73	0.0113387753358421
mGR4st	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	106.922319493816	74	0.00738642126069544
mGR4st	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.133522407716951	74	1
mGR4st	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	87.9765573809743	72	0.0970410194292233
mGR4st	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	79.243241199126	71	0.23510842578589
mGR4st	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	88.011812912256	72	0.0966003535052119
mGR4st	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.725907275977852	72	1
MgY5Na	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	110.457907133516	76	0.00603247532983968
MgY5Na	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int.imputed.txt_snps.txt	MR Egger	109.613743116142	75	0.0056516129553264
MgY5Na	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	110.526368135925	76	0.00595872454117645
MgY5Na	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.108787219078859	76	1
MgY5Na	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	108.49190952041	76	0.00854314518637441
MgY5Na	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int.imputed.txt_snps.txt	MR Egger	107.160525982656	75	0.00875060396508939
MgY5Na	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	108.569503219802	76	0.0084282621214159
MgY5Na	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.162182955630705	76	1
MgY5Na	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	70.8255608337202	74	0.583061552615824
MgY5Na	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int.imputed.txt_snps.txt	MR Egger	69.6628946763759	73	0.589042620373754
MgY5Na	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	70.9655944997357	74	0.578436729748431
MgY5Na	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.679573304136961	74	1
MjOqyw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int.imputed.txt_snps.txt	Maximum likelihood	28.2263015190867	16	0.029706542416648
MjOqyw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int.imputed.txt_snps.txt	MR Egger	26.5802878220488	15	0.032348019664447
MjOqyw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int.imputed.txt_snps.txt	Inverse variance weighted	28.2290693840291	16	0.0296838104363035
MjOqyw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	bOHbutyrate_int.imputed.txt_snps.txt	Unweighted regression	0.026357203382226	16	1
MjOqyw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int.imputed.txt_snps.txt	Maximum likelihood	23.1282417956025	16	0.110349067902267
MjOqyw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int.imputed.txt_snps.txt	MR Egger	23.0439066742687	15	0.0832120856256642
MjOqyw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int.imputed.txt_snps.txt	Inverse variance weighted	23.131315207893	16	0.110268977023692
MjOqyw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	bOHbutyrate_int.imputed.txt_snps.txt	Unweighted regression	0.0272684952784679	16	1
MjOqyw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int.imputed.txt_snps.txt	Maximum likelihood	18.7805782280049	14	0.173504028256145
MjOqyw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int.imputed.txt_snps.txt	MR Egger	18.749236830831	13	0.131086179905466
MjOqyw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int.imputed.txt_snps.txt	Inverse variance weighted	18.784188019607	14	0.173360511977596
MjOqyw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	bOHbutyrate_int.imputed.txt_snps.txt	Unweighted regression	0.0995045405147174	14	0.999999999999857
mlur4m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	110.544534470177	52	4.15445146353269e-06
mlur4m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int.imputed.txt_snps.txt	MR Egger	110.238246698068	51	3.01753433788208e-06
mlur4m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	110.54462524661	52	4.15434565191262e-06
mlur4m	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0700973812659855	52	1
mlur4m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	115.67271410727	52	9.61931996240611e-07
mlur4m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int.imputed.txt_snps.txt	MR Egger	112.043234435705	51	1.80085776290433e-06
mlur4m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	115.674182923159	52	9.61522534166552e-07
mlur4m	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.127910033102945	52	1
mlur4m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	61.2419384138918	50	0.132408562965021
mlur4m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int.imputed.txt_snps.txt	MR Egger	59.9827165824922	49	0.135195617125165
mlur4m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	61.4007132017546	50	0.129462455370371
mlur4m	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.5404753390645	50	1
mo6Fdr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	100.94133617354	71	0.0112686628099726
mo6Fdr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	99.1784989209917	70	0.0124500574570892
mo6Fdr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	100.958512152318	71	0.0112349054458533
mo6Fdr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.103282842140004	71	1
mo6Fdr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	82.6951805915272	71	0.161710008159582
mo6Fdr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	82.5367443272301	70	0.145081381949086
mo6Fdr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	82.7385884534172	71	0.160905349762548
mo6Fdr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.149264524144082	71	1
mo6Fdr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	85.5951351777931	70	0.0991191032700798
mo6Fdr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	85.6518343884388	69	0.0848805900237947
mo6Fdr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	85.6518345643133	70	0.0983902848496172
mo6Fdr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.819025892689512	70	1
N0ajZJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	109.90662230645	70	0.00164230805267124
N0ajZJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int.imputed.txt_snps.txt	MR Egger	109.41057593593	69	0.0014074510899384
N0ajZJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	109.924856540459	70	0.00163624334546335
N0ajZJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0697695487813073	70	1
N0ajZJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	105.432851199977	70	0.00396820739152274
N0ajZJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int.imputed.txt_snps.txt	MR Egger	105.432921663114	69	0.00312835352901512
N0ajZJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	105.445201874368	70	0.00395883760324084
N0ajZJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.105144319602157	70	1
N0ajZJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	73.7350036661905	67	0.267446242622186
N0ajZJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int.imputed.txt_snps.txt	MR Egger	73.567283642261	66	0.244290117706449
N0ajZJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	73.7593698209858	67	0.266797268108124
N0ajZJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.719807958370078	67	1
N5jGcp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	119.823323251972	78	0.00164759624035276
N5jGcp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	118.281650852751	77	0.00174903666343998
N5jGcp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	119.823378907297	78	0.00164757837210902
N5jGcp	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.168435366011958	78	1
N5jGcp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	114.914203710494	78	0.00416661612450562
N5jGcp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	112.790324601931	77	0.00492210606654319
N5jGcp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	114.914252283643	78	0.00416657909030792
N5jGcp	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.212092117374584	78	1
N5jGcp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	100.811885739804	74	0.0208648221298855
N5jGcp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	100.784195388182	73	0.0173095008004045
N5jGcp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	100.859084912292	74	0.0207066154583446
N5jGcp	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	1.48336786162051	74	1
NhAsDU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	133.464599003917	79	0.000125451642030833
NhAsDU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	132.796997977434	78	0.000109227213247537
NhAsDU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	133.464897330124	79	0.000125443391974678
NhAsDU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.100034311345161	79	1
NhAsDU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	133.230739610029	79	0.000132081614665207
NhAsDU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	133.105823088382	78	0.000101959498770562
NhAsDU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	133.236049650345	79	0.000131927411880472
NhAsDU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.174041477076871	79	1
NhAsDU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	115.297339299304	78	0.00388378947818928
NhAsDU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	111.769868185384	77	0.00591623703561252
NhAsDU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	115.43714740984	78	0.00378509147865258
NhAsDU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	1.05339934859863	78	1
NmU9ex	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	86.8337019315918	51	0.00130080123617118
NmU9ex	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int.imputed.txt_snps.txt	MR Egger	80.2768814361682	50	0.00422310187334302
NmU9ex	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	86.8944740877782	51	0.00128272001353037
NmU9ex	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0764412185638204	51	1
NmU9ex	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	87.8451510979005	51	0.0010290669517309
NmU9ex	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int.imputed.txt_snps.txt	MR Egger	84.3893743918254	50	0.00169299157443576
NmU9ex	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	87.8518676261069	51	0.00102745702195563
NmU9ex	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0915667496740876	51	1
NmU9ex	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	73.9071952158908	50	0.0156065446161049
NmU9ex	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int.imputed.txt_snps.txt	MR Egger	71.5925544012229	49	0.0192997064229603
NmU9ex	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	73.9599355993928	50	0.0154475366381685
NmU9ex	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.534084588883272	50	1
NnFeaS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	60.4742478581636	42	0.0322275684518185
NnFeaS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	59.3055971385928	41	0.0320070243599238
NnFeaS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	60.4821515365803	42	0.0321786607051741
NnFeaS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0635633077986755	42	1
NnFeaS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	55.0621849863198	42	0.0852399145652938
NnFeaS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	52.8717681870111	41	0.10126110675219
NnFeaS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	55.0852089153484	42	0.0849131700574013
NnFeaS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0859632021347314	42	1
NnFeaS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	39.5980927313465	40	0.488193254670017
NnFeaS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	39.5164108296752	39	0.446816156274012
NnFeaS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	39.5983132648106	40	0.488183369741946
NnFeaS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.388194528168078	40	1
NPlba8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	111.034123049102	51	2.40506933427602e-06
NPlba8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int.imputed.txt_snps.txt	MR Egger	109.907808483979	50	2.19094760328759e-06
NPlba8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	111.034123049102	51	2.40506933427602e-06
NPlba8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.075777406944224	51	1
NPlba8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	118.097012972316	51	3.05748304109852e-07
NPlba8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int.imputed.txt_snps.txt	MR Egger	113.959677436825	50	6.72041494041223e-07
NPlba8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	118.097874420251	51	3.05669813461581e-07
NPlba8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.135709406251996	51	1
NPlba8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	55.8315041941418	49	0.233595671041042
NPlba8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int.imputed.txt_snps.txt	MR Egger	53.443594767407	48	0.273134593465278
NPlba8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	55.9377265578165	49	0.230597745961094
NPlba8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.499292705424634	49	1
Ns7oi2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int.imputed.txt_snps.txt	Maximum likelihood	127.894363558621	68	1.52599972002383e-05
Ns7oi2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int.imputed.txt_snps.txt	MR Egger	120.086308178547	67	7.38405813658231e-05
Ns7oi2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int.imputed.txt_snps.txt	Inverse variance weighted	127.939267759634	68	1.50900116470116e-05
Ns7oi2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_L_int.imputed.txt_snps.txt	Unweighted regression	0.0821385422522985	68	1
Ns7oi2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int.imputed.txt_snps.txt	Maximum likelihood	128.474241559798	68	1.3200984408419e-05
Ns7oi2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int.imputed.txt_snps.txt	MR Egger	117.7239669491	67	0.000128806493025822
Ns7oi2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int.imputed.txt_snps.txt	Inverse variance weighted	128.514392572788	68	1.30688622738423e-05
Ns7oi2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_L_int.imputed.txt_snps.txt	Unweighted regression	0.136101342224304	68	1
Ns7oi2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int.imputed.txt_snps.txt	Maximum likelihood	75.7033778853886	67	0.218107699872169
Ns7oi2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int.imputed.txt_snps.txt	MR Egger	71.1863882361002	66	0.309310863410163
Ns7oi2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int.imputed.txt_snps.txt	Inverse variance weighted	75.7037751579739	67	0.218098383213818
Ns7oi2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_L_int.imputed.txt_snps.txt	Unweighted regression	0.654937991634278	67	1
NSjWwE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	161.983669624718	97	3.90833914670837e-05
NSjWwE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	160.493509591517	96	4.08619405613851e-05
NSjWwE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	161.993262012477	97	3.90030461157972e-05
NSjWwE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.256696592405771	97	1
NSjWwE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	157.083607918715	97	0.000109564852543754
NSjWwE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	152.716175448741	96	0.000206389461616546
NSjWwE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	157.083811907804	97	0.000109560245415147
NSjWwE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.348089988552718	97	1
NSjWwE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	132.044022603201	94	0.00592127677884191
NSjWwE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	132.186232096573	93	0.00474051827452657
NSjWwE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	132.205465972088	94	0.00576503469560063
NSjWwE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.77794417203103	94	1
NvLmfN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	123.748036677031	102	0.070495691038684
NvLmfN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int.imputed.txt_snps.txt	MR Egger	123.648069363155	101	0.0625129400533927
NvLmfN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	123.751802949618	102	0.0704643870445355
NvLmfN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.112692187570935	102	1
NvLmfN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	132.381058041428	102	0.0231837397800195
NvLmfN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int.imputed.txt_snps.txt	MR Egger	129.834764055788	101	0.0281607942266057
NvLmfN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	132.419779630114	102	0.023058877534335
NvLmfN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.219088976969649	102	1
NvLmfN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	113.6721840923	100	0.16538363996005
NvLmfN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int.imputed.txt_snps.txt	MR Egger	108.809967218605	99	0.235023004331524
NvLmfN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	113.803455985851	100	0.163274751064137
NvLmfN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.827306251016973	100	1
NxF2Mt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	125.968647437114	77	0.000364965519866509
NxF2Mt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int.imputed.txt_snps.txt	MR Egger	122.766231864119	76	0.00054863977131359
NxF2Mt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	126.016916209867	77	0.000361243399440142
NxF2Mt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.134003157451397	77	1
NxF2Mt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	131.24116457097	77	0.000115755888269609
NxF2Mt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int.imputed.txt_snps.txt	MR Egger	129.843260083213	76	0.000118410316031138
NxF2Mt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	131.251208487467	77	0.000115496737834493
NxF2Mt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.195555449206667	77	1
NxF2Mt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	98.4222739161921	73	0.0253753616292559
NxF2Mt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int.imputed.txt_snps.txt	MR Egger	92.7085460717327	72	0.0507288248398869
NxF2Mt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	98.4251462097964	73	0.0253638174941493
NxF2Mt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.826515979070294	73	1
o3ksb9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	126.413404981285	74	0.000142791143506293
o3ksb9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int.imputed.txt_snps.txt	MR Egger	126.154475281734	73	0.000112844975324827
o3ksb9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	126.44265319766	74	0.000141857204268709
o3ksb9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0938485197594242	74	1
o3ksb9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	122.255662292815	73	0.000269706549710194
o3ksb9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int.imputed.txt_snps.txt	MR Egger	122.068930696464	72	0.000211358393731601
o3ksb9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	122.269892690658	73	0.000268865798088109
o3ksb9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.133807052364803	73	1
o3ksb9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	90.4269913015421	72	0.0700100034411846
o3ksb9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int.imputed.txt_snps.txt	MR Egger	90.2195576700909	71	0.0615924115533044
o3ksb9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	90.4716948765441	72	0.0695810655924663
o3ksb9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	1.07993297668729	72	1
OATxvf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	60.7308360396344	54	0.246314406617624
OATxvf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int.imputed.txt_snps.txt	MR Egger	60.7495362448892	53	0.216838253831486
OATxvf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	60.7517985482579	54	0.245727195554806
OATxvf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0576428438911981	54	1
OATxvf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	57.7310275124963	54	0.339102508933669
OATxvf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int.imputed.txt_snps.txt	MR Egger	57.7374504675087	53	0.304518803400412
OATxvf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	57.7380480027155	54	0.338866259398941
OATxvf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0592004684558672	54	1
OATxvf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	61.6074810498678	52	0.170016158189057
OATxvf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int.imputed.txt_snps.txt	MR Egger	61.5557597742525	51	0.147851270256342
OATxvf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	61.7594312002726	52	0.166673424782495
OATxvf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.496859631570329	52	1
Oe0Acj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	140.116356030253	111	0.0322059868263681
Oe0Acj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int.imputed.txt_snps.txt	MR Egger	139.730672352689	110	0.0292513142113386
Oe0Acj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	140.117405829387	111	0.0322016300513735
Oe0Acj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.110291584702146	111	1
Oe0Acj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	150.388406386993	111	0.00762117957346511
Oe0Acj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int.imputed.txt_snps.txt	MR Egger	149.543491748761	110	0.007260443825036
Oe0Acj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	150.418792545999	111	0.00758619747529381
Oe0Acj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.173074207938751	111	1
Oe0Acj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	139.100938918804	108	0.0235217761971547
Oe0Acj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int.imputed.txt_snps.txt	MR Egger	138.147067222306	107	0.022944803176046
Oe0Acj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	139.192362782975	108	0.0232311986093309
Oe0Acj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	1.31559458138168	108	1
OEFzz8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int.imputed.txt_snps.txt	Maximum likelihood	49.455649273199	45	0.29986466653897
OEFzz8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int.imputed.txt_snps.txt	MR Egger	46.8588803867723	44	0.356002671434022
OEFzz8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	49.4810538559791	45	0.29899215113531
OEFzz8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0515351734225694	45	1
OEFzz8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int.imputed.txt_snps.txt	Maximum likelihood	48.4861928915038	45	0.334216400737867
OEFzz8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int.imputed.txt_snps.txt	MR Egger	44.5516511846711	44	0.448428937025134
OEFzz8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	48.5323002039501	45	0.332537267629973
OEFzz8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0600341426529174	45	1
OEFzz8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int.imputed.txt_snps.txt	Maximum likelihood	76.7563997713182	43	0.00117718312297921
OEFzz8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int.imputed.txt_snps.txt	MR Egger	75.99525191875	42	0.0010222979956144
OEFzz8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	76.9527803630104	43	0.00112174497537228
OEFzz8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.952865946233688	43	1
ohBGou	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	123.778495237343	56	4.99660827983907e-07
ohBGou	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int.imputed.txt_snps.txt	MR Egger	123.443766525702	55	3.60652367588069e-07
ohBGou	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	123.783492380739	56	4.98943273387744e-07
ohBGou	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0704738640142885	56	1
ohBGou	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	114.727552424466	56	6.28734700209519e-06
ohBGou	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int.imputed.txt_snps.txt	MR Egger	113.782054592958	55	5.53535982383773e-06
ohBGou	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	114.729845472813	56	6.28343214452618e-06
ohBGou	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.10214430420392	56	1
ohBGou	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int.imputed.txt_snps.txt	Maximum likelihood	64.0714868912811	54	0.164048310067553
ohBGou	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int.imputed.txt_snps.txt	MR Egger	64.1463063145759	53	0.140380105699812
ohBGou	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	64.1705897306615	54	0.161954364932217
ohBGou	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.532275011295096	54	1
OHWsVk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int.imputed.txt_snps.txt	Maximum likelihood	56.9449994868447	34	0.00812656350028242
OHWsVk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int.imputed.txt_snps.txt	MR Egger	56.9043162939427	33	0.00600271839909112
OHWsVk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int.imputed.txt_snps.txt	Inverse variance weighted	57.0106181278114	34	0.00800135927361893
OHWsVk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Tyr_int.imputed.txt_snps.txt	Unweighted regression	0.054600815083702	34	1
OHWsVk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int.imputed.txt_snps.txt	Maximum likelihood	54.3175335937129	34	0.0149076861372833
OHWsVk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int.imputed.txt_snps.txt	MR Egger	53.370803975953	33	0.0138569605111071
OHWsVk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int.imputed.txt_snps.txt	Inverse variance weighted	54.3721596031474	34	0.0147253081908726
OHWsVk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Tyr_int.imputed.txt_snps.txt	Unweighted regression	0.0856009295267475	34	1
OHWsVk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int.imputed.txt_snps.txt	Maximum likelihood	35.6331704659284	34	0.391425510902221
OHWsVk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int.imputed.txt_snps.txt	MR Egger	35.4326921819421	33	0.354174543449686
OHWsVk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int.imputed.txt_snps.txt	Inverse variance weighted	35.6341733649711	34	0.391380310386695
OHWsVk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Tyr_int.imputed.txt_snps.txt	Unweighted regression	0.334007712343845	34	1
oxCmzP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int.imputed.txt_snps.txt	Maximum likelihood	131.410029281548	59	1.95713581216623e-07
oxCmzP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int.imputed.txt_snps.txt	MR Egger	130.809096024059	58	1.52337739799662e-07
oxCmzP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int.imputed.txt_snps.txt	Inverse variance weighted	131.42881278516	59	1.94655895218554e-07
oxCmzP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Remnant_C_int.imputed.txt_snps.txt	Unweighted regression	0.0705083099111117	59	1
oxCmzP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int.imputed.txt_snps.txt	Maximum likelihood	113.586225671812	59	2.55936448495156e-05
oxCmzP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int.imputed.txt_snps.txt	MR Egger	113.289263644573	58	1.9363360625678e-05
oxCmzP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int.imputed.txt_snps.txt	Inverse variance weighted	113.628165320137	59	2.53192656278875e-05
oxCmzP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Remnant_C_int.imputed.txt_snps.txt	Unweighted regression	0.104491323770921	59	1
oxCmzP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int.imputed.txt_snps.txt	Maximum likelihood	58.0904731530758	56	0.39821127311626
oxCmzP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int.imputed.txt_snps.txt	MR Egger	57.7646977674197	55	0.373472749358716
oxCmzP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int.imputed.txt_snps.txt	Inverse variance weighted	58.1487911651441	56	0.396140278370719
oxCmzP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Remnant_C_int.imputed.txt_snps.txt	Unweighted regression	0.55206279337069	56	1
PAburS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	96.4866215161188	67	0.0106339109342443
PAburS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	96.1517148266944	66	0.00908476714541913
PAburS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	96.5654148927932	67	0.0104843604145551
PAburS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0740179639467456	67	1
PAburS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	99.0957602714073	67	0.00658909941810836
PAburS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	98.0123161138639	66	0.00642744302513822
PAburS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	99.1556785811856	67	0.00651557143489701
PAburS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.124225976236813	67	1
PAburS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	73.8524811735053	67	0.264325967472314
PAburS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	72.2517858699858	66	0.279111901420111
PAburS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	74.0950373336797	67	0.257952900112182
PAburS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.684266182778251	67	1
pb5fKI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int.imputed.txt_snps.txt	Maximum likelihood	152.835992925875	95	0.00015605210787985
pb5fKI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int.imputed.txt_snps.txt	MR Egger	149.795781858261	94	0.000224213338338923
pb5fKI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int.imputed.txt_snps.txt	Inverse variance weighted	152.896563065829	95	0.00015412956629278
pb5fKI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	TG_by_PG_int.imputed.txt_snps.txt	Unweighted regression	0.113612369486808	95	1
pb5fKI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int.imputed.txt_snps.txt	Maximum likelihood	144.118406565529	95	0.000864960671918854
pb5fKI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int.imputed.txt_snps.txt	MR Egger	138.10273174817	94	0.00208574681571892
pb5fKI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int.imputed.txt_snps.txt	Inverse variance weighted	144.147817112157	95	0.000860190625816878
pb5fKI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	TG_by_PG_int.imputed.txt_snps.txt	Unweighted regression	0.160533293710047	95	1
pb5fKI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int.imputed.txt_snps.txt	Maximum likelihood	136.803797076274	93	0.00211950461067599
pb5fKI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int.imputed.txt_snps.txt	MR Egger	136.738719067929	92	0.00172203344290958
pb5fKI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int.imputed.txt_snps.txt	Inverse variance weighted	136.829171142787	93	0.00210987826940112
pb5fKI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	TG_by_PG_int.imputed.txt_snps.txt	Unweighted regression	1.28105844394713	93	1
PhhGNS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	128.618313678751	90	0.00473421313403481
PhhGNS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	125.526825293535	89	0.00653544432082187
PhhGNS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	128.637042842113	90	0.0047190377786047
PhhGNS	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.153396843769805	90	1
PhhGNS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	109.675355890532	90	0.0777505158076742
PhhGNS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	109.501750765199	89	0.0692407829968602
PhhGNS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	109.702192191402	90	0.0774956597477337
PhhGNS	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.172126370641682	90	1
PhhGNS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	82.9544029809504	86	0.57299785764643
PhhGNS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	82.8014300921677	85	0.547294321558885
PhhGNS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	82.9922746321788	86	0.571838188126434
PhhGNS	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.42096482371386	86	1
pKm2N5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	101.817998573095	82	0.0682375773325789
pKm2N5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int.imputed.txt_snps.txt	MR Egger	96.4239340500862	81	0.116223136379771
pKm2N5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	101.823694269734	82	0.0681868754354223
pKm2N5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0948344961505395	82	1
pKm2N5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	119.711282794034	82	0.00419496419611736
pKm2N5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int.imputed.txt_snps.txt	MR Egger	117.362271734586	81	0.00514593210456601
pKm2N5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	119.727188907485	82	0.00418300932246669
pKm2N5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.139933040017743	82	1
pKm2N5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	93.8450269143273	77	0.0930430243791346
pKm2N5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int.imputed.txt_snps.txt	MR Egger	79.710905673211	76	0.363123677443457
pKm2N5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	93.8552179952462	77	0.0929232464508306
pKm2N5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.695877045614491	77	1
PvH3JE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int.imputed.txt_snps.txt	Maximum likelihood	72.9685927605138	26	2.42928048699473e-06
PvH3JE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int.imputed.txt_snps.txt	MR Egger	70.711382338881	25	3.01536527894385e-06
PvH3JE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int.imputed.txt_snps.txt	Inverse variance weighted	73.0337542051252	26	2.37579610690343e-06
PvH3JE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Glucose_int.imputed.txt_snps.txt	Unweighted regression	0.0316355614706583	26	1
PvH3JE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int.imputed.txt_snps.txt	Maximum likelihood	59.509266567321	26	0.000195138612041875
PvH3JE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int.imputed.txt_snps.txt	MR Egger	57.5465196821997	25	0.000225746328402867
PvH3JE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int.imputed.txt_snps.txt	Inverse variance weighted	59.5208224231785	26	0.000194445076281129
PvH3JE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Glucose_int.imputed.txt_snps.txt	Unweighted regression	0.0376438906122393	26	1
PvH3JE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int.imputed.txt_snps.txt	Maximum likelihood	17.6645404687116	25	0.856295318793064
PvH3JE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int.imputed.txt_snps.txt	MR Egger	16.4249471591814	24	0.872130621309427
PvH3JE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int.imputed.txt_snps.txt	Inverse variance weighted	17.6848958950711	25	0.855470955125914
PvH3JE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Glucose_int.imputed.txt_snps.txt	Unweighted regression	0.0488730242333227	25	1
Px8K1J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	96.7900751238764	57	0.000790725419806893
Px8K1J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int.imputed.txt_snps.txt	MR Egger	96.2411757256075	56	0.00066591065224683
Px8K1J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	96.8255310582978	57	0.00078437650294928
Px8K1J	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0913983574130665	57	1
Px8K1J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	95.3252409377845	57	0.00110006874965595
Px8K1J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int.imputed.txt_snps.txt	MR Egger	95.1502955912142	56	0.000855121978666871
Px8K1J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	95.3635824357659	57	0.00109068156266972
Px8K1J	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.134350189791586	57	1
Px8K1J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	62.8082949693187	54	0.192474217756136
Px8K1J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int.imputed.txt_snps.txt	MR Egger	62.7176664335138	53	0.169654291866534
Px8K1J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	62.8097840712593	54	0.192438796672911
Px8K1J	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.320493791603898	54	1
PzaSsl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	104.009532141196	76	0.0181590630877485
PzaSsl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	103.064835958977	75	0.0175016290905167
PzaSsl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	104.016880088054	76	0.0181374666327861
PzaSsl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0749832496224567	76	1
PzaSsl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	92.4836219324479	76	0.0960869403503509
PzaSsl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	90.2511964810502	75	0.110620689120505
PzaSsl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	92.4839564236214	76	0.0960828821259553
PzaSsl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.105268308149728	76	1
PzaSsl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	115.860664041046	75	0.00173099829847844
PzaSsl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	114.727774318215	74	0.00169482260523905
PzaSsl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	115.948519728319	75	0.00170126167193224
PzaSsl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.912985391492515	75	1
pZZnPE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	141.487527791582	83	6.6755073260501e-05
pZZnPE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	139.041938870226	82	8.61510683438929e-05
pZZnPE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	141.503479493683	83	6.65189884092012e-05
pZZnPE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.171905385168284	83	1
pZZnPE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	142.898640204642	83	4.87065869429713e-05
pZZnPE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	142.106872238981	82	4.33982298395364e-05
pZZnPE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	142.919176778198	83	4.84823551966151e-05
pZZnPE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.257681165263763	83	1
pZZnPE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	123.771150519051	80	0.00123498078025609
pZZnPE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	123.468981405809	79	0.00102534017544602
pZZnPE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	123.777708879484	80	0.00123339098602386
pZZnPE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	1.45496167461127	80	1
Q1cGKX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	122.85298099807	72	0.000177366561620114
Q1cGKX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int.imputed.txt_snps.txt	MR Egger	122.796526637502	71	0.000133836739104237
Q1cGKX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	122.878780470983	72	0.000176342308497172
Q1cGKX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.103677314886719	72	1
Q1cGKX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	109.081641636313	72	0.00315395209475803
Q1cGKX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int.imputed.txt_snps.txt	MR Egger	109.116752474953	71	0.00246480571344103
Q1cGKX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	109.123990143032	72	0.0031283420880041
Q1cGKX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.1647405071535	72	1
Q1cGKX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	76.5187612818031	70	0.277372525479222
Q1cGKX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int.imputed.txt_snps.txt	MR Egger	75.5683318877997	69	0.274696665893046
Q1cGKX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	76.5817651880213	70	0.275695028359094
Q1cGKX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.683475230397156	70	1
Qa6JMV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	101.365061267567	57	0.00027217209215142
Qa6JMV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int.imputed.txt_snps.txt	MR Egger	100.622899923975	56	0.00023655696544399
Qa6JMV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	101.402405051566	57	0.000269755678179723
Qa6JMV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0956100981711849	57	1
Qa6JMV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	97.1822504140103	57	0.000723138023727997
Qa6JMV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int.imputed.txt_snps.txt	MR Egger	97.1747312699358	56	0.000536295886405254
Qa6JMV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	97.2264803168826	57	0.000715869629347601
Qa6JMV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.112428831132062	57	1
Qa6JMV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	90.2996055996416	54	0.00142825360057648
Qa6JMV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int.imputed.txt_snps.txt	MR Egger	90.2436400842456	53	0.00107876611080387
Qa6JMV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	90.3033835878908	54	0.00142704250142843
Qa6JMV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.660736698761649	54	1
QbDqqB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	111.050886708451	55	1.16152834172629e-05
QbDqqB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int.imputed.txt_snps.txt	MR Egger	110.928108663621	54	8.20666210201487e-06
QbDqqB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	111.107765382706	55	1.14390656731382e-05
QbDqqB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0490390279287179	55	1
QbDqqB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	112.340988792494	55	8.19904930686866e-06
QbDqqB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int.imputed.txt_snps.txt	MR Egger	111.849884165727	54	6.37711998312908e-06
QbDqqB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	112.414379906226	55	8.03740784047498e-06
QbDqqB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0879947621077524	55	1
QbDqqB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	64.8139841445078	54	0.148833820662617
QbDqqB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int.imputed.txt_snps.txt	MR Egger	64.8483414663587	53	0.127469110989869
QbDqqB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	64.8562443354421	54	0.148000516063768
QbDqqB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.718396687384498	54	1
qEbyLj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	100.143386943844	72	0.015828573997376
qEbyLj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int.imputed.txt_snps.txt	MR Egger	99.006406117896	71	0.0157137162650028
qEbyLj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	100.173099584201	72	0.0157497647232716
qEbyLj	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.108617424641987	72	1
qEbyLj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	109.197783367585	72	0.00308417808594453
qEbyLj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int.imputed.txt_snps.txt	MR Egger	107.858046720267	71	0.00315096194502239
qEbyLj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	109.213447802276	72	0.00307487818680361
qEbyLj	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.157500500302585	72	1
qEbyLj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	100.06940112308	70	0.0106502338086272
qEbyLj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int.imputed.txt_snps.txt	MR Egger	98.0436136539316	69	0.0123291616780508
qEbyLj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	100.0701825963	70	0.010648764468555
qEbyLj	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	1.02249018170896	70	1
qPpDK5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	153.731109544569	116	0.0109241938493267
qPpDK5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int.imputed.txt_snps.txt	MR Egger	152.864158599046	115	0.0104850024522656
qPpDK5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	153.748472002713	116	0.0108969809483597
qPpDK5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.127980296619767	116	1
qPpDK5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	168.142729997303	116	0.0011223503429432
qPpDK5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int.imputed.txt_snps.txt	MR Egger	166.084804859065	115	0.00129984064872465
qPpDK5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	168.182398263896	116	0.00111473840889508
qPpDK5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.194885271696213	116	1
qPpDK5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	154.342726088239	112	0.0049623504949615
qPpDK5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int.imputed.txt_snps.txt	MR Egger	153.784619986399	111	0.00450388003330052
qPpDK5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	154.36229979766	112	0.00494716796245955
qPpDK5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	1.35210737809921	112	1
qUpqnY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	84.9542973076642	80	0.331296403897864
qUpqnY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	82.0250943955538	79	0.385693597891363
qUpqnY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	84.9623918639367	80	0.331073573909261
qUpqnY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0873653309624454	80	1
qUpqnY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	83.579755181227	80	0.370158788917037
qUpqnY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	81.3065979679203	79	0.407225253108723
qUpqnY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	83.5797690260431	80	0.370158387744085
qUpqnY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.122444365376108	80	1
qUpqnY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	94.4783384098967	78	0.0987090682759316
qUpqnY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	94.5428603263435	77	0.0851206053819125
qUpqnY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	94.7136176935027	78	0.0958593317870181
qUpqnY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	1.07099480440352	78	1
QWwWO9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	149.540172382571	77	1.43609751463585e-06
QWwWO9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int.imputed.txt_snps.txt	MR Egger	149.038665766652	76	1.14712738311552e-06
QWwWO9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	149.656598898397	77	1.3940157337353e-06
QWwWO9	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0866648310245722	77	1
QWwWO9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	146.603534693896	77	3.01919667739806e-06
QWwWO9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int.imputed.txt_snps.txt	MR Egger	146.50308954471	76	2.19419288295734e-06
QWwWO9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	146.701715181235	77	2.94577293928418e-06
QWwWO9	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.11251642764909	77	1
QWwWO9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	97.848940790678	76	0.0465687697959652
QWwWO9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int.imputed.txt_snps.txt	MR Egger	93.2751980182544	75	0.0750515626256423
QWwWO9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	97.8520296268932	76	0.0465481261845483
QWwWO9	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.607948813920886	76	1
qZXwaJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	87.7070555118469	60	0.0113434171380824
qZXwaJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	87.3709170702517	59	0.00961744343472649
qZXwaJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	87.7105813769798	60	0.011335963751721
qZXwaJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.106798509543747	60	1
qZXwaJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	77.905821311863	60	0.0599731226672693
qZXwaJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	77.8089937544135	59	0.0509674817018609
qZXwaJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	77.9072736322268	60	0.0599598463782891
qZXwaJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.124337513969571	60	1
qZXwaJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	49.76115980652	58	0.770895204705695
qZXwaJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	48.7555103817059	57	0.773256944724527
qZXwaJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	49.8034336183806	58	0.769576735150011
qZXwaJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.642605501373874	58	1
R5MzJN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	104.201040861189	55	6.97466488774249e-05
R5MzJN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int.imputed.txt_snps.txt	MR Egger	101.614993050241	54	9.52153035135761e-05
R5MzJN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	104.251355042805	55	6.88594230072799e-05
R5MzJN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0889851894154686	55	1
R5MzJN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	98.2869751943806	55	0.000301647351222886
R5MzJN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int.imputed.txt_snps.txt	MR Egger	97.4014633951682	54	0.000270965102505024
R5MzJN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	98.2922768632856	55	0.00030126282157501
R5MzJN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.125391113341645	55	1
R5MzJN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	58.5050004879464	54	0.31356626728378
R5MzJN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int.imputed.txt_snps.txt	MR Egger	58.6344856553947	53	0.276505829563085
R5MzJN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	58.6567601337284	54	0.308683092662429
R5MzJN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.655492805359174	54	1
RCrWmA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	76.6077958025504	71	0.30349604020391
RCrWmA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	76.5924562791585	70	0.275410961147104
RCrWmA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	76.6167878738154	71	0.303245546888286
RCrWmA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.094982913084342	71	1
RCrWmA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	65.2408406969159	70	0.638709092732784
RCrWmA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	65.0963769202583	69	0.610920628408229
RCrWmA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	65.2413328676635	70	0.638692773501111
RCrWmA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.114512756715196	70	1
RCrWmA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	76.1509427113985	69	0.259398127584227
RCrWmA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	75.8767071225785	68	0.239581425075663
RCrWmA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	76.3775125296253	69	0.253590222736622
RCrWmA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.819209498828357	69	1
RKNXnF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	125.430652404614	91	0.00977641776038431
RKNXnF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	124.649194633484	90	0.00917615095557769
RKNXnF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	125.437263852011	91	0.00976605995565884
RKNXnF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.119161649004152	91	1
RKNXnF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	105.409270501682	91	0.143386312361595
RKNXnF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	104.594540937878	90	0.139383318916993
RKNXnF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	105.411005607216	91	0.143359936467238
RKNXnF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.139533133906093	91	1
RKNXnF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	130.882609625702	89	0.00257462711331826
RKNXnF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	130.396378382578	88	0.00225733857144392
RKNXnF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	130.916829002277	89	0.0025588102701357
RKNXnF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	1.47876676762317	89	1
RM1tqh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	90.856475512212	62	0.0098981885635894
RM1tqh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int.imputed.txt_snps.txt	MR Egger	90.5352504102739	61	0.00836766465987789
RM1tqh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	90.8777606220266	62	0.00985900131186094
RM1tqh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0610964032586547	62	1
RM1tqh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	89.6616427653431	62	0.0123391781317053
RM1tqh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int.imputed.txt_snps.txt	MR Egger	89.5244530858935	61	0.0101260322905646
RM1tqh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	89.6656662404282	62	0.0123301147709145
RM1tqh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.106781578507388	62	1
RM1tqh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	75.590265607798	61	0.0989541869158393
RM1tqh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int.imputed.txt_snps.txt	MR Egger	75.5495158671262	60	0.0849879921359901
RM1tqh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	75.6003096365375	61	0.0988169441899191
RM1tqh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.466960327855691	61	1
rOOvE4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	126.521270958636	73	0.000103796287868369
rOOvE4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	124.117530682865	72	0.000133315214365293
rOOvE4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	126.556919870039	73	0.000102955011245856
rOOvE4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.142745698843379	73	1
rOOvE4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	115.491487076497	73	0.001130810647304
rOOvE4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	108.824863709135	72	0.00331346234596887
rOOvE4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	115.503382649355	73	0.0011280672839031
rOOvE4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.180805702430463	73	1
rOOvE4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	108.246221087649	71	0.00292238990043516
rOOvE4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	106.992968260338	70	0.00293444185873996
rOOvE4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	108.258804670689	71	0.00291524546415042
rOOvE4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.20936328307627	71	1
RTeFnl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	132.105764829507	89	0.0020622978631612
RTeFnl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	131.310355302061	88	0.00190885856358195
RTeFnl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	132.127967748646	89	0.00205394553113885
RTeFnl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.09282060624972	89	1
RTeFnl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	121.671545986038	89	0.0122521189495392
RTeFnl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	121.110969681197	88	0.0111166820798465
RTeFnl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	121.678751832914	89	0.0122381530094393
RTeFnl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.119450741960413	89	1
RTeFnl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	108.895514534192	83	0.0298664359073819
RTeFnl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	108.881539019561	82	0.0252116639820133
RTeFnl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	109.042855283688	83	0.0292247650452184
RTeFnl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_HDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.726562157528573	83	1
s3BFMY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	143.326915014711	90	0.00030051013973799
s3BFMY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int.imputed.txt_snps.txt	MR Egger	143.325988518894	89	0.000232454153302775
s3BFMY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	143.328544956266	90	0.000300410935195697
s3BFMY	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0980853629462087	90	1
s3BFMY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	149.047974431801	90	9.14332272544963e-05
s3BFMY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int.imputed.txt_snps.txt	MR Egger	148.811743563874	89	7.306801524821e-05
s3BFMY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	149.067686062306	90	9.10496188753406e-05
s3BFMY	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.151578963908415	90	1
s3BFMY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	96.4539827824113	86	0.206881604303378
s3BFMY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int.imputed.txt_snps.txt	MR Egger	88.6497411779551	85	0.371836621736867
s3BFMY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	96.4679961007825	86	0.206599046594124
s3BFMY	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.58307260086224	86	1
s9jCBv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	115.400365020327	78	0.00381083029868216
s9jCBv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	114.423490469262	77	0.00364661201143123
s9jCBv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	115.401062934447	78	0.00381034042074516
s9jCBv	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.113458795699164	78	1
s9jCBv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	103.692219111411	78	0.0275125615893398
s9jCBv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	99.7359808926476	77	0.0417992535359873
s9jCBv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	103.709394157705	78	0.0274405197554147
s9jCBv	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.129248982884118	78	1
s9jCBv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Maximum likelihood	104.633765763739	74	0.0110327172359449
s9jCBv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	MR Egger	103.79273469793	73	0.0103858083584081
s9jCBv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Inverse variance weighted	104.638250696551	74	0.0110242016928807
s9jCBv	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_CE_pct_int.imputed.txt_snps.txt	Unweighted regression	0.852243863782146	74	1
sIphZM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	64.9202187631073	62	0.375273151550905
sIphZM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	62.2401029141957	61	0.431787738631347
sIphZM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	64.9849143112636	62	0.373140583464527
sIphZM	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.106026382945152	62	1
sIphZM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	57.7893462668297	61	0.593000057536947
sIphZM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	54.8314488489319	60	0.664487246185776
sIphZM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	57.8151200919832	61	0.592061967121013
sIphZM	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.111014631886999	61	1
sIphZM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	63.7815650301064	59	0.312124323189772
sIphZM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	62.3418728541535	58	0.324531641640563
sIphZM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	63.8220113775418	59	0.310875846789689
sIphZM	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	1.17131958061445	59	1
SKH3Y2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	118.746605629952	92	0.0317400197604186
SKH3Y2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	110.218729805432	91	0.083222774567746
SKH3Y2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	118.804250510199	92	0.0314850372071732
SKH3Y2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0874674564302782	92	1
SKH3Y2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	105.768336502908	92	0.154582434247929
SKH3Y2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	103.363277876162	91	0.177005056612652
SKH3Y2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	105.7845889432	92	0.154322916734349
SKH3Y2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.128842301732097	92	1
SKH3Y2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	129.785279379424	88	0.00252253316967967
SKH3Y2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	124.665015629141	87	0.00504573491126495
SKH3Y2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	129.904169351489	88	0.00246876725808092
SKH3Y2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	1.29614422244821	88	1
sLnYFx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	175.295654934022	102	8.75881573472589e-06
sLnYFx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	174.68006148831	101	7.51978635151904e-06
sLnYFx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	175.295986467228	102	8.75817231159917e-06
sLnYFx	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.174805104178941	102	1
sLnYFx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	169.095033833063	102	3.35942151710371e-05
sLnYFx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	168.648595899118	101	2.81290023410591e-05
sLnYFx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	169.124919039728	102	3.33821111463403e-05
sLnYFx	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.206175802947314	102	1
sLnYFx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	139.391669719913	97	0.0031316141618017
sLnYFx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	136.425054231183	96	0.00423467857659626
sLnYFx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	139.414123834849	97	0.00311955991285029
sLnYFx	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	1.06088256775615	97	1
SnBkOX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	120.838945796084	89	0.0139657085916475
SnBkOX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int.imputed.txt_snps.txt	MR Egger	118.043277616241	88	0.0179748361162022
SnBkOX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	120.840766277504	89	0.013961738372035
SnBkOX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.115750511299789	89	1
SnBkOX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	137.621185311214	89	0.000728429100096856
SnBkOX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int.imputed.txt_snps.txt	MR Egger	137.349807211844	88	0.000602415597336389
SnBkOX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	137.623855754349	89	0.000728050873346271
SnBkOX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.174755700388644	89	1
SnBkOX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	98.0219883970959	85	0.158075490697122
SnBkOX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int.imputed.txt_snps.txt	MR Egger	82.9524217156796	84	0.51182441363098
SnBkOX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	98.0579931791631	85	0.157470224791349
SnBkOX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.969573211133414	85	1
sQ0l0q	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	83.8724229635583	69	0.107328404077038
sQ0l0q	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	83.5406122233284	68	0.0969771578466732
sQ0l0q	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	83.872472205768	69	0.107327724011636
sQ0l0q	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0832424559281035	69	1
sQ0l0q	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	88.6529041170202	69	0.0557181733262505
sQ0l0q	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	88.6533415877277	68	0.0470752826248692
sQ0l0q	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	88.6533441680128	69	0.0557146079217099
sQ0l0q	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.115011299225518	69	1
sQ0l0q	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	53.4352470324094	68	0.901979450795897
sQ0l0q	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	51.8653803181722	67	0.91348266423265
sQ0l0q	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	53.5707879549491	68	0.899598139971147
sQ0l0q	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.55114419740977	68	1
srsCBm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	31.5420050787031	28	0.29354620227276
srsCBm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int.imputed.txt_snps.txt	MR Egger	31.5934198942253	27	0.247476902825177
srsCBm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	31.6006402110111	28	0.291065139134771
srsCBm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	SFA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0277776465148865	28	1
srsCBm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	37.0049140617326	28	0.118752184998522
srsCBm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int.imputed.txt_snps.txt	MR Egger	35.7142832747055	27	0.121679080460399
srsCBm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	37.0816087183137	28	0.11707166373686
srsCBm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	SFA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0401515153960315	28	1
srsCBm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int.imputed.txt_snps.txt	Maximum likelihood	47.0451158507734	27	0.00979460321503135
srsCBm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int.imputed.txt_snps.txt	MR Egger	47.0953672471497	26	0.00686214151657757
srsCBm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int.imputed.txt_snps.txt	Inverse variance weighted	47.2078028689908	27	0.00939944826824479
srsCBm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	SFA_pct_int.imputed.txt_snps.txt	Unweighted regression	0.52321192734164	27	1
SSDwOf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int.imputed.txt_snps.txt	Maximum likelihood	89.4885150920445	53	0.00128183853955042
SSDwOf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int.imputed.txt_snps.txt	MR Egger	88.5882820845602	52	0.00117108360079237
SSDwOf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int.imputed.txt_snps.txt	Inverse variance weighted	89.5034933251784	53	0.00127748037204138
SSDwOf	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Gly_int.imputed.txt_snps.txt	Unweighted regression	0.0564519445711268	53	1
SSDwOf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int.imputed.txt_snps.txt	Maximum likelihood	74.350224189863	53	0.0280992215970421
SSDwOf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int.imputed.txt_snps.txt	MR Egger	73.65276250696	52	0.0257236200582083
SSDwOf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int.imputed.txt_snps.txt	Inverse variance weighted	74.3964771254876	53	0.0278685600831969
SSDwOf	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Gly_int.imputed.txt_snps.txt	Unweighted regression	0.0840450722138614	53	1
SSDwOf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int.imputed.txt_snps.txt	Maximum likelihood	63.5369368302158	50	0.0945664227099181
SSDwOf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int.imputed.txt_snps.txt	MR Egger	63.0917855598462	49	0.0850186661015424
SSDwOf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int.imputed.txt_snps.txt	Inverse variance weighted	63.5606435688279	50	0.0942263695809761
SSDwOf	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Gly_int.imputed.txt_snps.txt	Unweighted regression	0.652561480869367	50	1
st1s6o	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	99.9778800429024	70	0.0108235913864493
st1s6o	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	99.2585355281984	69	0.00994474389099046
st1s6o	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	100.003938617601	70	0.0107739728435612
st1s6o	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0973906581720996	70	1
st1s6o	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	103.289952602319	70	0.0059434097874605
st1s6o	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	102.774389335958	69	0.00521391370040317
st1s6o	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	103.297800063257	70	0.00593475871286492
st1s6o	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.135274558642438	70	1
st1s6o	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	85.1308948446419	68	0.0782182414267727
st1s6o	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	84.457087842212	67	0.0734660219988246
st1s6o	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	85.1916755637888	68	0.0775643350877815
st1s6o	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.987739577010895	68	1
Svf91n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	124.274786710805	96	0.0276873342900733
Svf91n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	121.475886950832	95	0.0348354304553178
Svf91n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	124.329699455394	96	0.0274754061081702
Svf91n	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.082944238158538	96	1
Svf91n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	117.427670477359	96	0.0678962675619984
Svf91n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	113.672518410604	95	0.0930005312421764
Svf91n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	117.453779635884	96	0.0676803757298165
Svf91n	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.116716446334291	96	1
Svf91n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	128.833438987839	93	0.00825224226512073
Svf91n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	128.927504514423	92	0.0067031510514038
Svf91n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	128.960935906521	93	0.00808397186051446
Svf91n	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	1.19108612981933	93	1
T2Mh1P	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int.imputed.txt_snps.txt	Maximum likelihood	148.761607589314	73	4.12370874897125e-07
T2Mh1P	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int.imputed.txt_snps.txt	MR Egger	146.18530320895	72	5.6385031459103e-07
T2Mh1P	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int.imputed.txt_snps.txt	Inverse variance weighted	148.767301253045	73	4.11744476158983e-07
T2Mh1P	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Omega_6_int.imputed.txt_snps.txt	Unweighted regression	0.075174540735867	73	1
T2Mh1P	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int.imputed.txt_snps.txt	Maximum likelihood	125.90658124173	73	0.000119384612470449
T2Mh1P	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int.imputed.txt_snps.txt	MR Egger	119.505839174336	72	0.000371503215148862
T2Mh1P	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int.imputed.txt_snps.txt	Inverse variance weighted	125.927474968876	73	0.000118819664155756
T2Mh1P	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Omega_6_int.imputed.txt_snps.txt	Unweighted regression	0.112573145488328	73	1
T2Mh1P	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int.imputed.txt_snps.txt	Maximum likelihood	69.1179559878188	72	0.574433329840927
T2Mh1P	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int.imputed.txt_snps.txt	MR Egger	68.8467604593674	71	0.550304377689729
T2Mh1P	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int.imputed.txt_snps.txt	Inverse variance weighted	69.1468073366851	72	0.57346549613303
T2Mh1P	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Omega_6_int.imputed.txt_snps.txt	Unweighted regression	0.351564945811907	72	1
TBTrp4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	123.459429348325	63	8.2702720282533e-06
TBTrp4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int.imputed.txt_snps.txt	MR Egger	122.841281675648	62	6.7689980463314e-06
TBTrp4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	123.496589450403	63	8.19072607120284e-06
TBTrp4	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0635142243441625	63	1
TBTrp4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	110.696437023029	63	0.000194663257536598
TBTrp4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int.imputed.txt_snps.txt	MR Egger	110.388184997144	62	0.000153377450761145
TBTrp4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	110.722362633301	63	0.00019348543104744
TBTrp4	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.106723522296971	63	1
TBTrp4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int.imputed.txt_snps.txt	Maximum likelihood	76.1725786212778	61	0.0912442504576019
TBTrp4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int.imputed.txt_snps.txt	MR Egger	76.1444370330237	60	0.0779843277412316
TBTrp4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	76.1725786212779	61	0.0912442504576016
TBTrp4	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.747514559541694	61	1
tc8Inl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	76.2457764806605	49	0.00760980511772746
tc8Inl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int.imputed.txt_snps.txt	MR Egger	70.0960593193582	48	0.0203907152153641
tc8Inl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	76.3027194283131	49	0.00752006065348635
tc8Inl	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0702830749233204	49	1
tc8Inl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	80.8881141985572	49	0.00279256724654215
tc8Inl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int.imputed.txt_snps.txt	MR Egger	79.244812270076	48	0.00302879839636828
tc8Inl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	80.9358619787134	49	0.00276292785935871
tc8Inl	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.110665447901998	49	1
tc8Inl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	36.9291771771028	46	0.827766680834278
tc8Inl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int.imputed.txt_snps.txt	MR Egger	34.0577735947663	45	0.883180088142889
tc8Inl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	36.9795583688513	46	0.826211002856134
tc8Inl	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.305933761815136	46	1
TKOHVR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int.imputed.txt_snps.txt	Maximum likelihood	73.8700151892506	53	0.0305952041798026
TKOHVR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int.imputed.txt_snps.txt	MR Egger	65.7959732187162	52	0.0946021876950011
TKOHVR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int.imputed.txt_snps.txt	Inverse variance weighted	73.8714337822392	53	0.0305875528041117
TKOHVR	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	DHA_int.imputed.txt_snps.txt	Unweighted regression	0.0826022243206559	53	1
TKOHVR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int.imputed.txt_snps.txt	Maximum likelihood	54.3971064988869	53	0.421055387358187
TKOHVR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int.imputed.txt_snps.txt	MR Egger	51.4735275227847	52	0.494540078756467
TKOHVR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int.imputed.txt_snps.txt	Inverse variance weighted	54.4069523082962	53	0.420688234863628
TKOHVR	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	DHA_int.imputed.txt_snps.txt	Unweighted regression	0.0890238643782486	53	1
TKOHVR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int.imputed.txt_snps.txt	Maximum likelihood	68.7012654102726	49	0.0330367186902563
TKOHVR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int.imputed.txt_snps.txt	MR Egger	68.7165931953271	48	0.0264734184626554
TKOHVR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int.imputed.txt_snps.txt	Inverse variance weighted	68.7169246984631	49	0.0329435987041194
TKOHVR	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	DHA_int.imputed.txt_snps.txt	Unweighted regression	0.665193861259893	49	1
tkZxpd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	69.9360548183842	40	0.00236080151842493
tkZxpd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	69.8643537577625	39	0.00173659933219647
tkZxpd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	69.9460902216995	40	0.00235507035324973
tkZxpd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0422857424396082	40	1
tkZxpd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	63.8674546470367	40	0.00961890516879073
tkZxpd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	63.9048754169745	39	0.00717872499735384
tkZxpd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	63.9178363263302	40	0.00951272714631831
tkZxpd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0544625891190806	40	1
tkZxpd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	43.4822478641267	39	0.286322282047365
tkZxpd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int.imputed.txt_snps.txt	MR Egger	42.208617702401	38	0.293944960069441
tkZxpd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	43.5303001681577	39	0.284605517286411
tkZxpd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.287105845889532	39	1
TrvrC3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	103.017903847474	57	0.000182829041363376
TrvrC3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int.imputed.txt_snps.txt	MR Egger	103.009406354885	56	0.000132015144709005
TrvrC3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	103.019033762146	57	0.000182778916130938
TrvrC3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0754782347376609	57	1
TrvrC3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	107.08021318923	57	6.69478951751465e-05
TrvrC3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int.imputed.txt_snps.txt	MR Egger	104.815257544418	56	8.41692775181488e-05
TrvrC3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	107.080224880964	57	6.69476980549018e-05
TrvrC3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.118620028791034	57	1
TrvrC3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	58.3153847221396	56	0.390248061205419
TrvrC3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int.imputed.txt_snps.txt	MR Egger	58.3674218600927	55	0.352698664817295
TrvrC3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	58.3820124801983	56	0.387901592370971
TrvrC3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.610848326032905	56	1
ts4Ia8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int.imputed.txt_snps.txt	Maximum likelihood	141.327938840246	60	1.63674459876595e-08
ts4Ia8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int.imputed.txt_snps.txt	MR Egger	141.237356611122	59	1.07013738574843e-08
ts4Ia8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int.imputed.txt_snps.txt	Inverse variance weighted	141.330135035997	60	1.63566879635444e-08
ts4Ia8	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_int.imputed.txt_snps.txt	Unweighted regression	0.0577401247573358	60	1
ts4Ia8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int.imputed.txt_snps.txt	Maximum likelihood	126.730604811541	60	1.10684117973027e-06
ts4Ia8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int.imputed.txt_snps.txt	MR Egger	126.597209189969	59	7.70261636868054e-07
ts4Ia8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int.imputed.txt_snps.txt	Inverse variance weighted	126.736067158319	60	1.10516630815983e-06
ts4Ia8	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_int.imputed.txt_snps.txt	Unweighted regression	0.100749833675572	60	1
ts4Ia8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int.imputed.txt_snps.txt	Maximum likelihood	77.0809337039022	59	0.0571020123228681
ts4Ia8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int.imputed.txt_snps.txt	MR Egger	77.083598913095	58	0.0476179772122299
ts4Ia8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int.imputed.txt_snps.txt	Inverse variance weighted	77.4396701773374	59	0.0540056793939832
ts4Ia8	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_int.imputed.txt_snps.txt	Unweighted regression	0.542273230782863	59	1
UBH38S	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	71.9076045134311	69	0.38181724488938
UBH38S	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	71.0724866385145	68	0.375776833982968
UBH38S	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	71.9077299493716	69	0.381813286885057
UBH38S	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0944920688682292	69	1
UBH38S	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	78.196657749478	69	0.209904656736727
UBH38S	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	77.9988220052091	68	0.190738389384985
UBH38S	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	78.201476967133	69	0.20979597560603
UBH38S	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.135955139756445	69	1
UBH38S	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	51.9819021939618	64	0.859304287689974
UBH38S	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int.imputed.txt_snps.txt	MR Egger	47.4999566079383	63	0.926891802552241
UBH38S	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	51.9975324427705	64	0.858949472898641
UBH38S	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_HDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.462842205116302	64	1
UFEBAe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	145.017615010705	55	4.82352526680043e-10
UFEBAe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int.imputed.txt_snps.txt	MR Egger	144.97762868389	54	2.93747001767547e-10
UFEBAe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	145.138253495949	55	4.64026861031915e-10
UFEBAe	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0716336976449052	55	1
UFEBAe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	128.896682151951	55	7.21053156198123e-08
UFEBAe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int.imputed.txt_snps.txt	MR Egger	128.889122635335	54	4.59887098427237e-08
UFEBAe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	128.916914004021	55	7.16698291110662e-08
UFEBAe	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.101715692567099	55	1
UFEBAe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	63.1373108316901	55	0.210852278171488
UFEBAe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int.imputed.txt_snps.txt	MR Egger	63.1647015364361	54	0.184125707857033
UFEBAe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	63.4978491205119	55	0.20192965539375
UFEBAe	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.505045651822168	55	1
unvWNa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	115.016030639547	77	0.00326520441297722
unvWNa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	114.148182665479	76	0.00305545329720389
unvWNa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	115.052331305206	77	0.00324308802440892
unvWNa	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.189167805358614	77	1
unvWNa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	101.279858258183	77	0.0332920853971101
unvWNa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	98.8822817413097	76	0.0400828708374121
unvWNa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	101.316523042102	77	0.0331097650240734
unvWNa	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.230000729301401	77	1
unvWNa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	125.760383205826	75	0.000219808189705399
unvWNa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	125.565578291806	74	0.0001725759434926
unvWNa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	125.800503895801	75	0.000217882534214935
unvWNa	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	1.66257446892211	75	1
uQm8qr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	96.4756147752367	76	0.0565490261688318
uQm8qr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int.imputed.txt_snps.txt	MR Egger	89.9741239601376	75	0.114446932606666
uQm8qr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	96.4835689965731	76	0.0564864288512416
uQm8qr	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0819284995154159	76	1
uQm8qr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	107.899671682222	75	0.00768365820267072
uQm8qr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int.imputed.txt_snps.txt	MR Egger	103.835936318565	74	0.0126458055144711
uQm8qr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	107.906093269499	75	0.00767493367954178
uQm8qr	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0996441205733097	75	1
uQm8qr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	94.3261862309571	73	0.0473129411550909
uQm8qr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int.imputed.txt_snps.txt	MR Egger	84.1913122238314	72	0.154214746622117
uQm8qr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	94.3734090868473	73	0.0469884609684812
uQm8qr	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.727327823665162	73	1
uwco5a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	121.765494396027	85	0.00551040387520724
uwco5a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	121.54864900714	84	0.00464209948491025
uwco5a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	121.773003479277	85	0.0055032423394516
uwco5a	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.126171695097228	85	1
uwco5a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	122.788799381578	85	0.00460968352652036
uwco5a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	122.63140679657	84	0.00382977215135697
uwco5a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	122.800086311878	85	0.00460055328759697
uwco5a	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.19238394072331	85	1
uwco5a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	137.951413840546	84	0.000190091642332625
uwco5a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	129.311569262206	83	0.00086324108875945
uwco5a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	138.073986821018	84	0.00018521275594169
uwco5a	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	1.3601620250761	84	1
uzlx3D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Maximum likelihood	106.171867415828	76	0.0127098402906699
uzlx3D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int.imputed.txt_snps.txt	MR Egger	104.743315381902	75	0.0132487561057658
uzlx3D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Inverse variance weighted	106.203639326062	76	0.0126421473607095
uzlx3D	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Unweighted regression	0.127491039644429	76	1
uzlx3D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Maximum likelihood	89.4957942023633	76	0.138035002628103
uzlx3D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int.imputed.txt_snps.txt	MR Egger	88.4439245590265	75	0.137436820026806
uzlx3D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Inverse variance weighted	89.5150045949565	76	0.137727229491186
uzlx3D	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Unweighted regression	0.154804611328101	76	1
uzlx3D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Maximum likelihood	82.2640330004138	71	0.169859995155151
uzlx3D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int.imputed.txt_snps.txt	MR Egger	74.5206045280742	70	0.333518410323586
uzlx3D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Inverse variance weighted	82.364560128215	71	0.16793404283293
uzlx3D	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	ApoB_by_ApoA1_int.imputed.txt_snps.txt	Unweighted regression	0.716110308501275	71	1
V8rntF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int.imputed.txt_snps.txt	Maximum likelihood	11.7622081823545	7	0.108654978810086
V8rntF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int.imputed.txt_snps.txt	MR Egger	11.593409665924	6	0.0716788256739775
V8rntF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int.imputed.txt_snps.txt	Inverse variance weighted	11.77316655088	7	0.10826952547342
V8rntF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Acetoacetate_int.imputed.txt_snps.txt	Unweighted regression	0.00810589009260931	7	0.999999999636768
V8rntF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int.imputed.txt_snps.txt	Maximum likelihood	5.91231271910294	7	0.550024752037552
V8rntF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int.imputed.txt_snps.txt	MR Egger	5.7657452355901	6	0.449936510432271
V8rntF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int.imputed.txt_snps.txt	Inverse variance weighted	5.91286320118266	7	0.549960022296998
V8rntF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Acetoacetate_int.imputed.txt_snps.txt	Unweighted regression	0.00464629581381303	7	0.999999999948139
V8rntF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int.imputed.txt_snps.txt	Maximum likelihood	9.6092872876171	7	0.211816805655494
V8rntF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int.imputed.txt_snps.txt	MR Egger	5.57623914885942	6	0.472290480056883
V8rntF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int.imputed.txt_snps.txt	Inverse variance weighted	9.6192215785896	7	0.211198026120872
V8rntF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Acetoacetate_int.imputed.txt_snps.txt	Unweighted regression	0.0826833477748659	7	0.999998803917721
vJDltm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	143.159754543362	70	5.97529226925802e-07
vJDltm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	143.132670858424	69	4.11257853124409e-07
vJDltm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	143.160175936133	70	5.97461678531932e-07
vJDltm	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0948676034190146	70	1
vJDltm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	134.38469037128	70	5.91320178399294e-06
vJDltm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	133.309076742829	69	5.48647407730019e-06
vJDltm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	134.387478001779	70	5.9090186715336e-06
vJDltm	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.14312460262282	70	1
vJDltm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	84.8035641542726	68	0.0818173514306144
vJDltm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	84.7110280803499	67	0.0708829574343785
vJDltm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	84.8549413892568	68	0.081243719213024
vJDltm	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.998677138913062	68	1
VkC5B2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	55.4738816750263	55	0.456749073312385
VkC5B2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	54.6141490715177	54	0.451045692120495
VkC5B2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	55.4749525889804	55	0.456708849753925
VkC5B2	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0749879349917103	55	1
VkC5B2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	55.353671156835	55	0.461270200444685
VkC5B2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	54.2378213884676	54	0.465322374363766
VkC5B2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	55.3537686550007	55	0.46126652877061
VkC5B2	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0901949659972561	55	1
VkC5B2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	55.2752635095553	49	0.249706328969921
VkC5B2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	54.0821810238403	48	0.253427537240205
VkC5B2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	55.3097448748433	49	0.248687611811031
VkC5B2	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.422074798655292	49	1
VNd2ZQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	145.657062210176	96	0.000815769743251227
VNd2ZQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int.imputed.txt_snps.txt	MR Egger	144.253307079698	95	0.000843284745877331
VNd2ZQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	145.663131512265	96	0.000814840025295621
VNd2ZQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.136475563309427	96	1
VNd2ZQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	130.658631408568	96	0.0107818673215936
VNd2ZQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int.imputed.txt_snps.txt	MR Egger	130.660091283865	95	0.0089705812411553
VNd2ZQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	130.660096534062	96	0.0107794123161338
VNd2ZQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.182283803002801	96	1
VNd2ZQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int.imputed.txt_snps.txt	Maximum likelihood	108.738794682937	91	0.0990989701871278
VNd2ZQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int.imputed.txt_snps.txt	MR Egger	104.400408346207	90	0.142310620595419
VNd2ZQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	108.765570698263	91	0.0987919720540239
VNd2ZQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.72616411138185	91	1
vpKbzE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	127.933497222349	80	0.000534913107480559
vpKbzE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	127.111201916004	79	0.000488683624963677
vpKbzE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	127.951726918797	80	0.000532912311323879
vpKbzE	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.110607990965612	80	1
vpKbzE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	114.002182969164	80	0.00751599316813299
vpKbzE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	113.871707557551	79	0.00624030297998957
vpKbzE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	114.004318386506	80	0.00751321998415492
vpKbzE	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.151158734692091	80	1
vpKbzE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	116.591394540701	79	0.00382625850268338
vpKbzE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	110.908446837333	78	0.00849661397366501
vpKbzE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	116.695507401816	79	0.00375390090689409
vpKbzE	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.960598817399578	79	1
VPzDmh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	111.470179185764	89	0.0537767045782598
VPzDmh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	110.305166557257	88	0.054087273095954
VPzDmh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	111.496971373224	89	0.0535879675635182
VPzDmh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.122025567761523	89	1
VPzDmh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	89.8665776502276	89	0.454342122486865
VPzDmh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	89.8602255213672	88	0.424875903176194
VPzDmh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	89.9053674806224	89	0.453198319181926
VPzDmh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.142345775246841	89	1
VPzDmh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	98.1057274816798	84	0.139294769004863
VPzDmh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	95.8799643854558	83	0.157849982985997
VPzDmh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	98.1407619327647	84	0.138754931933761
VPzDmh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.929439730591799	84	1
vR7MkV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int.imputed.txt_snps.txt	Maximum likelihood	60.5963392320222	42	0.0314793337888452
vR7MkV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int.imputed.txt_snps.txt	MR Egger	60.2703348259717	41	0.0264863451128162
vR7MkV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	60.6595001071301	42	0.0310983002901352
vR7MkV	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	LDL_size_int.imputed.txt_snps.txt	Unweighted regression	0.0604654000970643	42	1
vR7MkV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int.imputed.txt_snps.txt	Maximum likelihood	50.3194248165782	42	0.177332568967802
vR7MkV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int.imputed.txt_snps.txt	MR Egger	50.3639801533601	41	0.149909234452996
vR7MkV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	50.3740728851919	42	0.17596297619578
vR7MkV	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	LDL_size_int.imputed.txt_snps.txt	Unweighted regression	0.0714514308957683	42	1
vR7MkV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int.imputed.txt_snps.txt	Maximum likelihood	61.9281854850538	40	0.0146338437419347
vR7MkV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int.imputed.txt_snps.txt	MR Egger	60.4882502016266	39	0.0152533208317692
vR7MkV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int.imputed.txt_snps.txt	Inverse variance weighted	61.9311610260468	40	0.0146245948285486
vR7MkV	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	LDL_size_int.imputed.txt_snps.txt	Unweighted regression	0.65917317559269	40	1
Vs02gB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int.imputed.txt_snps.txt	Maximum likelihood	18.169945973727	23	0.748206888900669
Vs02gB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int.imputed.txt_snps.txt	MR Egger	18.0584290119922	22	0.702518494207587
Vs02gB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int.imputed.txt_snps.txt	Inverse variance weighted	18.177580009845	23	0.747786963770272
Vs02gB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Val_int.imputed.txt_snps.txt	Unweighted regression	0.0223254628502381	23	1
Vs02gB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int.imputed.txt_snps.txt	Maximum likelihood	16.8292567052195	23	0.817545312259344
Vs02gB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int.imputed.txt_snps.txt	MR Egger	16.5400479907881	22	0.788209972993357
Vs02gB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int.imputed.txt_snps.txt	Inverse variance weighted	16.8513418032064	23	0.816482205911045
Vs02gB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Val_int.imputed.txt_snps.txt	Unweighted regression	0.0239092509773526	23	1
Vs02gB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int.imputed.txt_snps.txt	Maximum likelihood	23.0032662573736	22	0.401545192574857
Vs02gB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int.imputed.txt_snps.txt	MR Egger	23.0065807954395	21	0.343627635391343
Vs02gB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int.imputed.txt_snps.txt	Inverse variance weighted	23.0095753439394	22	0.401189083304265
Vs02gB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Val_int.imputed.txt_snps.txt	Unweighted regression	0.14913137299876	22	1
w0GD8d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int.imputed.txt_snps.txt	Maximum likelihood	142.366466703225	71	1.07096777657199e-06
w0GD8d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int.imputed.txt_snps.txt	MR Egger	142.15925936226	70	7.80893985205166e-07
w0GD8d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int.imputed.txt_snps.txt	Inverse variance weighted	142.373932142905	71	1.06886154700233e-06
w0GD8d	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphoglyc_int.imputed.txt_snps.txt	Unweighted regression	0.106525329015926	71	1
w0GD8d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int.imputed.txt_snps.txt	Maximum likelihood	141.292446865526	71	1.4202737404489e-06
w0GD8d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int.imputed.txt_snps.txt	MR Egger	139.055918404198	70	1.77312452005694e-06
w0GD8d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int.imputed.txt_snps.txt	Inverse variance weighted	141.300973525856	71	1.41710467262235e-06
w0GD8d	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphoglyc_int.imputed.txt_snps.txt	Unweighted regression	0.174646486286769	71	1
w0GD8d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int.imputed.txt_snps.txt	Maximum likelihood	103.893022528084	69	0.00421522333432333
w0GD8d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int.imputed.txt_snps.txt	MR Egger	103.477347600567	68	0.00360330686454792
w0GD8d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int.imputed.txt_snps.txt	Inverse variance weighted	103.894305686751	69	0.00421418717131579
w0GD8d	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphoglyc_int.imputed.txt_snps.txt	Unweighted regression	0.842563270269816	69	1
w1Uduy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	122.216486652914	64	1.61981670176957e-05
w1Uduy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	122.14025019672	63	1.16360365224605e-05
w1Uduy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	122.217128706165	64	1.61955270060627e-05
w1Uduy	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.114219356920947	64	1
w1Uduy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	121.100023114525	64	2.14802518064501e-05
w1Uduy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	120.993365555732	63	1.56159424581177e-05
w1Uduy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	121.108465440978	64	2.14346514377276e-05
w1Uduy	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.164117435864502	64	1
w1Uduy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	83.0389274403591	62	0.0384993063911581
w1Uduy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int.imputed.txt_snps.txt	MR Egger	81.3495635498223	61	0.0419181046144456
w1Uduy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	83.0394524848137	62	0.038496060243541
w1Uduy	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.69632515967977	62	1
weQraB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int.imputed.txt_snps.txt	Maximum likelihood	67.0383193292271	39	0.00345767321774361
weQraB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int.imputed.txt_snps.txt	MR Egger	66.9546489283102	38	0.00256735649227591
weQraB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int.imputed.txt_snps.txt	Inverse variance weighted	67.0811307228845	39	0.00342249097867005
weQraB	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Citrate_int.imputed.txt_snps.txt	Unweighted regression	0.072310001219905	39	1
weQraB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int.imputed.txt_snps.txt	Maximum likelihood	53.3948271821051	39	0.0621031578646729
weQraB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int.imputed.txt_snps.txt	MR Egger	53.2982053357392	38	0.0508118561989806
weQraB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int.imputed.txt_snps.txt	Inverse variance weighted	53.422200507097	39	0.0617957856379754
weQraB	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Citrate_int.imputed.txt_snps.txt	Unweighted regression	0.0911853654653056	39	1
weQraB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int.imputed.txt_snps.txt	Maximum likelihood	49.5271779967431	39	0.120400674747013
weQraB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int.imputed.txt_snps.txt	MR Egger	47.6874715627964	38	0.134835746601976
weQraB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int.imputed.txt_snps.txt	Inverse variance weighted	49.5945267312265	39	0.11910215334501
weQraB	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Citrate_int.imputed.txt_snps.txt	Unweighted regression	0.814372018573911	39	1
WeZ1BH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	135.540811481264	91	0.00171627983771138
WeZ1BH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	134.024213801925	90	0.00181331348426408
WeZ1BH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	135.580481410734	91	0.00170383685862019
WeZ1BH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.133272951621318	91	1
WeZ1BH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	126.793266637968	91	0.00784029898675445
WeZ1BH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	125.617295613352	90	0.00783537160332395
WeZ1BH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	126.8149467357	91	0.00781253587610196
WeZ1BH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.201172032873887	91	1
WeZ1BH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	138.26681536015	88	0.000502287066938702
WeZ1BH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	137.193660632422	87	0.000484984822780232
WeZ1BH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	138.411369542823	88	0.000488022575958027
WeZ1BH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	1.41223700928316	88	1
whDDvX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int.imputed.txt_snps.txt	Maximum likelihood	103.165287902071	73	0.0115779605545024
whDDvX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int.imputed.txt_snps.txt	MR Egger	102.123426438423	72	0.0112863418055746
whDDvX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int.imputed.txt_snps.txt	Inverse variance weighted	103.165692649125	73	0.0115771531630495
whDDvX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Phosphatidylc_int.imputed.txt_snps.txt	Unweighted regression	0.0887788590307625	73	1
whDDvX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int.imputed.txt_snps.txt	Maximum likelihood	102.66357988959	73	0.0126188326021203
whDDvX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int.imputed.txt_snps.txt	MR Egger	102.571263220167	72	0.0104388753233669
whDDvX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int.imputed.txt_snps.txt	Inverse variance weighted	102.671093220745	73	0.012602641390423
whDDvX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Phosphatidylc_int.imputed.txt_snps.txt	Unweighted regression	0.19306776632557	73	1
whDDvX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int.imputed.txt_snps.txt	Maximum likelihood	103.692256349012	70	0.00551455390114905
whDDvX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int.imputed.txt_snps.txt	MR Egger	103.691990131092	69	0.00438050624797398
whDDvX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int.imputed.txt_snps.txt	Inverse variance weighted	103.693877423497	70	0.00551288505767085
whDDvX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Phosphatidylc_int.imputed.txt_snps.txt	Unweighted regression	0.602556995780531	70	1
wImhZX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	134.079026000596	67	2.19025427744762e-06
wImhZX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int.imputed.txt_snps.txt	MR Egger	133.968186504226	66	1.55597315269074e-06
wImhZX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	134.091284551529	67	2.18317804750498e-06
wImhZX	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.081051622875988	67	1
wImhZX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	121.326305356481	67	5.48851944873438e-05
wImhZX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int.imputed.txt_snps.txt	MR Egger	118.185178333524	66	8.46663233164639e-05
wImhZX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	121.33836335088	67	5.47262509147893e-05
wImhZX	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.123650554727034	67	1
wImhZX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	84.8264639334778	65	0.0499558938735727
wImhZX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int.imputed.txt_snps.txt	MR Egger	84.8442596217624	64	0.0417280462202556
wImhZX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	84.9064135927819	65	0.0493531773490609
wImhZX	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.70361802573336	65	1
wjLDbw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int.imputed.txt_snps.txt	Maximum likelihood	128.102293037354	81	0.000667542054039545
wjLDbw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int.imputed.txt_snps.txt	MR Egger	128.055811030805	80	0.000521624004088588
wjLDbw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int.imputed.txt_snps.txt	Inverse variance weighted	128.178555604001	81	0.000657318405575318
wjLDbw	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	MUFA_int.imputed.txt_snps.txt	Unweighted regression	0.133861071630819	81	1
wjLDbw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int.imputed.txt_snps.txt	Maximum likelihood	127.667495859433	81	0.000728768494520091
wjLDbw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int.imputed.txt_snps.txt	MR Egger	127.343424353001	80	0.000603665059523858
wjLDbw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int.imputed.txt_snps.txt	Inverse variance weighted	127.725967941602	81	0.000720235797975722
wjLDbw	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	MUFA_int.imputed.txt_snps.txt	Unweighted regression	0.174836788601329	81	1
wjLDbw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int.imputed.txt_snps.txt	Maximum likelihood	104.179552316244	79	0.0304214783431708
wjLDbw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int.imputed.txt_snps.txt	MR Egger	103.083245151122	78	0.0301761299100115
wjLDbw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int.imputed.txt_snps.txt	Inverse variance weighted	104.200961112069	79	0.03032398755907
wjLDbw	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	MUFA_int.imputed.txt_snps.txt	Unweighted regression	1.06811468456414	79	1
wQAsn5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	119.67323844623	69	0.000150454609031959
wQAsn5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	118.998473372753	68	0.000129975181780071
wQAsn5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	119.673563143317	69	0.000150443407255362
wQAsn5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.0769654996890006	69	1
wQAsn5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	103.904454643323	69	0.00420600010375815
wQAsn5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	103.775433951894	68	0.00339959231723274
wQAsn5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	103.907402724364	69	0.0042036246788487
wQAsn5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.117086386201908	69	1
wQAsn5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	65.7922562418632	66	0.484053734350045
wQAsn5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	63.7473478994172	65	0.520724219591695
wQAsn5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	65.8950667868712	66	0.480484686192798
wQAsn5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.424969278741179	66	1
wWlTng	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	88.5784574328936	72	0.0897332019133488
wWlTng	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int.imputed.txt_snps.txt	MR Egger	88.2043869763219	71	0.0813251555896021
wWlTng	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	88.6354026083584	72	0.0890652217181448
wWlTng	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.115496978489933	72	1
wWlTng	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	98.039156019095	72	0.0223909663678369
wWlTng	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int.imputed.txt_snps.txt	MR Egger	96.0513647057843	71	0.0255565016852364
wWlTng	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	98.1551493620805	72	0.021974506939692
wWlTng	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.203015614939781	72	1
wWlTng	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	82.0316282844525	68	0.117919479152985
wWlTng	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int.imputed.txt_snps.txt	MR Egger	78.3137369594604	67	0.16254215805744
wWlTng	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	82.0659658828906	68	0.117406880135356
wWlTng	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	HDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.07618711912022	68	1
wzXjyP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	152.627959629536	79	1.31608952482797e-06
wzXjyP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int.imputed.txt_snps.txt	MR Egger	148.941140883417	78	2.36411198961224e-06
wzXjyP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	152.80494488274	79	1.25824351985174e-06
wzXjyP	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.160750371313625	79	1
wzXjyP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	140.822257828637	79	2.35337498677192e-05
wzXjyP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int.imputed.txt_snps.txt	MR Egger	133.580913105013	78	9.16785025944127e-05
wzXjyP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	140.952241136041	79	2.28276931123291e-05
wzXjyP	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.221727532516049	79	1
wzXjyP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	119.818293480426	77	0.00129243053769011
wzXjyP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int.imputed.txt_snps.txt	MR Egger	119.635845266434	76	0.00104435809892161
wzXjyP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	119.871051794712	77	0.00127895022100713
wzXjyP	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	1.21636894805265	77	1
XaQFNk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int.imputed.txt_snps.txt	Maximum likelihood	53.5592732475923	32	0.0098265793327758
XaQFNk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int.imputed.txt_snps.txt	MR Egger	53.5972804735238	31	0.00710025220028411
XaQFNk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int.imputed.txt_snps.txt	Inverse variance weighted	53.5972919913456	32	0.00973797092430575
XaQFNk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Albumin_int.imputed.txt_snps.txt	Unweighted regression	0.0230194405219874	32	1
XaQFNk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int.imputed.txt_snps.txt	Maximum likelihood	54.8086436413048	32	0.00727307511557073
XaQFNk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int.imputed.txt_snps.txt	MR Egger	54.1461398026108	31	0.00619751443291471
XaQFNk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int.imputed.txt_snps.txt	Inverse variance weighted	54.8389227232581	32	0.00721963520882932
XaQFNk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Albumin_int.imputed.txt_snps.txt	Unweighted regression	0.0319718001859257	32	1
XaQFNk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int.imputed.txt_snps.txt	Maximum likelihood	36.0511922294884	32	0.284645953343748
XaQFNk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int.imputed.txt_snps.txt	MR Egger	34.0833352075427	31	0.321530199446231
XaQFNk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int.imputed.txt_snps.txt	Inverse variance weighted	36.0542521941459	32	0.284526263129187
XaQFNk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Albumin_int.imputed.txt_snps.txt	Unweighted regression	0.16446152651281	32	1
Xb4Yz5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	108.911120766037	66	0.00070058611605425
Xb4Yz5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	106.294929605183	65	0.000936236229255789
Xb4Yz5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	108.918285428905	66	0.00069949649547393
Xb4Yz5	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.0840009327428037	66	1
Xb4Yz5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	104.911727924367	66	0.00163782296713304
Xb4Yz5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	101.768980616006	65	0.00241550335526655
Xb4Yz5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	104.927173807225	66	0.001632586067011
Xb4Yz5	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.140396072646534	66	1
Xb4Yz5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int.imputed.txt_snps.txt	Maximum likelihood	78.7560853577966	66	0.135002339524369
Xb4Yz5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int.imputed.txt_snps.txt	MR Egger	75.1115830553629	65	0.18341720871029
Xb4Yz5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int.imputed.txt_snps.txt	Inverse variance weighted	78.8364209739534	66	0.133657915946189
Xb4Yz5	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_PL_int.imputed.txt_snps.txt	Unweighted regression	0.646526762814348	66	1
xFEdD3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	110.151628022116	54	1.01364441277348e-05
xFEdD3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int.imputed.txt_snps.txt	MR Egger	110.059776960455	53	7.06534465626346e-06
xFEdD3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	110.16427370211	54	1.01017360597238e-05
xFEdD3	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0592138208467223	54	1
xFEdD3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	93.7381091414723	54	0.000649327031025957
xFEdD3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int.imputed.txt_snps.txt	MR Egger	93.5565373657382	53	0.000496994408733514
xFEdD3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	93.7485087122751	54	0.000647749663258058
xFEdD3	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0950496567089566	54	1
xFEdD3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int.imputed.txt_snps.txt	Maximum likelihood	47.3084384080689	53	0.694460882995704
xFEdD3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int.imputed.txt_snps.txt	MR Egger	47.0171317154762	52	0.669736304799124
xFEdD3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	47.335918938295	53	0.693451733132435
xFEdD3	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.593460135521661	53	1
xHhejQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	159.725984555537	88	4.56212093411852e-06
xHhejQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int.imputed.txt_snps.txt	MR Egger	159.612814765762	87	3.40706329460009e-06
xHhejQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	159.733705252105	88	4.55376690566619e-06
xHhejQ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.134328186762423	88	1
xHhejQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	150.411542586083	88	3.88020119586268e-05
xHhejQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int.imputed.txt_snps.txt	MR Egger	147.851699918499	87	5.13353625941711e-05
xHhejQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	150.459736236964	88	3.8389037857272e-05
xHhejQ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	0.212010534352886	88	1
xHhejQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int.imputed.txt_snps.txt	Maximum likelihood	100.614285988979	85	0.118676700258877
xHhejQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int.imputed.txt_snps.txt	MR Egger	99.3103093828992	84	0.121614004945487
xHhejQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int.imputed.txt_snps.txt	Inverse variance weighted	100.623528404294	85	0.118551000405745
xHhejQ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_pct_int.imputed.txt_snps.txt	Unweighted regression	1.00786632897908	85	1
xJkxO0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	107.821458579043	89	0.0851618849005238
xJkxO0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int.imputed.txt_snps.txt	MR Egger	107.827723368767	88	0.0742996837802538
xJkxO0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	107.828046212783	89	0.0850941735722563
xJkxO0	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.10030838356884	89	1
xJkxO0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	106.627062148885	89	0.0981666368462615
xJkxO0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int.imputed.txt_snps.txt	MR Egger	106.449342583828	88	0.0879749708626019
xJkxO0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	106.632852123588	89	0.0981000254819398
xJkxO0	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.146196572001415	89	1
xJkxO0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	104.244356140572	89	0.12870679964338
xJkxO0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int.imputed.txt_snps.txt	MR Egger	104.231446062691	88	0.114101735478431
xJkxO0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	104.244564725183	89	0.128703843563769
xJkxO0	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_FC_int.imputed.txt_snps.txt	Unweighted regression	1.09828651410894	89	1
XJThNK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	113.92897201241	65	0.000169052340810906
XJThNK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int.imputed.txt_snps.txt	MR Egger	111.34510773905	64	0.000227154239845947
XJThNK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	113.931043688454	65	0.000168970783899894
XJThNK	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.0912049104593595	65	1
XJThNK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	107.458552149781	65	0.00072767549919423
XJThNK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int.imputed.txt_snps.txt	MR Egger	104.454375971936	64	0.00105800424397004
XJThNK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	107.466281068252	65	0.000726450433834756
XJThNK	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.146061182390335	65	1
XJThNK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int.imputed.txt_snps.txt	Maximum likelihood	77.2867244083295	65	0.141413962423064
XJThNK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int.imputed.txt_snps.txt	MR Egger	72.0385052997422	64	0.229302446752226
XJThNK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int.imputed.txt_snps.txt	Inverse variance weighted	77.3736046802322	65	0.139898636831138
XJThNK	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_VLDL_P_int.imputed.txt_snps.txt	Unweighted regression	0.642016372629003	65	1
xTKh86	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	132.095127827118	71	1.47219416469783e-05
xTKh86	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	129.431047760261	70	2.03451434542982e-05
xTKh86	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	132.095273259598	71	1.47214144857927e-05
xTKh86	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.101722803488412	71	1
xTKh86	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	122.068358116087	71	0.000157936722314585
xTKh86	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	120.149937019647	70	0.000181649294681069
xTKh86	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	122.076335649575	71	0.000157651436919284
xTKh86	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.144582617567158	71	1
xTKh86	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int.imputed.txt_snps.txt	Maximum likelihood	71.8101640843238	70	0.417634245301939
xTKh86	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int.imputed.txt_snps.txt	MR Egger	62.5056450299443	69	0.696357739921455
xTKh86	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int.imputed.txt_snps.txt	Inverse variance weighted	71.8832951614832	70	0.415266112851255
xTKh86	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_pct_int.imputed.txt_snps.txt	Unweighted regression	0.511373273177964	70	1
xU2nZJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int.imputed.txt_snps.txt	Maximum likelihood	68.7194113142514	52	0.0600179574476841
xU2nZJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int.imputed.txt_snps.txt	MR Egger	66.9094855247327	51	0.0667361574669695
xU2nZJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int.imputed.txt_snps.txt	Inverse variance weighted	68.7396793798393	52	0.0598213760289716
xU2nZJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Unsaturation_int.imputed.txt_snps.txt	Unweighted regression	0.104966207133265	52	1
xU2nZJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int.imputed.txt_snps.txt	Maximum likelihood	63.176531079057	52	0.137780550382892
xU2nZJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int.imputed.txt_snps.txt	MR Egger	62.9121511301772	51	0.122352396842248
xU2nZJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int.imputed.txt_snps.txt	Inverse variance weighted	63.1861714697776	52	0.13759785157251
xU2nZJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Unsaturation_int.imputed.txt_snps.txt	Unweighted regression	0.143641911412655	52	1
xU2nZJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int.imputed.txt_snps.txt	Maximum likelihood	82.101671067151	48	0.00157751841056151
xU2nZJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int.imputed.txt_snps.txt	MR Egger	82.0218306338913	47	0.00118173895919559
xU2nZJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int.imputed.txt_snps.txt	Inverse variance weighted	82.161139516085	48	0.00155583238588369
xU2nZJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Unsaturation_int.imputed.txt_snps.txt	Unweighted regression	1.22410159647423	48	1
xy5hEA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	94.3008708976888	70	0.0280693167990576
xy5hEA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int.imputed.txt_snps.txt	MR Egger	94.2616862399015	69	0.023401814947177
xy5hEA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	94.3163584653831	70	0.0280001878773267
xy5hEA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XXL_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.0914819061970676	70	1
xy5hEA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	71.1341388540593	70	0.439733156711297
xy5hEA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int.imputed.txt_snps.txt	MR Egger	71.0209948551094	69	0.410196461937363
xy5hEA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	71.1342212259658	70	0.439730442541924
xy5hEA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XXL_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.100746935858603	70	1
xy5hEA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int.imputed.txt_snps.txt	Maximum likelihood	104.293877184747	68	0.00307060433078192
xy5hEA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int.imputed.txt_snps.txt	MR Egger	103.484195126988	67	0.00282128430483569
xy5hEA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	104.320084813181	68	0.00305478854317749
xy5hEA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XXL_VLDL_L_int.imputed.txt_snps.txt	Unweighted regression	1.08845826972538	68	1
XZLMly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int.imputed.txt_snps.txt	Maximum likelihood	150.782592336934	72	1.63125549734249e-07
XZLMly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int.imputed.txt_snps.txt	MR Egger	149.766080372115	71	1.45912070054633e-07
XZLMly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int.imputed.txt_snps.txt	Inverse variance weighted	150.79206265776	72	1.6270407677477e-07
XZLMly	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Sphingomyelins_int.imputed.txt_snps.txt	Unweighted regression	0.114123633275706	72	1
XZLMly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int.imputed.txt_snps.txt	Maximum likelihood	127.244159624021	72	6.48956098886349e-05
XZLMly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int.imputed.txt_snps.txt	MR Egger	127.175103812262	71	4.83372393134878e-05
XZLMly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int.imputed.txt_snps.txt	Inverse variance weighted	127.256179573106	72	6.47138031535578e-05
XZLMly	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Sphingomyelins_int.imputed.txt_snps.txt	Unweighted regression	0.163018640066706	72	1
XZLMly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int.imputed.txt_snps.txt	Maximum likelihood	95.2654177551628	71	0.0289554603611694
XZLMly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int.imputed.txt_snps.txt	MR Egger	95.1208115523835	70	0.0246086845334997
XZLMly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int.imputed.txt_snps.txt	Inverse variance weighted	95.2817132489439	71	0.0288811564493945
XZLMly	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Sphingomyelins_int.imputed.txt_snps.txt	Unweighted regression	0.763817831761787	71	1
y0WogF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	107.872373071895	78	0.0141766651611177
y0WogF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	107.178052829929	77	0.0130862241696653
y0WogF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	107.898646827933	78	0.0141155161016735
y0WogF	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.137330885585601	78	1
y0WogF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	99.5264491419873	77	0.043086284747669
y0WogF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	98.3414329259155	76	0.0433740145511705
y0WogF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	99.5264801288708	77	0.0430860919408413
y0WogF	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.168071728662936	77	1
y0WogF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	90.459373897293	76	0.123221676895104
y0WogF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	89.7827117263781	75	0.117149342295456
y0WogF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	90.4894549616089	76	0.122779494980117
y0WogF	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.21630671838156	76	1
ya5Jlh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int.imputed.txt_snps.txt	Maximum likelihood	122.550784878843	68	5.63074859829836e-05
ya5Jlh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int.imputed.txt_snps.txt	MR Egger	122.510598462327	67	4.12236956278294e-05
ya5Jlh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	122.553076025911	68	5.62766470720491e-05
ya5Jlh	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	IDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0990038220896823	68	1
ya5Jlh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int.imputed.txt_snps.txt	Maximum likelihood	120.951708212983	68	8.23185774380176e-05
ya5Jlh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int.imputed.txt_snps.txt	MR Egger	117.085660711452	67	0.000149400970253505
ya5Jlh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	120.9517560488	68	8.23176486603184e-05
ya5Jlh	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	IDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.133267933947684	68	1
ya5Jlh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int.imputed.txt_snps.txt	Maximum likelihood	91.7693403008186	66	0.0197028993703167
ya5Jlh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int.imputed.txt_snps.txt	MR Egger	91.6135151747022	65	0.0165098036476701
ya5Jlh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	91.8751271833824	66	0.0193516134906132
ya5Jlh	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	IDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.934364470537676	66	1
yCirKJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	123.942888127296	79	0.000932632652444176
yCirKJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int.imputed.txt_snps.txt	MR Egger	122.168046563809	78	0.0010367220793918
yCirKJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	123.998763542295	79	0.00092223932241003
yCirKJ	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.144235303321082	79	1
yCirKJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	136.086169669838	79	6.99184961576086e-05
yCirKJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int.imputed.txt_snps.txt	MR Egger	133.863607885856	78	8.60419596816215e-05
yCirKJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	136.11417518853	79	6.94782651210458e-05
yCirKJ	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.252458862375481	79	1
yCirKJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	103.435972346959	75	0.0164681690989912
yCirKJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int.imputed.txt_snps.txt	MR Egger	103.445211618767	74	0.013510951583142
yCirKJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	103.462267499341	75	0.016397060932619
yCirKJ	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.22726483118599	75	1
YmYMDU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	87.4239672732427	58	0.00752045546380882
YmYMDU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int.imputed.txt_snps.txt	MR Egger	87.3959262493761	57	0.00592511357235776
YmYMDU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	87.4264485627745	58	0.00751680497578139
YmYMDU	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.0635720813237452	58	1
YmYMDU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	78.3452611455621	58	0.038788533352356
YmYMDU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int.imputed.txt_snps.txt	MR Egger	77.0221256179978	57	0.0398171664172301
YmYMDU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	78.3565050911496	58	0.0387166780096677
YmYMDU	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.108353942202274	58	1
YmYMDU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	69.740678229204	57	0.119832894651167
YmYMDU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int.imputed.txt_snps.txt	MR Egger	69.7629643064828	56	0.102245234943057
YmYMDU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	69.8179716811581	57	0.118573205328828
YmYMDU	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_LDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.805924908766783	57	1
YxAnkc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	135.511336320989	89	0.00109292274258921
YxAnkc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	135.302638964321	88	0.000898313898570455
YxAnkc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	135.57544612166	89	0.00107967971584119
YxAnkc	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.184469525645456	89	1
YxAnkc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	131.043850491382	89	0.00250088645743433
YxAnkc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	130.785249905802	88	0.00210237821800018
YxAnkc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	131.109264968846	89	0.00247153513623357
YxAnkc	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	0.227475375544288	89	1
YxAnkc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int.imputed.txt_snps.txt	Maximum likelihood	103.500079496845	86	0.0962301179437999
YxAnkc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int.imputed.txt_snps.txt	MR Egger	103.477913558514	85	0.084391926505445
YxAnkc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int.imputed.txt_snps.txt	Inverse variance weighted	103.512189045082	86	0.0960909099474735
YxAnkc	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_TG_int.imputed.txt_snps.txt	Unweighted regression	1.6539741186754	86	1
YZj9Bd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	123.306525450892	86	0.00519016863449673
YZj9Bd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	123.220577195718	85	0.00427206614055573
YZj9Bd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	123.306640835328	86	0.00519006490125519
YZj9Bd	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	S_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.139627154485872	86	1
YZj9Bd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	124.85431088888	86	0.00395828297727433
YZj9Bd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	124.854328341798	85	0.00319089985864122
YZj9Bd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	124.854328690373	86	0.00395827051298836
YZj9Bd	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	S_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	0.229591206900034	86	1
YZj9Bd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int.imputed.txt_snps.txt	Maximum likelihood	91.127581806736	84	0.278874400310316
YZj9Bd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int.imputed.txt_snps.txt	MR Egger	89.7734990469709	83	0.286547448482087
YZj9Bd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int.imputed.txt_snps.txt	Inverse variance weighted	91.2357760823087	84	0.276226656284568
YZj9Bd	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	S_VLDL_CE_int.imputed.txt_snps.txt	Unweighted regression	1.26552625077445	84	1
Z5tFXH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	78.7051149772778	58	0.0365452886630383
Z5tFXH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	78.7810848388632	57	0.0295927161341123
Z5tFXH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	78.8125813300783	58	0.0358975786323404
Z5tFXH	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0679445521065695	58	1
Z5tFXH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	62.4495302148346	58	0.321117288364638
Z5tFXH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	62.4240814626592	57	0.289533287965281
Z5tFXH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	62.499070070671	58	0.319552480110611
Z5tFXH	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.102361715377249	58	1
Z5tFXH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Maximum likelihood	84.3314908283186	56	0.00852605189355091
Z5tFXH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	MR Egger	81.5407467241667	55	0.0115664679508722
Z5tFXH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Inverse variance weighted	84.4961450130634	56	0.00825459418821385
Z5tFXH	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_FC_pct_int.imputed.txt_snps.txt	Unweighted regression	0.745941675698924	56	1
zdZw2I	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	87.2748187781887	62	0.018907985914137
zdZw2I	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	87.2003983069342	61	0.0155100069464599
zdZw2I	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	87.2865612573675	62	0.0188691749873183
zdZw2I	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0671132478327411	62	1
zdZw2I	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	76.5431841501583	62	0.101196904698477
zdZw2I	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	76.2945260860827	61	0.0896923062732024
zdZw2I	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	76.566913420083	62	0.100869419251014
zdZw2I	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0999545800262486	62	1
zdZw2I	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	60.3381036188965	61	0.499874248793962
zdZw2I	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	60.4577290079631	60	0.45916139958132
zdZw2I	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	60.4577297833957	61	0.495528885472958
zdZw2I	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XS_VLDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.537703924651998	61	1
ZgV1jN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	70.6862758642017	53	0.0525910442729915
ZgV1jN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	70.5333919208415	52	0.0444493729517772
ZgV1jN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	70.7337236249472	53	0.0521835168391091
ZgV1jN	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	L_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.0600676863353016	53	1
ZgV1jN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	76.583994230925	53	0.0187017726061784
ZgV1jN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	76.6001595446379	52	0.0148338939372482
ZgV1jN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	76.6074116407759	53	0.018620327222438
ZgV1jN	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	L_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.105749602368349	53	1
ZgV1jN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int.imputed.txt_snps.txt	Maximum likelihood	61.0896957409171	50	0.135281362655497
ZgV1jN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int.imputed.txt_snps.txt	MR Egger	58.2858091329139	49	0.170812969760247
ZgV1jN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int.imputed.txt_snps.txt	Inverse variance weighted	61.0948595585013	50	0.135183150011668
ZgV1jN	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	L_LDL_PL_pct_int.imputed.txt_snps.txt	Unweighted regression	0.568531662482105	50	1
Zhp1Tt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int.imputed.txt_snps.txt	Maximum likelihood	106.381382629262	72	0.00525350225380525
Zhp1Tt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int.imputed.txt_snps.txt	MR Egger	106.139243194127	71	0.00437734576093142
Zhp1Tt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int.imputed.txt_snps.txt	Inverse variance weighted	106.390620954366	72	0.00524451118984574
Zhp1Tt	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	Total_FA_int.imputed.txt_snps.txt	Unweighted regression	0.103437173276083	72	1
Zhp1Tt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int.imputed.txt_snps.txt	Maximum likelihood	100.88838509613	72	0.0139557082228592
Zhp1Tt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int.imputed.txt_snps.txt	MR Egger	99.6517298694628	71	0.0140813567233156
Zhp1Tt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int.imputed.txt_snps.txt	Inverse variance weighted	100.889276981751	72	0.0139535909661414
Zhp1Tt	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	Total_FA_int.imputed.txt_snps.txt	Unweighted regression	0.146613567634894	72	1
Zhp1Tt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int.imputed.txt_snps.txt	Maximum likelihood	82.4829392709091	67	0.0962737586630525
Zhp1Tt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int.imputed.txt_snps.txt	MR Egger	82.1827573896989	66	0.0862097308098561
Zhp1Tt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int.imputed.txt_snps.txt	Inverse variance weighted	82.4835358451157	67	0.0962660982241289
Zhp1Tt	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	Total_FA_int.imputed.txt_snps.txt	Unweighted regression	0.77918792235416	67	1
zm6kQn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	125.560905780023	77	0.000397898776657992
zm6kQn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	125.609940145965	76	0.000300058242467328
zm6kQn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	125.697627145018	77	0.000386552544262081
zm6kQn	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.107009319477407	77	1
zm6kQn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	115.049481390936	77	0.00324481930170376
zm6kQn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	114.709055696328	76	0.00274708283845768
zm6kQn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	115.11682118944	77	0.00320414025202275
zm6kQn	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.15253204226003	77	1
zm6kQn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int.imputed.txt_snps.txt	Maximum likelihood	87.6162411657092	75	0.151229492549241
zm6kQn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int.imputed.txt_snps.txt	MR Egger	87.6183239780644	74	0.133212176613796
zm6kQn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int.imputed.txt_snps.txt	Inverse variance weighted	87.701966289691	75	0.149755573390814
zm6kQn	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_VLDL_FC_int.imputed.txt_snps.txt	Unweighted regression	0.934772256013191	75	1
zo84lA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	128.380385512971	90	0.00493094788561729
zo84lA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int.imputed.txt_snps.txt	MR Egger	128.3853572808	89	0.00400797144839554
zo84lA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	128.387795106589	90	0.00492470928152566
zo84lA	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.0979846075133301	90	1
zo84lA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	140.246133437452	90	0.000555708694779821
zo84lA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int.imputed.txt_snps.txt	MR Egger	139.165262388176	89	0.000538158685996096
zo84lA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	140.246232023713	90	0.000555697930083528
zo84lA	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.152748593725034	90	1
zo84lA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int.imputed.txt_snps.txt	Maximum likelihood	95.6617027851367	87	0.246294744251789
zo84lA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int.imputed.txt_snps.txt	MR Egger	83.1279396380311	86	0.567681866504403
zo84lA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int.imputed.txt_snps.txt	Inverse variance weighted	95.6822909123267	87	0.24583331245368
zo84lA	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_HDL_C_int.imputed.txt_snps.txt	Unweighted regression	0.67382462779449	87	1
zstBYI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	178.92283509434	101	2.87615964583483e-06
zstBYI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int.imputed.txt_snps.txt	MR Egger	178.94249525012	100	2.11055254802284e-06
zstBYI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	178.944401633402	101	2.86195038033815e-06
zstBYI	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	XL_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.161412118394573	101	1
zstBYI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	147.750675220755	101	0.00168686101422587
zstBYI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int.imputed.txt_snps.txt	MR Egger	147.776165927839	100	0.00135413654748721
zstBYI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	147.792674792748	101	0.0016744078585325
zstBYI	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	XL_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.181945004919155	101	1
zstBYI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int.imputed.txt_snps.txt	Maximum likelihood	118.635971952519	95	0.0507509201377642
zstBYI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int.imputed.txt_snps.txt	MR Egger	118.602494629549	94	0.0440309044866587
zstBYI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	118.764325256657	95	0.0499180158312898
zstBYI	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	XL_HDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.877333047156927	95	1
zUhgqk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	82.4918484730143	54	0.00753753771068179
zUhgqk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int.imputed.txt_snps.txt	MR Egger	78.9121409274489	53	0.0120035506986765
zUhgqk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	82.5444650274607	54	0.00745821593498132
zUhgqk	ebi-a-GCST006464	Endometrial cancer || id:ebi-a-GCST006464	M_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.090796334385302	54	1
zUhgqk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	89.8314415249553	54	0.0015860789062522
zUhgqk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int.imputed.txt_snps.txt	MR Egger	88.1514764037098	53	0.00173283387203058
zUhgqk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	89.8660769706126	54	0.00157386100028894
zUhgqk	ebi-a-GCST006465	Endometrial cancer (endometrioid histology) || id:ebi-a-GCST006465	M_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.143008838800385	54	1
zUhgqk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int.imputed.txt_snps.txt	Maximum likelihood	53.9340267634211	51	0.362838412014989
zUhgqk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int.imputed.txt_snps.txt	MR Egger	54.0556929848942	50	0.322260593486103
zUhgqk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int.imputed.txt_snps.txt	Inverse variance weighted	54.0862694160107	51	0.357415202756403
zUhgqk	ebi-a-GCST006466	Endometrial cancer (Non-endometrioid histology) || id:ebi-a-GCST006466	M_LDL_L_int.imputed.txt_snps.txt	Unweighted regression	0.61453952499043	51	1
